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Abstract 
Honey is an old remedy recently rediscovered as a possible alternative to modem 
antibiotics in wound management but its mode of action is not fully understood. The 
antibacterial activity of honey can be divided into hydrogen peroxide and non-hydrogen 
peroxide-derived activity. This later type of activity is characteristic of honeys from 
Australasia (e. g. manuka honey) and preferred for wound management, although 
historically local honeys have been used. The main aim of this study was to investigate 
the mechanisms of antibacterial action of manuka honey. The stability of antibacterial 
action of manuka honey under different conditions was determined, it was observed that 
manuka. honey lost its antibacterial activity when pH was increased and that it remained 
the same with heating. Storage seemed to increase the potency of manuka honey. The 
effects of honey on Staph. aureus and Pseud. aeruginosa, were investigated using 
MIC/MBC detenninations, time-kill studies, commitment to death, resistance training, 
electron microscopy, effects on respiration rates, leakage of intracellular material, and for 
Staph. aureus the proteome of treated and non-treated cells were compared. It was 
observed that the effect of manuka honey on Gram positive and Gram-negative cells is 
different. Gram-positive bacteria had a lower MIC than Gram-negative bacteria, but the 
time-kill experiments and the commitment-to-death showed that Gram negative were 
inhibited more rapidly. Clinical strains of both bacteria showed different time-kill profiles 
to type strains. The methodology used for MIC determination was found to affect to the 
results obtained. No honey-resistant Gram-positive bacteria were recovered, but Gram- 
negative bacteria were found to be able to become phenotypically resistant to manuka 
honey. Electron microscopy showed that honey inflicted physical damages in both types 
of cells, and in Gram-positive bacteria led to an increase in the proportion of population 
of cells with a complete septum. Gram-positive cells incubated in honey increased their 
endogenous respiration rate whilst this was decreased in Gram-negative, major leakage 
was observed in Gram-negative bacteria whilst only minor leakage was observed in 
Gram-positive bacteria, which is consistent with the amount of damage observed with 
electron microscopy. The proteome analysis of Staph aureus, revealed a general down 
regulation of protein synthesis. Thirty Portuguese honeys were assayed for their 
antibacterial activity and honeys derived from Lavandula stoechas (lavender) were found 
to possess non-peroxide activity. A selection of manuka honeys was screened for 
antimicrobial producing bacteria. In total 106 bacteria were recovered (85% were 
identified as Bacillus sp. ) and of those, 76 were capable of inhibiting the growth of at 
least one strain of bacteria tested, meaning that some of the antibacterial activity in 
manuka honey could be due to the presence of antimicrobial agents of bacterial origin. 
The antibacterial activity of manuka honey has previously been claimed to be due to 
hydrogen peroxide production and not to a non-peroxide source of activity. A study of 
free radical production and antioxidant potential demonstrated that manuka honey did not 
produce any hydroxyl radicals via the Fenton reaction. Thus hydrogen peroxide could not 
be present It was also observed that even free radical-producing honeys were able to 
quench radical production in vitro. In conclusion this study has demonstrated that the 
non-peroxide activity of manuka honey is not exclusive to Australasia honeys, that it is 
not derived from hydrogen peroxide generation and may have a microbial origin. 
Furthermore the action of manuka honey on Gram-negative bacteria seems to be more 
physical than in Gram positive where it appears to interfere with the cell physiology, 
perhaps by stopping the cell cycle before cytokinesis. 
15 
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1. Honev and healint! 
1.1 History of the use of honey in Medicine 
20 cm ii-ý 
Today honey is mainly known for its sweetening capacity and as a desirable natural 
food product, however it has not always been so. In ancient communities it was 
regarded as an important medical treatment for all kinds of health problems (Molan 
1992; Zaghloul et al. 2001). 
Honey and other bee products have been important to Mankind for many millennia, 
where it has been used by man either for food, or for medical purposes. Consequently 
bees gained a near sacred place in some religions. It is difficult to be accurate about 
when the relation between Man and bee first started, but since Man started to express 
himself through cave paintings, bees are pictured and the act of honey hunting 
depicted (Figure 1). The Bible, the Hebraic religion, the Koran and the Hindu sacred 
texts refer to honey as the life nectar, and the bees that make it are sacred and must be 
protected (Apimondia 2001; Crane 2001). 
Figure 1. Honey hunters (Crane 2001), reproduced here with the permission from 
International Bcc Rescarch Association. 
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In the Hebrew religion the Promised Land is described as "a country, which abounds 
in olive oils and in honey", while in the Koran it states that "... your Lord inspired the 
bee ( ... ) it brings out from its entrails a liquid of various colours, where remedy 
for 
Man is ( ... )". The Christian Bible contains at least 21 references to honey or bees. In 
the Hindu religion there is the belief that life fed on honey and milk can be extended 
by 500 years (Apimondia 2001) 
1.1.2 Egyptians/ Sumerians 
For many centuries, honey was the only sweetening agent available in Europe and 
although most people regard honey as merely a food product and think of its 
medicinal application as a relatively new concept, the reality is that references to its 
uses in Medicine began at least 4000 years ago (Jones 2001). 
The first written records referring to the use of honey in medicine date back to 2000 
B. C to Sumerian clay tablets where there was a description of the use of honey as an 
ingredient for ointments to be used in wound infections (Jones 2001). References to 
honey's healing properties and its use in Medicine are found in Old Egyptian papyrus, 
the best known being the Smith Papyrus, found in Ebers, that dates to 1800 B. C, a 
document describing diagnosis and treatment procedures for several ailments (Molan 
1992). Honey used to be added to other ingredients, like olive oil, animal fat, herbs 
and essential oils, or used on its own for the treatment of many different types of 
ailments that ranged from stomach problems, infected wounds, oplithalmologic 
problems to energy tonic and beauty ingredient, among many others (Figure 2). 
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Honey and the honeybees were of such importance to the ancient Egyptians that one 
of the symbols of the kingdom of Lower Egypt was a honeybee, signifying the 
importance that this society gave to this animal (Ransome 1986). 
iv 
Figure 2. Bee-keeping in Ancient Egypt. Relief shows cylindrical hives made of clay. 
(Tomb of Pabasa) in Hamad Medical Corporation website (www. hmc. org. qq). 
Its use is also mentioned in ancient Babylonian texts for rubbing on skin, ophthalmic 
remedies, illnesses of the ear and in gynaecology. Its use has also been described in 
Affican tribes as a laxative, to help lower fever, as a remedy against snakebites, and to 
combat inflammation and infections. Furthermore, the Masai tribe warriors 
recognised. its powers to increase strength, most likely due to its sugar content 
(Apimondia 2001). 
1.1.3 Greeks and Romans 
References to the use of honey are also found in literature dating back to ancient 
Greece and the Roman Empire (Zumla and Lulat 1989). 
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Beekeeping dates back to at least 3400 B. C. in the Greek civilisation, with 
archaeological remains of hives discovered in Phaistos. Several well-known 
physicians and philosophers like Democrit of Abderos, Zenos and Pythagoras claimed 
that their longevity was due to their consumption of honey and honey drinks, a fact 
that is also claimed nowadays when in a Russian census the majority of Russia's 
oldest people were found to be beekeepers that consumed products from the beehive 
on a regular basis (Norris 1970). Furthermore, Hippocrates, today considered the 
father of Modem Medicine, recommended it for the treatment of a number of 
conditions, including stomach and ophthalmologic problems. Honey was also one of 
the ingredients of the food of the Gods (ambrosia) and was the preferred energy tonic 
of the athletes that competed in the Olympic games (Apimondia 2001). 
In the Roman Empire, beekeeping was continued as done in Ancient Greece, with 
records of it being described by Virgil and by Plinius (Pliny) The Elder. Again honey 
was recommended for the treatment of wounds, but as a topical agent in conjunction 
with fish liver oil (Apimondia 2001). It also remained a revered product for use in 
religious ceremonies (Apimondia 2001). 
1.1.4 Middle Ages and Renaissance 
All of these uses of honey continued through the Middle Ages (Figure 3), not only in 
human medicine, but also in veterinary medicine to treat wounds in farm animals 
(Jones 2001; Clewlow 2004). 
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Figure 3. Dioscorides, De Materia Medica, 15th c. Iviron Monastery, Mount Athos, 
Greece. (B) Illustration from De Materia Medica of Dioscorides, Baghdad, AD 1224 
Paulus Aegineta, (607-690) described in his work "Epitome" (summarized medical 
knowledge after Galen) the use of cooked honey as an astringent, and raw honey was 
used to clean wounds (Forrest 1982). Ambroise Parý (1510-1590) a French surgeon to 
four successive kings and a famous military surgeon described several different 
treatments for wounds, among which he advised the use of a dressing impregnated in 
a salve composed among other things of rose honey (Dealey 2004). 
1.1.5 Modern Times 
Honey was used in this way until the beginning of the 20th century, e. g. in World War 
I honey was part of the combat gear (Bergman et aL 1983). With the advent of Sir 
Alexander Fleming's discovery of the existence of antibiotics, honey was gradually 
relegated to Folk Medicine, and was no longer seen as suitable for use in modem 
medicine. The dismissal of honey from mainstream medicine was mainly due to the 
fact that its application was based on empirical knowledge, people knew that it 
worked but they did not know how or what were the mechanisms involved in its 
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effectiveness (Molan 2001b). Nurses that underwent training in British hospitals in 
the 1970s still used honey regularly for its debriding action rather than as an 
antimicrobial agcnt (Robson 2005). 
The first record of antibacterial activity in honey dates back to Van Ketel in 1892 
(Dustman 1978) and research into the characteristics continued intermittently during 
the 20t" century. However it was not until the 1980's that interest in the healing 
properties of honey was rekindled and clinical research began again. 
1.2 The characteristics of honey 
Honey is the product of the honeybee's processing of the nectar or honeydew from 
flowering plants. Nectar is a sugar solution produced by the glands of flowers (the 
nectaries) that has functions in the attraction of insects and birds to visit the flower to 
allow cross-pollination. Once the honeybee collects the nectar it is transported back to 
the hive in the bee's nectar sack where it undergoes several transformations. When the 
bee arrives in the hive the nectar is transferred to the honey sac of a worker bee that 
will be responsible for taking it into the honeycombs. Here there will be a series of 
regurgitations and ingestions, whereby the bee will add some enzymes to the nectar 
and moisture content is reduced. The honey produced from honeydew (a sugar 
solution excreted by insects from the order Rhynchota) (Crane 1975) has different 
characteristics to nectar honey as it already contains enzymes added by the insect. 
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1.2.2 Chemical characteristics 
Honey is a complex substance, made up of at least 181 different substances known at 
present, (Jones 2001; White, Jr. et al. 1963); with some researchers believing that the 
number is actually closer to 600 different substances (Bogdanov et al. 2004). 
i Average composition of honey (%) 
0,57% 
Figure 4. Average chemical composition of honey (% by weight). 
Honey is a saturated or supersaturated sugar solution, meaning that it possesses a high 
concentration of sugar (with approximately 17% water on average) (Fig. 4). There are 
15 different sugars in honey. The main sugars present in honey are fructose (an 
average of 38%), glucose (-31%) and disaccharides like maltose (7.3%) and sucrose 
(1.3%), and higher sugars (1.5%) (White, Jr. 1979). The level of sucrose can be 
increased by over-feeding the bees with sugar during spring (Anklam 1998). The 
presence of fructose and glucose in honey is due to the action of the bee enzyme 
invertase on the sucrose molecules contained in nectar, producing a ratio between 
glucose and fructose of 1.2: 1 (Anklam 1998). Starch has also been recovered from 
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honey, and this is solely a product of the processing of the nectar, as it is not present 
in the raw nectar. 
Honey is also rich in organic acids, with at least 30 different organic acids being 
recovered from this product, among the most common are gluconic acid, acetic acid, 
citric acid, lactic acid, succinic acid and formic acid (Mato et al. 2003). These acids 
are the results of the action of enzymes like glucose oxidase on the sugars present in 
honey and makeup an average of 0.50% of the honey by weight (Crane 1975; Mato et 
al. 2003). The organic acids present in honey are believed to contribute to the 
organoleptic properties such as flavour and colour as well contributing to physical and 
chemical characteristics such as pH, acidity and electrical conductivity (Mato et al. 
2003; Suarez-Luque et al. 2003). 
In the 1930s citric and malic acid were thought to be the predominant acids in honey, 
but in 1960 gluconic acid was shown to be the predominant form. This organic acid is 
derived from two sources, the action of the enzyme glucose oxidase and the metabolic 
activity of certain Glucobacter spp bacteria (present in the bee's gut). The 
concentration of this organic acid depends on the time needed for the manufacture of 
the honey, strength of the bee colony and the quality of the nectar to be transformed. 
Other organic acids are either intermediates of the Krebs cycle or products of 
enzymatic pathways, and as such can differ significantly from honey to honey. Hence 
variations in the organic acids present in honey, can be used as indicators of 
deterioration, authenticity and purity (Mato et al. 2003). 
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Another important characteristic of honey is its low pH, the normal pH ranges 
between 3-6. This acidity is thought to be caused by the presence of the different 
organic acids in the honey, and is one of the factors limiting the growth of 
microorganisms (Ceyhan and Ugur 2001). 
Honey possesses a low amount of nitrogen (0.041% w/v) that is part of proteins, 
enzymes and free amino acids. The amount of nitrogenous compounds present in 
honey may affect its characteristics; the high protein concentration (2% w/v) in 
heather honey, for example is responsible for its viscous characteristics. Estimation of 
protein in honey by the volume of precipitate with tannin has been used in the past to 
distinguish between honey and artificial blends (White, Jr. and Rud)j 1978). The 
presence of enzymes in honey is important, as these aid the transformation of the 
nectar into honey, some of the most common enzymes recovered in honey are 
invertase, catalase, phosphatase, glucose oxidase and diastase (Crane 1975). 
The mineral component of honey is referred to as the ash portion and makes up about 
0.1% of all the components in honey. Ash is more abundant in darker honeys and 
monofloral honeys tend to have lower ash content (Crane 1975). Potassium makes up 
around half of the total ash content in honey, and other minerals found are calcium, 
copper, sodium, magnesium, manganese and chlorine salts. Another 30 different 
mineral complexes may be used to determine floral origin of the honeys as they are 
characteristic for each plant (Anklam 1998). 
Honey contains trace amount of vitamins, flavonoids, antioxidant components and 
unidentified plant derived elements (phytochemical components) (Sato and Miyata 
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2000). It also possesses trace amounts of other beehive products like propolis, royal 
jelly and wax of which the first two are recognised as antimicrobial agents as well 
(Anklam 1998). 
The actual chemical profile varies considerably from honey to honey, depending upon 
the floral origin of the nectar and even on the year and time of year in which the 
honey is collected (White, Jr. and RudA 1978). The type of bee producing the honey 
also changes its chemical characteristics (DeMera and Angert 2004), and there are 
certain chemical markers that are used to determine if the honey is authentic (that is if 
it has been altered in any way, like the addition of extra sugar or water), like protein, 
moisture, sugar, and hydroxyrnethylfurfural (HMF) content (Mateo and Bosch-Reig 
1998). HMF is a product of sugar breakdown in honey as a result of heating or 
storage, so this substance is useful to determine if the honey was heat processed or 
aged. 
Usually honeys used for medical purposes, since the first recordings, tended to be 
local honeys that were produced mainly from the nectar collected from one 
predominant flower source. Analysis of the pollen content of honey is mainly used to 
determine the predominant floral species that the bee has foranged, however as the 
composition of honeys is further characterised chemically, other markers, like specific 
proteins or organic acids are being used for honey classification (Ferreres et al. 1996; 
Mato et al. 2003; White, Jr. and Rud)j 1978). Unifloral honeys are largely derivecd 
from a single floral source and useful because their characteristics can be better 
defined than those of honeys that come from more than one floral source (multifloral 
do not demonstrate a predominant floral source when the pollen is analysed). 
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1.2.1 Physical characteristics 
Honey is a supersaturated sugar solution with a high osmolarity (Wahdan 1998); it 
will exert a high osmotic pressure on bacteria because water molecules will be largely 
bound to sugar molecules, making them unavailable for the growth of most 
microorganisms (one of the reasons why honey is not easily spoiled) (Ceyhan and 
Ugur 2001). Hence honey has a broad spectrum antimicrobial activity. 
Honey is usually a viscous substance (viscosity ranges from 3.10 poise for alfalfa 
honey to 4.11 poise for sumac honey), varying with the temperature at which it is 
measured (Crane 1975; White, Jr. et al. 1963). This is due to its high sugar 
concentration and protein profile (Apimondia 2001), which gives it properties that 
make it desirable for use in the topical treatment of infections. It will act as a barrier 
when applied to wounds (Molan 2001a), protecting the wound from external 
contamination, as well as limiting the release of microbes. 
Other physical characteristics that can help in the identification of the different honey 
types are colour (colours range from white to almost black), the thennal conductivity 
(helps distinguish between floral and honeydew honeys) and hygroscopicity (the 
capacity of each honey to absorb humidity) (Crane 1975). 
1.3 Manuka honey, a unique product 
Throughout history, physicians have selected certain honeys for medicinal purposes 
from those locally available. Honeys from different geographical locations and 
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different floral origins are now known to have different antibacterial activities (Al- 
jabri et al. 2003a; Allen et al. 1991; Ceyhan and Ugur 2001; DeMera and Angert 
2004; Molan et al. 1988; Taormina et al. 2001). Manuka honey (from Leptospermum 
scoparium) is one such product. 
Today it is understood that the antibacterial activity of honey is multi-factorial, as it 
depends on the action of different components present in the honey, and that these 
vary from honey to honey. High sugar concentration, low water content and low pH 
prevents the growth of many bacteria, but does not fully account for the total 
antimicrobial activity seen in some honeys. Additional activity may be due to the 
formation of hydrogen peroxide by the breakdown of the glucose present in the honey 
by the action of the enzyme glucose oxidase (present in bees' guts). This enzyme is 
introduced into honey by the bee during the nectar processing and converts glucose 
into gluconic acid and hydrogen peroxide upon dilution of the honey (Bang et al. 
2003). When honey is undiluted, little or no hydrogen peroxide production occurs; 
this seems to be due to the inhibition of the glucose oxidase activity, and has been 
suggested not to be due to components in the honey but to the low pH, (Bang et al. 
2003) or to high substrate concentration. When honey is diluted, levels of hydrogen 
peroxide released depend on the concentration of catalase in honey (enzyme capable 
of destroying hydrogen peroxide) and the amount of time, since kinetics of hydrogen 
peroxide production have been shown to reach a peak and decline with time (Bang et 
al. 2003). 
It had been observed that some honeys possessed an antibacterial compound sensitive 
to light and heat, and this compound was termed inhibine. This was later identified as 
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hydrogen peroxide, and the activity derived for the action of this substance on 
microbial cells was termed hydrogen peroxide-derived activity. Slow release of 
hydrogen peroxide at low concentration when some honeys are diluted inhibits 
microorganisms without damaging human cells and tissues (White, Jr. et al. 1963). 
A survey of 345 New Zealand honeys (which included manuka honeys from 
Leptospermum scoparium) used an agar diffusion assay for measuring antimicrobial 
activity in diluted honeys (diluted in water for determination of hydrogen peroxide- 
derived activity and in catalase solution for non-hydrogen peroxide-derived activity) 
and comparing them to known phenol standards. Most honeys in this study exhibited 
some type of antibacterial activity and 38% of manuka samples and 25% of viper's 
bugloss samples demonstrated non-hydrogen peroxide-derived activity (Allen et al. 
1991; Jones 2001). The inference from these observations is that certain honeys 
contain antimicrobial factors in addition to sugar content, low pH and hydrogen 
peroxide generation. 
It is thought that non-hydrogen peroxide activity may be due to plant derived 
components such as flavonoids and phenolic compounds, but at the moment no 
identification has been achieved, although some researchers have been able to define 
one of its characteristics: it seems to remain in the acidic fraction of the honey and be 
destroyed by an increase in pH (Bogdanov 1997). 
In order for honey to be accepted as an alternative to antibiotics, it is necessary to 
characterise the components that are responsible for its activity. Although several of 
the major components of the antibacterial activity of honey are known, like the sugar 
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concentration, pH and hydrogen peroxide, these do not account for the total 
antibacterial activity observed in many honeys. Part of the problem with the 
identification of antibacterial components is the complexity of honey itself and the 
possible interaction between the different substances that comprise it. Also, each 
honey type possesses different characteristics due to the differences in composition. 
At present non-hydrogen peroxide honeys derived from Leptospermum species (such 
as manuka in New Zealand and jellybush in Australia) are being developed for 
clinical use (Cooper 2005b; Cooper et al. 1999; Cooper et al. 2002c). 
Today, there are already 3 honey-based products on drug tariff in the UK. The first 
was licensed in March 2004, Activon TullJ, from Advancis Medical (Notingharn, 
UK). It is a tulle dressing impregnated with manyka (Leptospermum scoparium) 
honey. Since the introduction of this product two more have been introduced into the 
UK: Mesitrano from Medlock Medical (Oldham, UK) which consists of a range of 
products that contain at least 20% of medical grade honey and Medihoney Wound 
Gellý from Medihoney (Reading UK). Medihoney contains predominatly Australian 
jellybush (Leptospermum polygalifolium) honey. Yet within Europe and the world 
many more honey-based products are being developed for clinical use like 
HoneySoO (MediProf), Melmaxe (Dermagenics, Netherlands), ApiNatJ and 
Manuka Care 18+0 from Comvita (New Zealand). A range of products from Bfactory 
(Wageningen, Netherlands) which include Revamillý (hydrophilic gel for chronic and 
infected wounds), Hypogeen'ý (ointment for superficial wounds), Vetramyl'ý' (Honey 
based ointment for veterinary use), Honeyfeel"o (range of honey based products for 
dry or irritated skin), DermasilO (honey based cream for irritation and minor wounds 
caused by eczema) and Revamilfemo (pure honey product to restore the vaginal pH 
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and the natural vagina flora). Besides the products currently available in the UK on 
drug tariff it is also possible to buy honey for medical purposes in supermarkets or 
over the counter in health food shops in the form of tubes of sterilised honey and raw 
honey. 
The majority of the medical products based on honey available in the UK use 
Leptospermum sp. honeys, therefore this thesis concentrates on manuka honey derived 
from Leptospermum scoparium. This honey has been demonstrated to possess a wide 
range of antimicrobial activity, being effective against Gram positive and negative 
bacteria (Al-Jabri et al. 2005; Al-Waili 2005; AIjadi and Yusoff 2003; Alnaqdy et al. 
2005; Badawy et al. 2004; DeMera and Angert 2004; French et al. 2005; Gulati et al. 
1996; Henriques et al. 2005; Jeddar et al. 1985; Lusby et al. 2005; Molan et al. 1988; 
Mundo et al. 2004; Temnov 1944; Wilkinson and Cavanagh 2005; Willix et al. 1992; 
Al Waili and Saloom 1999; Alsomal et al. 1994; Cooper and Molan 1999; Cooper et 
al. 1999; Cooper et al. 2000; Cooper et al. 2002a; Cooper et al. 2002c; English et al. 
2004; McGovern et al. 1999; Natarajan et al. 2001), yeasts and dermatophytes (Al 
Waili 2004a; Brady et al. 1996; Al-Waili 2005), viruses (Al Waili 2004b) and 
parasites (Zeina et al. 1997). 
1.4 Honey and the search for new antimicrobial agents 
When antibiotics were first discovered, they were regarded as the cure for all 
infections. For some time this seemed to be the case, with deaths from infection 
drastically being reduced, but early on there were some danger signs with the first 
penicillin resistant bacteria, more precisely Staphylococcus aureus, being isolated in 
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1944 by Kirby and by the 1950's penicillin resistance was already common in UK 
hospitals (Gosbell 2003). In order to fight the emergence of penicillin resistance, 
semisynthetic penicillins were introduced in the UK, the first being benzy1penicillin 
followed after by methicillin in 1959 but this was soon followed (1980s) by reports of 
methicillin resistance (Greenwood 2000; Perez-Roth et al. 2001) and when 
vancomycin was introduced to everyday practice, as an antibiotic of last resort, 
reports soon followed about the emergence of resistance to this as well in 1998 
(Gosbell 2003; Schmitz et al. 2000). Within one year of the approval of 
oxazolidinones (a new class of synthetic antimicrobials) by the FDA resistance has 
emerged, making treatment of Staphylococcus infections difficult (Schmitz et al. 
2000). 
The increasing prevalence of different antibiotic resistant bacteria in both hospital and 
community, and the decreased rate of discovery/development of new antibiotics 
(Greenwood 1995), makes the discovery of alternatives treatments necessary to 
combat resistant bacteria (Dzidic and Bedekovic 2003; Greenwood 1995; Martinez 
and Baquero 2002). 
1.4.1 Multiresistant strains or superbugs 
"Superbugs" is how the media refers to antibiotic-resistant bacteria. Although it has 
become a great concern recently to the general public, with media titles like 
"Superbug hits the healthy" (Le Page 2003) or "Superbug crackdown is launched" 
(Collignon 2002), the truth is that antibiotic-resistant bacteria always existed in nature 
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but that they were discovered soon after the introduction of antibiotics into clinical 
practice (Gosbell 2003). 
Some of the bacterial species with antibiotic resistance causing the greatest concerns 
are methicillin-resistant Staphylococcus aureus (MRSA) and multi-resistant 
Pseudomonas aeruginosa. 
There is a natural variance among all communities of living organisms, and this 
means that in a population of bacteria there will always be those which are more 
resistant to some antibiotics than others (Felmingham 2002; Normark and Normark 
2002); this phenomenon is innate resistance. When bacteria are faced with an 
antimicrobial agent, the ones that are more resistant tend to survive better than 
susceptible cells and are able to pass their characteristics onward to their progeny. 
Hence later populations of bacteria appear to have an increased resistance in 
comparison to the initial population. The process of natural selection is particularly 
effective in bacteria, and because they have short generation times, the results can be 
observed in only relative short time (Ang et al. 2004a). 
Another important factor is that bacterial cells have a high spontaneous mutation rate 
(about 10-7 per cell division) (Schmitz et al. 2000). This means that they can change 
their characteristics rapidly, thus providing a greater variation on which natural 
selection can act, which helps them to survive in ever-changing environmental 
conditions. 
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There are also mechanisms through which bacteria can acquire antimicrobial 
resistance by gene transfer from resistant cells during transduction, transformation 
and conjugation (Dzidic and Bedekovic 2003). 
The indiscriminate use of antimicrobial agents, that is their use for conditions that do 
not require their prescription, and the lack of compliance with proper treatment 
regimes, has led to the emergence by natural selection of resistant bacteria in Europe 
(Fig. 5) and around the world (Schmidt 2004). 
Figure 5. Incidence of MRSA in bacteraernias Europe during 2004 (EARSS, 
downloaded on 18-01-06). 
One of the main problems faced in the treatment of antibiotic resistant bacteria is the 
fact that some have become multi-resistant, for example vancomycin-resistant 
Slaphylococcus aureus (VRSA), so that in addition to being resistant to vancomycin 
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(a) EARSS 
resistance to methicillin, penicillin, teicoplanin, and others has been acquired 
(Schmidt 2004). Infections with these organisms are difficult to treat because the 
majority of the antibiotics available are not effective, leaving limited choice, which 
can be a problem when the tolerance of the patient has to be considered (Gosbell 
2003). 
1.4.2 Decrease in new antibiotics 
After Sir Alexander Fleming discovered penicillin in 1928, there was a pause until the 
1940s when the discovery of new antibiotics was made at a steady pace until the 
1960's. Agents such as streptomycin, tetracyclines, chloramphenicol, vancomycin, 
erythromycin and cephalosporins were discovered (Schmidt 2004). After this initial 
burst of new antimicrobial agents, came the idea that the chemical configuration of 
known antimicrobial agents could be altered in order to make them more effective and 
more tolerated by the human body. This lead to the introduction of antibiotics like 
methicillin, oxacillin, and flucloxacillin, which were derived from the penicillin 
nucleus (Rolinson 1998). 
The next step in the discovery of new antimicrobial agents was thought to be the 
analysis of bacterial genomes to identify possible targets for the design of new 
antimicrobial agents. This has so far not led to the development of new antibiotics 
directed at new microbial targets, and finding targets that are suitable for more than 
one species of bacteria is proving difficult both in time and financial terms (Lowy 
2003; Varaldo 2002). 
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Hence few new antibiotics, like linezolid, have been developed in the past decade. 
Much of the money and research time that was initially allocated by pharmaceutical 
companies to the research into new antimicrobial agents has been withdrawn or 
seriously decreased as it is no longer economically viable (Lowy 2003; Varaldo 
2002). The sequencing of bacterial pathogen genomes that heralded a new age of 
antimicrobial discovery has, as yet, not bore fruit and the amount of money involved 
in the research of molecular techniques is not proving a cost-effective investment for 
pharmaceutical companies (Lowy 2003). 
The increasing development of resistant strains seems to be fuelled as well by the 
increase in global travel, urbanization that leads to overcrowding, the use of 
inappropriate antimicrobial therapies and the use of antibiotics on animal feeds as 
growth accelerators (Schmidt 2004). All these facts have lead to a decrease in options 
for the treatment of infections caused by resistant bacteria, and thus an increase in 
mortality and morbidity. Traditional medicine might offer an alternative source of 
treatments. 
1.5 Wound care problems 
Wounds can simply be divided into two categories: acute or chronic. Acute wounds 
tend to heal with minimal medical intervention, while chronic wounds will not heal 
within predicted time frames. With an ageing population, especially in developed 
countries, there is a need to focus on the problems that this kind of population entails 
(Howell-Jones et al. 2005). One such problem is the increase in the incidence of 
chronic wounds due to a variety of factors: bad circulation, diabetes and other types of 
insufficiencies (Collier 2004). 
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One of the biggest problems in wound care is how to treat wounds infected with 
antibiotic resistant bacteria in patients that are usually fragile. The options at the 
moment are the use of antibiotics and radical surgery either for the debridment of the 
wound or amputation of the affected area. However in patients that have a fragile 
health state like the elderly these might not be viable options, thus alternatives are 
required (Eron et A 2003). However aggressive therapy is not always well received 
and compliance may be an issue. 
Undeveloped countries also face wound management problems as a result of poor 
living conditions and wars. In some these of countries where health resources are 
limited, and AIDS prevalence high, mortality due to infected wounds is high and the 
main medical resources used are those from traditional medicine as the cost of 
treatments is high and the distribution of drugs is poor (Ryan 2000). This is made 
more serious by the mobility of bacterial resistance, which has resulted in increased 
incidence of antibiotic resistance in countries where antibiotic use is not widespread. 
(Schmidt 2004). These two aspects of wound care combined show the need for 
effective, cheap alternative antimicrobial agents. 
1.5.1 Factors influencing wound healing 
There are many reasons why a wound might not progress to complete healing within 
the expected time. Conditions that affect healing times are nutritional status, diabetes, 
cardiac or respiratory insufficiency, ischaernia, infections, antimicrobial therapy, 
mobility, hydration, age, underlying illnesses and previous immunosuppressive 
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therapies, such as chemotherapy and radiotherapy. These factors will all contribute to 
the way in which the patient's body responds to a wound and will influence its 
capability for healing (Collier 2004). 
Although some may believe that if a wound has bacteria it will not heal, most wounds 
support polyrnicrobial communities (Bowler et al. 2001). The actual presence of 
bacteria may contribute to the stimulation of the immune response for a rapid wound 
healing (Edward-Jones and Greenwood 2003). Furthermore, nowadays there is an 
increasing understanding of the difference between colonization and infection. A 
wound may be colonized but not infected. Infection status will depend on many 
factors, not only on the microbiological results but also the actual symptoms 
presented, as there are species of bacteria that can exist in wounds and still allow it to 
heal (Cooper 2005c). 
Cutting and White (2005) have described the symptoms required for the diagnosis of 
an infection as being: localised erythrema, localised pain, localised heat, cellulitis, 
oederna, abscess, discharge, delayed healing, discoloration, friable and bleeding tissue 
and bad odour. 
To assess whether a wound is infected or not, besides the visual analysis samples are 
collected either by swabs or by wound biopsy and the bacteria present identified and 
quantified (Bowler et al. 2001). The interpretation of the microbiological results 
requires caution, as the species/strains of bacteria need to be identified, numbers, 
virulence and possible interactions between them need to be determined in order to 
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assess the need for antimicrobial therapy, and to be able to provide the right type of 
therapy for the situation at hand (Howell-Jones et al. 2005; O'Meara et al. 2000). 
The range of organisms that can be recovered from an infected wound is large and 
may include any number of the following: beta-haernolytic streptococci (like 
Streptococcus pyogenes), enterococci (like Enterococcus faecium or Enterococcus 
faecalis), staphylococci (like Staphylococcus aureus, MRSA or Staphylococcus 
epidermidis), Gram negative aerobic (like Pseudomonas aeruginosa) and facultative 
rods (like Acinetobacter, Enterobacter, Escherichia coli, Klebsiella, Proteus and 
Serratia species). Anaerobes are also found (usually in deeper wounds) as well as 
yeasts and fungi (Cooper et al. 2002b). This means that in most cases broad-spectrum 
antimicrobial agents are required to resolve the infection. 
Infected wounds tend to have a complex mixed population of microorganisms. This 
population is capable of forming communities, also known as biofilms, which allow 
them to thrive in the wound environment. Biofilms are three-dimensional structures of 
bacteria attached to a surface (in this case a wound bed) and encapsulated in slime 
that communicate among each other using chemical signals (quorum sensing). This 
arrangement protects them from phagocytosis and the action of antimicrobial agents, 
making their eradication more difficult (Cooper 2005c). 
1.5.3 Cost 
Since the problem with antibiotic resistance first arose, there have been increasing 
limitations on the materials that can be used for wound management. Alternatives 
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have consisted of combination therapy whereby more than one type of antibiotic is 
used so that the therapy has a broader range of action, and can effectively kill the 
maximum number of microorganisms, but this has increased costs. 
Another approach is the use of new types of wound dressing with added antimicrobial 
agents like silver, or iodine (Cooper 2004; Stewart 2002). This kind of approach has 
shown some efficacy, nevertheless, as with all new developments these products are 
expensive and not easily accessible to physicians in less developed countries, and 
even in the developed countries it requires significant cost to be supported either by 
the patient or by the health care system. 
There is an increase in the costs relating to hospital stays, as patients with chronic 
wounds or with wounds infected with antibiotic resistant bacteria tend to be 
hospitalised for longer periods (Cooper et al. 2002c). The application of new 
approaches to wound healing requires more specialised training and increased nursing 
time until the wound heals. All of these approaches require substantial financial 
commitment by the health system which must be balanced against the possible 
savings resulting from the use of new treatments, which in the case of less developed 
countries is not always possible. 
1.6 Alternative antimicrobial wound management. 
Besides honey there are other alternative antimicrobial therapies being used in wound 
management with varying success like, maggots, bacteriophage, tea tree oil, and 
antimicrobial peptides, as well as surgical debridment. 
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Maggots are an ancient form of wound management that besides allowing for the 
physical debridment of the wounds, by removing the necrotic tissue, are reported to 
promote wound healing by decreasing the microbial levels (by ingesting bacteria), 
increasing wound pH, promoting granulation and stimulating human fibroblasts. 
Nevertheless the acceptance of this therapy is sometimes an issue as some patients 
feel discomfort (Leach 2004). 
Bacteriophages are viruses that specifically target bacteria. Since the emergence of 
antibiotics the idea that they could be used as antimicrobials was ignored in most 
places except in Georgia (Carson and Riley 2003). The idea of targeting specific 
pathogens with their naturally existing "enemies" is appealing as resistance to 
conventional antimicrobial therapy increases. Nevertheless, there are concerns of the 
possible development of antiphage antibodies during therapy. The bioavailability of 
the phages may be limited during therapies as they are quickly cleared from the 
circulation by the reticuloendothelial system. The emergence of mutant phages is 
possible, and the fact that for example MRSA seems to be less susceptible to 
bacteriophage attack than the antibiotic-susceptible S aureus may restrict application 
(Carson and Riley 2003). 
The use of tea tree oil and other essential oils extracted from plants (aromatherapy) 
has been recognised for a long time. Tea tree oil has been recognised for its capacity 
to eliminate MRSA and has been considered an alternative for the treatment of 
mupirocin-resistant MRSA (Bowler et aL 2001). It has also been demonstrated to 
have a broad-spectrum of action and its mechanisms of action in vitro has been 
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elucidated for different types of bacteria like Escherichia coli, Staphylococcus aureus 
and Candida albicans (Cox et al. 1998; Cox et al. 2000; Cox et al. 2001; Gustafson et 
al. 1998; Hada et al. 2003) 
Antimicrobial peptides are molecules that occur naturally in many types of cells, 
including human neutrophils. These molecules attach themselves to bacterial cell 
walls and form pores inducing leakage of the cell contents and death. These types of 
molecules are the target of research into compounds that have a wide spectrum of 
activity and that can be formulated for use in wound management (Bowler et A 
2001). 
Surgical debridment is also considered as an option for the elimination of infection 
from a wound. It consists in the removal of the devitalised and contaminated tissue in 
the wounds and exposing healthy tissue that can proceed to healing. This can be done 
using surgery, speciality dressings or maggots (Bowler et al. 2001). 
Today conventional antibiotic therapy is no longer the solution for all cases of 
infection, and this is especially true in the case of wound management. As such 
alternatives to modem treatment options (antibiotics) may be found in traditional 
medicine remedies such as honey. It has been used for many millennia as a potent and 
effective antimicrobial agent and has recently been rediscovered for use in modem 
medicine. It is a complex chemical and physical substance that is known for its broad- 
spectrum antimicrobial action and wound healing properties. 
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Some attempts have been made to analyse the composition of honey in an attempt to 
identify the most potent antimicrobial components. Little success has been achieved, 
and to this day there is limited knowledge of the identity of components responsible 
for antimicrobial activity. Manuka honey is one of the honeys that has had been the 
object of much of the research in wound management, mainly due to its high 
antimicrobial activity. As a result many of the recently introduced wound 
management products, available on drug tariff in the UK are based on this honey. 
Although there has been more research into honey in the last 20 years that in the last 
two centuries, there are still many questions unanswered. Studies often have been 
conducted using different methodologies, making results difficult to compare; they 
usually concentrate on the effectiveness of honey, or its spectrum of antimicrobial 
action and not on the way that it is able to produce such an effect. Furthennore, 
studies with local honeys are few and once again, they tend to be done with many 
different methodologies. 
This work attempts to fill some of these gaps in our knowledge of the antimicrobial 
activity of honey. It concentrates on manuka honey, which is the base of most honey- 
based medical products currently available but includes a search for honeys in Europe 
with potential for medical use. The possibility of the inhibitory activity of manuka 
honey being derived from a microbial source, and the relation between its antioxidant 
potential and antimicrobial activity are examined. 
The need to understand the way in which manuka honey inhibits bacteria led to the 
study of the kinetics of death of common wound infecting bacteria treated with 
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manuka honey and its capacity for selecting resistant strains in the short-term. In order 
to better understand its mode of action, studies on the effects of manuka honey on 
bacterial morphology and physiology were also conducted. Despite the large numbers 
of studies that report the antimicrobial activity of honey, few have included these 
aspects. 
Therefore the general aims and objectives for each chapter can be summarized as: 
Chapter 2. To investigate the antimicrobial activity of selected Portuguese honeys 
1. To collect and characterise physicochemically selected Portuguese honeys 
2. To determine the antimicrobial potential of these Portuguese honeys 
3. To assess the non-hydrogen peroxide-derived antimicrobial activity and 
relate it to the floral origin. 
Chapter 3. To investigate the possibility of the presence of inhibitory components in 
honey derived from bacterial sources. 
1. To isolate bacteria froma range of manuka and jellybush honeys 
2. To characterise and identify isolates recovered from a range of different 
honeys 
3. To determine the potential for organisms isolated from honey samples to 
produce substances that inhibit other bacteria in liquid and solid media 
assays. 
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Chapter 4. To study of the antioxidant potential of selected honeys 
1. To detennine the superoxide quenching capabilities of a range of hydrogen 
peroxide producing and non-hydrogen peroxide producing honeys 
2. To detect the formation of hydroxyl radicals in peroxide and non-peroxide 
honeys 
3. To assess the hydroxyl radical quenching potential of a range of honeys 
4. To relate the antimicrobial activity and colour of a range of honeys to their 
free radical quenching potencial. 
Chapter 5. To investigate the kinetics of death of Staphylococcus aureus and 
Pseudomonas aeruginosa exposed to manuka honey. 
1. To characterise the antibacterial activity of a manuka honey in response to 
storage, pH, temperature and equivalence to penicillin. 
2. To determine the Minimum Inhibitory Concentrations of honeys, using a 
range of media and methods. 
3. To determine whether manuka honey possessed bactericidal activity in 
time-kill studies. 
4. To determine if bacterial cells lysc after treatment with manuka honey by 
performing total cell counts of honey-treated bacterial cultures. 
5. To determine wheter honey selects for resistant bacteria in short-term. 
6. To determine the time for commitment to death of bacteria in the presence 
ofhoney. 
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Chapter 6. To observe the effects of manuka, honey on the morphology of bacterial 
cells (Staphylococcus aureus and Pseudomonas aeruginosa) 
1. To determine changes to the suface morphology of bacterial cells using 
scaning electron microscopy 
2. To determine changes to the interior of bacterial cells using transmission 
electron microscopy 
3. To assess the difference in damage observed between exponential phase 
cells and stationary phase cells 
Chapter 7. To evaluate the physiological effects of honey on bacterial cells 
(Staphylococcus aureus and Pseudomonas aeruginosa) 
1. To assess the sensitivity of stress response and cytokinesis mutants to 
manuka honey 
2. To determine the effects of honey on the respiration rates of bacteria 
3. To assess whether bacterial energy conservation becomes uncoupled from 
electron transport processes by incubation in honey 
4. To investigate the possibility of materials being leaked from bacterial cells 
incubated with manuka honey. 
5. To characterise the changes in protein synthesis of cells incubated in 
honey. 
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11 Methods and Experiments 
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2. A survey of the antimicrobial activity of some European honeys 
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2.1 Introduction 
Yhe data presented in this chapter was published in: A Henriques, NF Burton, and 
RA Cooper "Antibacterial activity of selected Portuguese honeys " Journal of 
Apicultural Research, 44(3): 119-123,2005 
Honey, an ancient remedy rediscovered during the 1990s, is now being utilised for 
wound care in Australia (Johnston et aL 2003), New Zealand (Molan and Betts 2003) 
and in the UX (Dunford and Hanano 2004; Stephen-Haynes 2004). A range of wound 
dressings, ointments and sterile products has been developed, but most employ 
honeys with proven antibacterial activity such as manuka and jellybush, which are 
produced in Australia and New Zealand. Yet bees have been introduced in 
Australasia only relatively recently. Because recorded evidence to the use of honey as 
medicine dates back to at least 4000 years these types of honey could not be the ones 
being referred to in the Smith papyrus for example. 
Evidence from historical documents indicates that ancient people carefully selected 
honey for medicinal purposes from locally available honeys, for example Ambroise 
Par6 (1510-1590) specifically advocated the use of rose honey for the production of a 
debriding agent for wounds (Dealey 2004), Dioscorides advised the use of pale 
yellow honey from Attica for the treatment for "rotten and hollow ulcers", and 
Aristoles refers to pale honey as particularly useful for the preparation of salves for 
66sore eyes and wounds" (Molan 2000). Even today in folk medicine some honeys are 
of more value than other, like strawberry honey in Sardinia, lotus honey in India (for 
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the treatment of eye problems) and honey from the Jirdin valley in Yemen for their 
high therapeutic usefulness (Molan 2000). 
It seems probable that most countries should have honeys suitable for use as a 
medicine, whose selection for medical purposes is possible. This is a common 
practice in some undeveloped countries, but many developed countries do not utilise 
their sources. 
Previously in UWIC a survey of 139 Welsh honeys was performed for the 
determination of antibacterial potency and healing stimulation potential (by assaying 
the release of TNFa from monocytic cell line, Monomac-6). This study demonstrated 
limited antimicrobial activity, and the activity was found to be hydrogen peroxide- 
based. The honeys studied did, however, demonstrate a strong potential for 
stimulation of wound healing (Wheat 2004). 
The aim of this study was to quantify the antibacterial activity of 30 Portuguese 
honeys with specific attention to the non-hydrogen peroxide derived activity, with a 
view to evaluating their antimicrobial potential for wound care. Wound healing 
stimulation was not assessed because it was outside the scope of this project, which 
focuses on the antimicrobial action of honey. 
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2.2 Methods 
2.2.1 Honey sample collection 
With the support of the Portuguese beekeepers society (mostly amateurs) (S. A. P, 
Sociedade dos Apicultores de Portugal), 30 samples of the most common types of 
honey produced in Portugal were collected between the summer of 2003 and the 
summer of 2004. These were representative of the major sources of honey being 
produced in Portugal and were collected from all geographical areas of the country. 
All the honeys were raw, unprocessed honeys, that were stored at 4*C in the dark, 
once they had been received in the laboratory. 
The suspected floral source of each honey was reported by the beekeepers, but this 
was determined by pollen analysis in the laboratory. 
2.2.2 Physicochemical characterization 
2.2.2.1 Determination of pH 
The pH of the honey was determined following the method described by the 
International Honey Commission (Bogdanov 2002). Ten grams of honey that had 
been equilibrated to 20"C for 24 hours in an air-conditioned laboratory was dissolved 
in 10 ml ultrapure water (<15ppb TOC), making a 50% (w/v) solution and mixed 
using a magnetic stirrer. The pH of the final solution was measured by using a 
Chemlab instrument pH 1000 meter previously calibrated using buffers of known pH 
(Fisher). 
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2.2.2.2 Colour 
The colour of all samples was determined using the optical density method 
recommended by the National Honey Board, where the absorbance of a 50% (w/v) 
honey solution was determined at 560 nm in a Cecil spectrophotometer (10 
millimetres path length) and absorbance was multiplied by 2, to give the absorbance 
value of the undiluted solution. Honeys were then categorised according to a 
previously established reference table (USDA 1985). 
2.2.2.3 Protein content 
Protein content was determined using the DC Protein assay kit (BioRad) that is based 
on the Lowry method for the determination of protein content in honey (White, Jr. and 
RudA 1978). In short a 50% (w/v) solution of honey in sterile deionised water was 
prepared as well as a 1/10 dilution, 5 [d of these solutions were dispensed into the 
wells of a 96-well microtiter plate, then 25 pl of Reagent A (alkaline copper tartrate) 
were added followed by 200 [tl of Reagent B, (dilute Folin reagent). The plate was 
incubated at room temperature for 15 minutes and then read in a microtiter plate 
reader (Anthos Reader 2001, Anthos Labtec Instruments) at 750 run. Suitable 
standard solutions of bovine serum albumin (Sigma) (range 0.2-2 mg/ml) were used 
and a calibration curve obtained, to which a best-fit line was added and the equation 
of this line was used to obtain the concentration of proteins in the honey samples. 
Each sample was run in triplicate. 
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2.2.2.4 Moisture content 
Water content was determined using an Atago HHR-2N refractometer. The samples 
were prepared according to the International Honey Commission guidelines 
(Bogdanov 2002). Representative samples of each honey were transferred to sterile 
universal containers, sealed and incubated in a shaking waterbath at 50'C for 30 
minutes. After incubation the samples were allowed to cool to 20 T in an air- 
conditioned laboratory. Before testing the sample was thoroughly mixed. A drop of 
honey was placed on the lens of the refractometer, and the lid closed carefully to 
ensure an even spread of the sample with no air bubbles on the lens. Then the 
refractometer was held towards the light and the position of the interface was 
recorded. Between each sample, the refractometer was cleaned and dried. 
2.2.2.5 Sugar content 
Sugar content was determined using a Bellingham & Stanley 40-85% sugar 
refractometer. The undiluted honey samples were allowed to equilibrate to 20"C for 
24 hours then thoroughly mixed before testing. A drop of honey was placed on the 
lens of the refractometer, and the lid closed carefully to ensure an even spread to the 
sample with no air bubbles on the lens. Then the refractometer was held towards the 
light and the position of the interface was recorded, which gives % readout, 
equivalent to the % sugars present in the sample. Between each sample, the 
refractometer was cleaned and dried. 
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2.2.2.6 Hydroxymethylfurfural (HMF) concentration 
The hydroxyrnethylfurfural (HMF) in honey was determined using the method 
described by White, Jr. (1979). Five grams of each of the honey samples were 
weighed into 50 ml volumetric flasks with a total of 25 ml of water and 0.50 ml of 
Carrez Solution I (15 g potassium ferrocyanide in 100 ml of water) was added to each. 
The solution was mixed and 0.50 ml. of Carrez; solution 11 (30 g zinc acetate in 100 ml 
of water) was added to each of the volumetric flasks, and the solution diluted to 
volume with water. The solutions were filtered through paper rejecting the first 10ml. 
Of the remaining filtrate 5 ml were added to each of two l8xl50 mm. test tubes and 5 
ml of water were added to tube one (sample), and 5 ml of 0.20% sodium bisulphite 
(breaks down HMF) into tube two (blank). The solutions were mixed well in a vortex 
mixer and the absorbance was read at 284 and 336 nm in a Cecil spectrophotometer 
and the HMF calculated using the following formula: 
HMF (mg/Kg honey)= (A284-A336) X 149.7 x 51 weight of sample in grams 
2.2.2.7 Antibacterial activity 
The method used was as described by Allen et al. (1991), except that the test 
organism used was Staphylococcus aureus NCTC 6571. This method is used to 
determine the amount and type of antibacterial activity present in the honey and 
compare it to a phenol (disinfectant) standard. Each sample was assayed in 
quadruplicate and activity compared to phenol, and a New Zealand manuka honey 
(MI09) was also tested as a control for high activity. Each sample was diluted in 
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distilled water for the determination of total antibacterial activity, in order to bring the 
antibacterial activity within the range covered by the phenol standards. Each sample 
was also diluted in catalase solution (1 mg/ml) to destroy any peroxide present so that 
residual non-peroxide antibacterial activity could be detennined. Honeys were 
assayed as 50 % and 25% (w/v) solutions to allow for a range of antibacterial activity. 
2.2.2.8 Pollen analysis 
The pollen analysis was performed according to the method described by Loveaux et 
aL (1978). Ten grains of honey were dissolved in 20ml of water and centrifuged for 
10 minutes, 2500 rpm at room temperature (Sanyo Harrier 15/18 centrifuge). 
Supernatant was decanted; the sediment was resuspended in liquefied glycerine- 
gelatine, transferred to a glass slide and mounted with a coverslip. At least 100 pollen 
grains in each sample were counted and identified using light microscopy. Samples 
were classified according to the predominant pollen (>45% of pollen grains), except 
for monofloral honeys normally with under-represented pollen (such as lavender) 
where 20% was used (Loveaux et al. 1978). 
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2.3 Results 
2.3.1 Physicochemical characterisation 
The results of the chemical and physical analysis of the honeys (Table 1) indicated 
that all fell within the ranges normally expected for pH, water, sugar and protein 
content of blossom honeys. However, HMF levels of seven samples were above the 
40mg/Kg standard in draft EU 96/0114 (EC 2005; EC 2005), and two exceeded the 60 
mg/Kg standard of the draft CL 1998/12-S of the Codex Alimentarius (FAO and 
WHO 1993). It should be noted that the summers of 2003 and 2004 were particularly 
hot in Portugal (UNEP 2004), possibly resulting in the elevated levels of HMF. 
2.3.2 Pollen analysis and antibacterial activity 
Floral sources reported by beekeepers were not reliable and corresponded to 
confirmed identities on 13 occasions (Table 2). Only 4 samples were multifloral and 
Lavandula sp. was the most frequent type at 11 samples. Although reported as orange 
blossom, sample 26 did not contain the low percentage of Citrus sinesis pollen grains 
normally expected (Loveaux et al. 1978). 
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Table 1. Physicochemical characterization results of 30 Portuguese honeys 
Honey 
number 
pH Water content % 
(w/V) 
Sugar content 
% (w/V) 
Protein 
content 
(Mg/9) 
HMF 
(mg/Kg) 
Colour 
1 4.34 17 79 24.78 18.9 amber 
2 4.19 16.2 81 15.78 38.9 extra light amber 
3 4.44 16.6 81 24.92 67.5 amber 
4 4.02 16.3 81 14.34 5.9 extra light amber 
5 3.88 16 80 12.83 9.8 extra light amber 
6 3.99 16.4 76 15.54 15.4 extra light amber 
7 4.36 17 81 25.36 104.6 amber 
8 3.74 17.1 80 12.57 45.4 light amber 
9 3.92 15.1 80 12.27 17.2 light amber 
10 4.05 16.9 81 18.36 33.5 amber 
11 4.02 17 80 13.83 24.6 light amber 
12 4.49 16.1 80 11.82 0 extra light amber 
13 4.02 16.8 80 7.13 47.6 light amber 
14 3.85 16.5 81 20.46 10.2 light amber 
15 3.91 15.5 81 11.35 13.6 extra light amber 
16 4.09 16.4 82 15.87 46.3 light amber 
17 3.97 17.2 80 8.69 6.7 light amber 
18 4.33 16.3 80 18.64 32.0 light amber 
19 4.41 16.3 82 12.46 22.7 light amber 
20 4.04 17.5 81 25.57 64.4 light amber 
21 3.88 18 80 12.99 20.5 light amber 
22 4.44 16.5 79 24.87 34.4 amber 
23 3.94 17.1 81 13.33 12.7 amber 
24 4.38 16.7 80 12.12 27.2 light amber 
25 3.76 15.7 79 14.73 20.6 light amber 
26 3.86 16 81 9.82 26.3 light amber 
27 3.91 16.4 81 10.24 3.1 light amber 
28 3.64 16.4 80 13.58 49.9 light amber 
29 3.59 16.1 81 10.00 21.9 extra light amber 
30 3.89 16.9 83 10.48 23.3 light amber 
Mean 4.04 16.53% 80.4% 15.16 28.8 Light amber 
S. D. 0.25 0.59 1.2 5.35 22.3 NA 
S. D = Standard deviation, NA = not applicable 
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The bioassay method compares inhibition zones created by the honey to zones of 
inhibition produced by phenol standards (Fig. 6). 
Figure 6. Example of a honey bioassay plate. The diameter of the inhibition zones ir 
proportional to the potency of the honeys tested. 
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The diameter of the zones of inhibition of the phenol standards were measured and 
plotted against the phenol concentration used, and the trendline equation of the graph 
(Fig. 7) was used to calculate the potency relating to phenol of the honey samples. 
Figure 7. Example of a phenol calibration curve in a honey bioassay experiment. 
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The bioassay used in this study allows for the distinction between the peroxide (the 
honey is diluted in sterile water and hydrogen peroxide generation is allowed to 
occur) and non-peroxide antibacterial activity (the honey is diluted in a catalase 
solution that will breakdown the hydrogen peroxide formed upon dilution) in the 
honeys and compares it to a phenol standard. The lowest phenol standard able to 
produce an inhibition zone in this assay is 2% (w/v), and absence of zones of 
inhibition indicated activity lower than 2% (w/v) phenol equivalent. 
All of the Portuguese honeys tested possessed some antibacterial activity (total 
activity, peroxide + non-peroxide activity) as shown in Table 2, but levels were lower 
than the reference manuka sample and ranged from 4.3% (w/v) to 13.2% (w/v). 
Manuka had non-peroxide activity equivalent to 18% (w/v) phenol, this type of 
activity was found in only 7 Portuguese honeys (of which 5 were Lavandula 
stoechas), with a maximum of 11.5% (w/v) phenol equivalent. 
Of the honeys that showed non-peroxide antibacterial activity, only one had an 
elevated HMF value (honcy 28,49 mg/kg), nevertheless this value was still within the 
tolerated values for warm countries of 60 mg/kg, and its non-peroxide antimicrobial 
potency was one of the lowest recorded in this study, 5.8% (w/v) phenol equivalent. 
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Table 2. The antibacterial activity and floral source of 30 selected Portuguese honeys. 
Honey 
Sample 
Total antibacterial activity as 
phenol equivalent (w/v) % 
(peroxide + non-peroxide 
activity) 
Non-peroxide 
activity as phenol 
equivalent (w/v) 
% 
Presumed floral 
source 
Confirmed 
floral source 
1 7.1 ND Calluna sp. Multifloral 
2 4.4 ND Eucalyptus sp. Rubus sp. 
3 7.1 ND Multifloral Calluna sp. 
4 6.5 ND Rosmarinus sp. Rosmarinus sp. 
5 6.6 ND Multiflora Rosmarinus sp. 
6 7.5 ND Rosmarinus sp., Lavandula sp. 
Eucalyptus sp 
7 5 ND Calluna sp. Calluna sp. 
8 7.6 7.6 Multifloral. Echium sp. 
9 7.6 6.8 Multifloral Lavandula sp. 
10 6.1 ND Multifloral Eucalyptus sp. 
11 9.8 ND Multifloral Rubus sp. 
12 13.2 ND Lavandula sp. Lavandula sp. 
13 10.1 ND Rubus sp. Multifloral 
14 12.8 11.5 Lavandula sp. Lavandula sp. 
15 4.6 ND Lavandula sp. Multifloral 
16 4.3 ND Rubus sp., Lavandula sp. 
Origanum sp. 
17 7 ND Eucalyptus sp. Eucalyptus sp. 
18 5.8 ND Multifloral Rubus sp. 
19 11 ND Lavandula sp. Lavandula sp. 
Eucalyptus sp. 
20 8.8 ND Multifloral Multifloral 
21 7.3 ND Eucalyptus sp. Eucalyptus sp. 
22 7.8 ND Calluna sp. Calluna sp. 
23 6.9 5.6 Eucalyptus sp. Multifloral 
24 5.3 ND Not known Rubus sp. 
25 10.5 8.9 Lavandula sp. Lavandula sp. 
26 5.6 ND Citrus sinesis Lavandula sp. 
27 9.8 ND Echium sp. Echium sp. 
28 6.7 5.8 Lavandula sp. Lavandula sp. 
29 7.7 ND Lanvandula sp. Lavandula sp. 
30 10.9 6.2 Lavandula sp. Lavandula sp. 
Median 7.2 6.8 
ND: Not detectable 
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3.4 Discussion 
The bioassay showed that all honeys tested possessed detectable antibacterial activity. 
More than half of them demonstrated antibacterial activity between 7 and 12% (w/v) 
phenol equivalent. When tested for non-peroxide antibacterial activity by incubation 
with catalase, 76% of the honeys showed no detectable activity; i. e. all of their 
antibacterial activity was due to the production of hydrogen peroxide. Most of the 
honeys that demonstrated non-peroxide antibacterial activity were Lavandula 
stoechas honeys (5 out of 7), one was Echium sp., and the other was multifloral. 
In testing 345 New Zealand honeys, 25 honey samples were shown to be non- 
peroxide honeys, these identified as manuka (Leptospermum scoparium) and viper's 
bugloss (Echium vulgare) honeys (Allen et al. 1991). A similar study of Welsh 
honeys, showed that all possessed some total antimicrobial activity, but no non- 
peroxide activity was detected (Wheat 2004). Most of the honeys used in that study 
were presumed multifloral, although pollen anaylis was not performed (Cooper, 
personal communication) 
Honeys from Lavanduld stoechas possess higher concentrations of cournarin than 
other Lavandula sp honeys, this being one of the identifying features of this honey 
(Guyot-Declerek et al. 2002; Molan et al. 1988). Cournarin is a product of 
phenylalanine metabolism that also has as an intermediate cinnamic acid. Both these 
components (cournarin and cinnamic acid) have been shown to possess antibacterial 
activity (AIjadi and Yusoff 2003; Sanchez et A 1986) and it is possible that they 
contribute to the measured non-peroxide activity of these honeys. 
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One of the reasons that manuka honey has been advocated for wound care is its non- 
peroxide antibacterial activity (Molan and Betts 2004). Most wounds produce some 
exudate that could be expected to contain catalase (5-8 gmoles/ml), because it is 
present in plasma. This might cause the inactivation of a peroxide honey with low 
potency if applied to the surface of a wound, whereas a non-peroxide honey would 
not be affected in this way (Molan 2000). 
According to Molan (Molan 2000) honey to be used in wound care should have a 
UMF (Unique Manuka Factor) rating of non-peroxide activity of at least 10 (i. e. non- 
peroxide activity equivalent to 10% (w/v) phenol) and in the present study two of the 
Lavandula stoechas honeys possessed ratings of 11.5 and 9 that could indicate 
suitability for use in wound care. 
Although there have been many studies on the effectiveness of honey as an 
antibacterial agent for wound management, many of the studies do not state the type 
of honey used (Molan 1999). Of the studies that evaluate the antibacterial activity of 
specific honeys, most show manuka as the most potent. The honeys used in this study 
do not show an activity as high as manuka honey, but nevertheless it is possible that 
other honeys with higher activity might be found if larger and more extensive studies 
were conducted. 
The results obtained in this study suggest that selected Portuguese honeys could be 
used as antimicrobial agents in wound care, especially for emergency use in the home 
for the treatment of superficial bums and minor injuries. Another application might 
arise in veterinary medicine, where regulations regarding the use of antibiotics 
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commonly used for human treatments limit the range of antimicrobial agents available 
for treating infected wounds. 
Local wild unprocessed honey is already used in many countries for wound care (Al- 
Jabri et al. 2003b; Lev 2003; Meda et al. 2004; Sanchez et al. 1986; Subrahmanyam 
and Ugane 2004). The potential exists for a country like Portugal to develop sterilised 
dressings and other honey-based products for wound care with local honey as a novel 
alternative for the treatment of infected wounds. 
It is probable that a larger study with a wider variety of honeys derived from all of the 
different regions that produce honey in Portugal would yield a better indication as to 
which honeys are the most suitable for wound care. As would a more comprehensive 
study of the chemical and physical properties of Lavender honeys produced in 
Europe, for the understanding and possible identification of new antimicrobial 
compounds. 
Of the Portuguese honeys studied here, a median level of antibacterial activity was 
observed in 20% of the samples tested. Further studies are needed into the chemical 
and antibacterial activity characterisation of both unifloral and multifloral defined 
European honeys, together with the determination of its wound healing potential 
through the testing of its effects on cell lines, as there is the potential to find a high 
activity honey that would be an ideal alternative antimicrobial for wound 
managemcnt. 
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3. Bacterial inhibitory components in honey 
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3.1 Introduction 
All honeys are non-sterile with a natural bacterial flora (total viable count ranging 
between 0 and 5000 cfu/g) mainly composed of Gram-positive sporing bacteria, such 
as Bacillus spp. which accounts for an average of 60% of bacteria recovered, 
depending on the amount of processing of the honey (Snowdon and Cliver 1996). The 
bacteria present in honey may have several origins, as both the production of honey 
by the bee and the handling of the final product by the beekeeper may introduce 
microorganisms other than those present in the honey's raw material, the nectar. This 
means that organisms found in the environment around honey (air, dust, flowers, soil) 
are likely to be identified in honey (primary contamination). 
Some of the bacteria most commonly found in the beehive environment and honey are 
Actinomyces, Bacillus, Clostridium, Corynebacterium, Pseudomonas, Micrococcus 
and many species of yeasts and fungi, which are capable of living in the presence of 
high sugar concentrations. The handling of the honey is the source of secondary 
contamination and is introduced by humans, equipment, containers, insects and 
animals (Snowdon and Cliver 1996). 
The main focus of is on the antibacterial activity of manuka honey (from 
Leptospermum scoparium), this honey was chosen as the focus for this research as 
most of the medical products developed and available for drugs tariff in the UK are 
based on this type of honey. Although honeys share some general antibacterial 
characteristics, like the high sugar concentration and low pH, manuka honey has been 
found to possess other characteristics that make it very useful to medicine. 
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Manuka honey possesses strong non-hydrogen peroxide derived antibacterial activity 
whose nature is not as yet known (Cooper 2005a). Although the honey-based products 
used on drug tariff are sterilised using gamma radiation, many of the studies on the 
antibacterial activity of honey were done using non-sterile honey (French et al. 2005; 
Al Waili and Saloom 1999; Postmes et al. 1996; Subrahmanyam 1994; Cooper et al. 
2002c), so there is the possibility that the non-hydrogen peroxide activity is derived 
from a microbial source in the honey. Furthermore, even if the bacteria in the honey 
are inactivated through gamma irradiation, it is still possible that their antibacterial 
metabolites would remain active in the honey after sterilisation, and could be the 
source of the as yet unexplained antibacterial activity or at least contribute to it in 
part. 
Although it is generally considered that all manuka honeys are useful as medical 
products, there is a wide range in the potency of honeys derived from the same floral 
origin, in this case the manuka shrub (Allen et aL 1991). This suggests that the 
antibacterial potency is not exclusively derived from plant components; as if this was 
the case all honeys derived from manuka shrub would possess similar potency. There 
is, therefore, a need to investigate "variable" sources of activity and microbial 
contamination might be one of these sources. 
The majority of the bacteria found in honey are Gram positive spore-forming bacteria, 
that are able to survive in honey by forming spore that can resist the extreme 
condition of pH and high osmolarity present in honey until the conditions change and 
the spores can germinate into vegetative cells (Snowdon and Cliver 1996). It is 
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known that there is a link between sporulation and the switching on of secondary 
metabolism in bacteria that can lead to the production of antimicrobial substances 
(Demain and Fang 2000; Tamehiro et al. 2002; Yan et al. 2003). Many of the 
organisms reported to be present in honey in the form of endospores, like Bacillus 
spp., are known to produce antimicrobial products (Demain and Fang 2000; Leifert et 
al. 1995; Takahashi et al. 1986; Tamehiro et al. 2002). 
American foul brood is a disease cause by Paenibacillus larvae subsp larvae, and it 
affects the larvae of bees in the hive. It is the cause of many problems in beekeeping 
and because of the close proximity of honey to the bee larvae inside the hive, honey is 
many times contaminated with the causative organism of this disease (Alippi et al. 
2002; Chantawannakul and Dancer 2001). This bacterium has been reported to be 
capable of producing a broad-spectrum antimicrobial substance (Glinski and Jarosz 
1992; Holst 1945). It is possible that honey collected from infected hives might be 
contaminated with substances, unlike honey from uninfected hives. 
The aim of this work was therefore to determine the potential for microorganisms 
present in manuka honey to produce antimicrobial agents. 
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3.2 Methods 
In this study 13 New Zealand manuka honeys and I Australian jellybush honey were 
tested from a stock of honeys held at UWIC, and kindly given by Professor Peter 
Molan. Selection of honeys was blind, the honeys were given by the supervisor and 
labelled with letters; they included a range of potencies, and included manuka honey 
M109 (used as a control in chapter 2 and more extensively in chapters 5,6 and 7). 
3.2.1 Isolation and identification of the bacteria present in honey 
Five grams of honey was diluted in sterile deionised water in a volumetric flask to 
give a 50% (w/v) solution which was then diluted down to 10-2 using 1/4 strength 
Ringer's solution and 100 gl of each solution was spread onto a plate of Tryptone 
Soya Agar (TSA) (Oxoid) in duplicate. After incubation for 48 hours at 30*C (to 
allow slower growing aerobes to produce visible colonies), the total viable number of 
organisms was determined. Aerobic counts were also determined by spreading I OOgI 
of the neat solution (50%) onto selective agar: MacConkey's Agar (Oxoid) and Blood 
Agar (Oxoid), which were incubated overnight, and Paenibacillus larvae Agar (PLA) 
(Schuch et al. 2001), which was incubated for 4 days at 37*C. An anaerobic total 
viable count (TVC) was also determined by spreading 100 [d of the 5 0% solution onto 
TSA and Blood Agar that were incubated anaerobically at 37*C for 48 hours in a 
anaerobic workstation (Modular Atmosphere Controlled System Workstation, DW 
Scientific). 
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After incubation, colonies were counted and TVC determined. Pure cultures were 
obtained from each colony type and identified using Gram stain, catalase production, 
BBL CRYSTAL Gram-positive identification kit (Becton, Dickinson) and in some 
cases API Coryne, API Staph and API 50 CHB kits (BioMerieux). 
3.2.2 Screening for antimicrobial activity of isolates after cultivation in liquid 
medium 
Initially all isolates were cultivated in Tryptone Soya Broth (TSB) (Oxoid) for 5 days 
at 30*C to obtain culture supernatant that was tested for antimicrobial activity by a 
bioassay. After the incubation two different methods were used. In the first method, 
lml of the culture was centrifuged in a microcentrifuge (Sanyo Centaur) at 13225 xg 
for 10 minutes in order to pellet out the cells, and 100 pl of supernatant was added to 
each well in a bioassay plate (243 mm x 243 nun x 18 mm). Bioassay plates each 
contained 150 ml BBL Nutrient agar (Becton, Dickinson) that was seeded with 100[d 
of an overnight culture of one of several test organisms (Staphylococcus aureus 
NCTC 6571, Bacillus subtilis ATCC 6633, Escherichia coli NCTC 10418 or Candida 
albicans). In this last case Sabouraud Dextrose Agar (Oxoid) was used instead of 
nutrient agar. Wells were cut with a sterile cork borer (size 4) and phenol standards 
(100 pl) ranging from 2% (w/v) up to 7% (w/v) were inoculated into some of the 
wells in a quasi Latin square. The bioassay plate was incubated overnight at 37*C and 
the inhibition zones recorded. Each sample was tested in duplicate. 
Cultures that presented some possible inhibition in this method were used for further 
experiments, using a second methodology. Briefly, five millilitres of a TSB overnight 
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culture was taken and centrifuged for 20 min at 9600 g in a bench top centrifuge 
(Sanyo Harrier 15/18 centrifuge). The resulting supernatant was removed and filtered 
through a 0.2 gm filter (Cellulose Nitrate Membrane Filter, Whatman International 
Ltd, England) to remove bacterial cells in order to determine if the inhibition was due 
to soluble factors in the culture supernatant 100 ýd of the filtrate (in duplicate) was 
inoculated into another bioassay plate, together with the phenol standards. The 
bioassay plate was incubated overnight at 37*C and the diameter of inhibition zones 
recorded. Because of low potency of the culture supernatants and filtrate that was 
observed, the procedures were repeated using Bailey's Liquid medium to cultivate all 
isolated organisms. This medium has been described as the ideal medium to grow 
Paenibacillus larvae subsp larvae and stimulate secondary metabolite production 
(Bailey and Lee 1962). 
3.2.3 Screening for antimicrobial activity of isolates after cultivation in solid 
medium 
In order to screen for the production of antimicrobial agents in solid medium, all of 
the isolates were streaked onto a segment of TSA plate and incubated for 5 days at 
30*C (as shown in Figures 8 and 9) to allow possible water soluble antimicrobials to 
diffuse into the agar. After incubation overnight cultures of the test organisms grown 
as before were streaked at right angles to the honey isolate, starting from the point 
furthest away from the segment on which the honey isolate had grown. Plates were 
incubated overnight at 37*C and observed for inhibition of growth of the test 
organism. 
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The test organisms used were 4 type cultures (Oxford strain Staphylococcus aureus 
NCTC 6571, Bacillus subtilis ATCC 6633, Escherichia coli NCTC 10418 and Staph. 
aureus NCTC 10017) and 9 clinical isolates recovered from infected wounds 
(Enterococcus faecalis, Klebsiella oxytoca, Pseudomonas aeruginosa, Escherichia 
coli, Staphylococcus aureus, Enterobacter cloacae, Streptococcus spp., 
Staphylococcus epidermidis and Streptococcus spp. ) from the collection of clinical 
wound isolates held by Dr. Rose Cooper at UWIC. Each isolate was tested in 
duplicate. 
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3.3.1 Isolation and identification of the bacteria present in honey 
The spread plates prepared from 14 honey samples yielded 106 isolates. The TVC 
(Table 3) for honeys ranged from >1.4 x 104 to 2x 101 cfu/g with a mean of 2.18 x 
103 cfu/g (SD 4.84 x 103) for the aerobes in TSA, and between 6.80 x 102 and 2x 101 
cfu/g with a mean of 8.14 x 102 cfu/g (SD 9.56 x 101) in the case of the anaerobes in 
TSA. It was not possible to identify all isolates to species level. 
Table 3. Aerobic and anaerobic total viable count for the honey samples tested using 
various growth media. 
Honey Aerobic Incubation Anaerobic Incubation 
TSA (cfu/g) BA (cfu/g) MAC (cfu/g) PLA (cfti/g) TSA (cfu/g) BA (cfu/g) 
A 1.41 X 104 TNTC NO NO 8x lo, 1.6 x 102 
B 1.20 x 103 2x 102 1.4 x 102 NO NO 2x 101 
C 2x 102 3.2 x 102 2x 101 NO 2xI01 2x 101 
D 8.9 x 102 8.4 x 102 6x 101 NO IX 102 8x 101 
E 7x 101 2x 102 1.6 x 103 NO IX 102 1 X102 
F 4x 101 NO 4x 101 NO 4x 101 4x 101 
G 1.3 x 104 TNTC NO NO 8x 101 2.2 102 
H 2x 101 8x 101 2x 101 NO 4x 101 2x 101 
2x 101 4x 101 2x 101 NO NO IX 102 
4x 101 3.8 X102 7.2 x 102 NO 3.4 x 102 4x 102 
K 2x 102 TNTC 3.2 x 102 NO 2.4 x 102 6.8 x 102 
L 1.75 x 102 1.4 x 101 2x 101 NO NO 4x 101 
m 2.5 x 102 2.6 x 102 NO NO 2x 101 8x 10' 
N 2.5 x 102 4x 101 2x 101 NO NO NO 
Average 2.18 x 103 >- 3.3 x 103 52.17 x 102 NO : 58.14 x 102 <-1.41 X 102 
Stand. Dev 4.84 x 103 6.3 x 103 4.43 x 102 NO 9.56 x 101 2.87 x 102 
Legend: TSA = Tryptone Soya Agar, BA = Blood Agar, MAC = MacConkey's Agar, PLA 
Paenibacillus larvae agar, NG = no growth (< 20cfu/g), TNTC =>1.5 X 104 CfU/ g. 
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The isolates were selected for characterization because they exhibited different 
morphological characteristics on the primary isolation plates, like colony shape, size 
or colour. However, it must be emphasised that the identification techniques used did 
not allow discrimination between strains or subspecies and so although 4 isolates 
from honey A had different colonial morphologies and may have represented different 
strains of the same species, all were reported as B. subtilis,. The bacteria that are listed 
as "other" in Table 4 were Lactococcus spp., Corynebacterium spp., Enterococcus 
spp., Micrococcus spp. and Pediococcus spp. 
Sample I and H had the lowest bacterial counts while samples A and G had the 
highest aerobic count and K the highest anaerobic count. It was possible to observe 
that isolates that yielded the same identification did not always have the same colony 
morphology, this might have been due to strain variation (methodology used in this 
study did not characterise isolates according to strain), for example for honey A 
(Table 4) where initially 7 different colony types were identified, but characterised to 
only 3 distinct species. 
Of the cultures recovered Bacillus spp. were most commonly observed (Table 4), 
from this table it is also possible to see that there was a difference in the types of 
organisms recovered in aerobic conditions and those recovered in anaerobic condition 
of incubation. 
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Table 4. Number of isolates recovered in each honey for the most common genera. 
Honev Number of aerobic Isolates Number of anaerobic Isolates Identification of the Bacillus spp. 
N* of Bacillus Staph. Micrococcus Other Staph. Enterococcus Bacillus Other Isolates 
isolates spp. SPP. sp. SPP. SPP. SPP. 
A 7 0 0 0 0 0 0 2 4 B. sublilis, 2 B. pumilus, I Bacillus spp. 
B 5 2 1 0 0 0 0 0 2 B. subtilis, 2 B. pumilus, I Bacillus spp. 
C 6 1 0 2 0 0 0 0 4 B. subtilis, I B. cereus, I B. brevis 
D 12 0 0 1 0 0 0 0 7 B. subtilis, I B. pumilus, I B. cereus, I 
B. brevis, 2 Bacillus spp. 
E 4 1 0 1 0 0 0 0 3 B. subtilis, I Bacillus spp. 
F I I 1 0 0 0 0 0 1 B. brevis 
G 7 0 2 0 2 3 0 2 2 B. subtilis, I B. pumilus, 4 Bacillus spp. 
H 1 3 0 0 0 0 0 0 1 B. subtilis 
1 0 1 0 0 0 0 0 0 None recovered 
1 2 2 2 2 3 2 0 2 1 B. pumilus, I Bacillus spp. 
K 6 0 0 2 0 2 0 2 3 B. subtilis, 3 Bacillus spp. 
L 7 2 1 0 0 0 0 0 2 B. subtilis, I B. pumilus, 4 Bacillus spp. 
m 3 1 1 0 0 0 0 0 1 B. subtilis, 2 Bacillus spp. 
N 8 0 1 0 0 0 0 0 5 B. subtilis, I B. brevis, I B. sphericus, I 
Bacillus spp. 
A total of 106 isolates were recovered from the 14 honey samples tested. The majority 
of the isolates recovered were from the Bacillus genus (65%), but 29% of these could 
not be identified to species. The most common species identified were Bacillus 
subtilis and Bacillus pumilus. 
4.3.2 Screening for antimicrobial activity of isolates after cultivation in liquid 
medium 
Attempts to identify antibacterial activity in the culture supernatants by growing the 
isolates recovered from the 14 types of honey in liquid medium were unsuccessful. 
4.3.3 Screening for antimicrobial activity of isolates after cultivation in solid 
medium 
Eleven of the thirteen test cultures were inhibited by one or more of the honey isolates 
and of the test bacteria exposed to the honey isolates, only two clinical isolates 
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(Pseudomonas aeruginosa and Enterobacter cloacae) were not inhibited by any 
isolate. Staphylococcus aureus NCTC 6571 showed the greatest inhibition and the 
other isolates were variously inhibited (Fig. 8 and 9). 
Figure 8. Example of no inhibition of growth of test organisms by bacterial strain 
isolated from honey (vertical= test organisms; horizontal= isolate from honey). 
S 
I 
Figure 9. Example of inhibition of growth of test organisms by bacterial strain 
isolated from honey (shown by arrows) (vertical= test organisms; horizontal= isolate 
from honey). 
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Of the 106 isolates recovered from the honey samples, 76 inhibited one or more 
species and 30 did not cause any inhibition (Table 5). The isolates that failed to inhibit 
any of the test bacteria were Staphylococcus capitis, Bacillus circulans, 
Staphylococcus warneri, Lactococcus lactis spp. lactis, Staphylococcus aureus, 
Micrococcus sp., Bacillus spp., Enterococcus durans and Bacillus sphericus. Of the 
isolates causing inhibition 85% were Bacillus sp. 
Table 5. Results for the antimicrobial screening in solid medium (x shows inhibition 
observed). 
Honey Isolate no Test strains Identification 
12 34 5 6 78 9 10 11 12 13 
A I x x x Bacillus subtilis 
2 x X x x x x X X Bacillus sublilis 
3 Xx x x x x X X X Bacilluspumilus 
4 xx x X x x x X X X Bacilluspumilus 
5 x x x x x Bacillus subtilis 
6 x x x x x x x X X Bacillus subtilis 
7 x x x Bacilluspumilus 
B I x x x x Bacillus subtilis 
3 x Micrococcus luteus 
5 x x x x x x X X Bacillus subtilis 
6 x x x x x x x Bacilluspumilus 
7 x xx X x x Bacilluspumilus 
I x Corynebactedum spp. 
2 x x x X x x Bacillus subtilis 
x x x x x X Bacillus subtilis 
5 x Bacillus brevis 
x x Slaphylococcus epidermis 
x x x X Corynebacterium spp. 
x x x Bacillus subtilis 
x x X x x x x x X Bacillus subtilis 
x x X Bacillus subtilis 
x x x Bacillus subtilis 
x x x x x x x Doubtful Bacillus pumilus 
x x X x x x X X Bacillus subtilis 
x x x x x Bacillus subtilis 
x x X Bacillus subtilisl megaterium 
x X Bacillus cereus 
x x x x x X Bacillus subtilis 
10 x x x x X Bacillus brevis 
x x x x Corynebacterium spp. 
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Table 5 (cont. ). Results for the antimicrobial screening in solid medium. 
Honey Isolate Test strains Identification 
no 12 34 5 6 78 9 10 11 12 13 
D 12 x x X Bacillus subtilis 
E I x X Bacillus subtilis 
3 x x Doubtful Bacillus pumilus 
5 x x x Bacillus subtills 
6 x x x x Bacillus sublilis 
F I x x x x x x x x x Bacillus brevis 
2 x Micrococcus luteus 
G I x x x x x x x x x Doubtful Bacillus pumilus 
3 x x x x X X Bacilluspumilus 
4 x Micrococcus luteus 
5 x x x x X X X Unacceptable Bacillus purnilus 
6 x x X X X Bacillus subtilis 
7 x x x x x x X Doubtful Bacillus pumilus 
8 x x x x x x X X X Bacillus subtilis 
9 x x x x x x x x Doubtful Bacillus pumilus 
H 3 x Slaphylococcus pasteuri 
i I xx x x x x X X X Bacilluspumilus 
2 x Micrococcus luteus 
6 x x Micrococcus luteus 
10 x x x x X X X Unacceptable Bacillus pumilus 
K I x x x x x X X X Bacillus sublilis 
2 x Micrococcus luteus 
3 x x X Bacillus subtilis 
5 x x x x x X Bacillus sublilis 
7 x x x x x X X X Doubtful Bacillus pumilus 
8 x x Doubtful Bacillus pumilus 
9 x x x x x x x Doubtful Bacillus pumilus 
L I x x X Unacceptable Bacillus pumilus 
2 x x Unac. B. cereus / thurginesis 
3 x x X Bacilluspumilus 
4 x Slaphylococcus epidermis 
7 x x x X Bacillus subfilis 
8 x x x Bacillus subtilis 
9 x Micrococcus luteus 
10 x Unacceptable Bacillus alvel 
M I x x Unacceptable Bacillus cereus 
3 x x Bacillus subtilis 
4 x Micrococcus luteus 
5 x x x X Unacceptable Bacillus pumilus 
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Table 5 (cont. ). Results for the antimicrobial screening in solid medium. 
Isolate Test strains Honey Identification 
no 123 45 678 9 10 11 12 13 
N I x x X Bacillus subtilis 
2 x X Bacillus brevis 
3 xx x Bacillus sublilis 
4 x Bacillus subtilis 
5 x x x Doubtful B. brevis 1pumilus 
7 xx x x x X Bacillus subtilis 
9 xx x xx xX XX Bacillus subtilis 
Legend: 
X: Inhibition observed 
Test Strains 
1: 
2: 
3: 
Oxford Staph. aureus 
NCTC 6571 
Enterococcus faecalis 
(clinical) 
Klebsiella oxytoca 
(clinical) 
4: 
Pseud. aeruginosa 
(clinical) 
5: Staph aureus NCTC 
10017 
6: E. coli NCTC 
10418 
7: B. subtilis ATCC 
6633 
8: E. coli (clinical) 
9: Staph. aureus 
(clinical) 
10: Enterobacter 
cloacae (clinical) 
11: Streptococcus 
spp. (clinical) 
12: Staph. 
epidermis (clinical) 
13: Streptococcus 
spp. (clinical) 
* Isolates with no inhibition were not shown on this table. 
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3.4 Discussion 
According to Snowdon and Cliver (1996) the majority of the microorganisms able to 
survive the harsh conditions present in honey are Gram positive spore-forming 
bacteria, especially of the Bacillus genus, and some yeasts. In this study neither 
filamentous fungi nor yeasts were sought. From the plate counts on various media it is 
evident that the bacterial loads in the different honey samples varied. Differences 
were probably due to differences in the origins of honey and the way that each of 
them has been handled. For example, honeys C, I, J, and L contained Staphylococcus 
epidermidis or Enterococcus durans, which are bacteria that are usually associated 
with the skin microbial flora, and as such might be indicators of contamination during 
handling. 
Usually the level of bacteria found in commercial honey is between 1 and 5000 cfu/g 
(Snowdon and Cliver 1996). Most of the honey samples tested here had a bacterial 
load between these two values and only honey A and honey G had greater than 5000 
cfu/ml. Although above the average, this does not mean that the honey is not fit for 
consumption, as that decision also depends on the type of microbial flora found in the 
honey. In general the majority of the bacterial flora in honey is aerobic, but it may 
also contain some anaerobic bacterial spores, such as Clostridium spp. Among the 
members of this group that are important in the clinical context is Clostridium 
botulinum, and cases of infant botulism have been linked to honey consumption but 
with low incidence (Eaton 2001). 
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It is worthwhile to note that in this work no Clostridium species were found. This is 
very important as if it was present and raw, unsterilised honey were to be used in 
wound managcment, therc is the potcntial to causc wound botulism (Eaton 2001). 
Aerobic bacteria are important in wounds; nevertheless anaerobic infections may 
develop (Brook and Frazier 1999; Brook 2001) and the existence of bacteria in honey 
able to grow under these conditions should be taken into account. In this case none of 
the bacteria recovered from the anaerobic incubation were known pathogens. In order 
to prevent any potentially dangerous bacteria infecting wounds through clinical use of 
honey it can be sterilised by gamma-radiation without significant loss of potency 
(Molan and Allen 1996). 
It is likely that the some of the bacteria recovered from the honey samples would have 
been present as endospores and germinated once media without honey was presented 
to them. The survival of vegetative bacterial cells in honey is usually not more than a 
few weeks (Snowdon and Cliver 1996). It is important to note that of the honeys used, 
only one was a processed honey, and that all of the others were raw honeys. 
Identification of isolates proved problematic using commercial test kits, particularly 
for Bacillus sp where the same isolate could be identified differently by the two kits 
used. Routine DNA methods are not yet available for the identification of the species 
found in this study. A technique such as RAPD (Randomly Amplified Polymorphic 
DNA) could give some idea of similarities and differences between strains, although 
it would not give a definite identification. One of the solutions could possibly be the 
use of sequencing analysis; nevertheless that technique is not available in UWIC. 
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Bacteria of the Bacillus genus are part of the normal bacterial flora found in soils. 
These have been found to contribute to the management of plant diseases (Milner et 
al. 1996) by producing antimicrobial agents that eliminate fungi and bacteria that 
otherwise would attack the plants. Bacillus subtilis is known to produce bacteriocins 
(microbially produced peptides that are active against bacteria of closely related 
bacterial species) (Zheng and Slavik 1999) as well as ribosomal (e. g TasA and 
subtilorin) and non-ribosomal antibiotics (eg. Surfactin, fengycin, etc) that have 
antifungal and antibacterial activities (Tamehiro et al. 2002). B. licheniformis, is 
known to produce bacitracin (Ishihara et al. 2002). Other Bacillus spp. isolates 
recovered also are known to produce different types of antimicrobial agents: B. cereus 
is known to produce kanosamine and zwittennicin A (Milner et al. 1996), B. pumilus 
is known to produce antifungal metabolites (Bottone and Peluso 2003; Munimbazi 
and Bullerman 1998), B. brevis is known to produce the antimicrobial agent 
gramicidin S (Leifert et al. 1995) and B. circulans was shown to produce nucleoside 
antibiotic (bagougeramines A and B) which demonstrate a broad range of 
antimicrobial activity (Takahashi et al. 1986). The possible presence and contribution 
of these to the antimicrobial activity of certain honeys would have to be addressed by 
using chemical analysis to try and detect the presence and concentration of these 
compounds. Techniques for detection of antibiotics in honey are mainly based on 
chromatography, like high-performance liquid chromatography, or mass spectroscopy 
(Thompson et al. 2005; Vivekanandan et al. 2005), but new methods involving 
biosensors (Caldow et al. 2005) and immunochemical methods (Heering et al. 1998) 
are being developed. 
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The production of antimicrobial substances by bacteria is often associated with 
enviromnental triggers, as starvation, or stress originated by the growth of other 
bacteria (Robertson et al. 1989; Marahiel et al. 1993). Another factor that can also 
affect the stimulation or inhibition of the production of antimicrobial substance is the 
physical characteristics of the growth medium, if it is solid or liquid (Madigan et al. 
2000) 
The use of PLA and Bailey's medium in this work was to detect the presence of 
Paenibacillus larvae subsp larvae. This bacterium is a pathogen of bees that causes 
American foulbrood disease, it might hold the potential for the production of 
antimicrobial agents (Holst 1945; Glinski and Jarosz 1992). However no 
Paenibacillus larvae subsp larvae was recovered. 
The production of any antimicrobial agent might be facilitated by the extreme 
conditions that the microorganisms face in the honey, which can induce sporulation 
and switch on secondary bacterial metabolism. Sporulation might be induced in solid 
medium rather than in liquid medium (Codon et al. 1995; Haggblom et al. 2002) and 
this might explain why no antibiotic activity was detected from isolates grown in 
liquid medium. 
The inhibition in the solid medium was widespread; most of the Bacillus spp. 
demonstrated some capacity to inhibit the test organisms in the solid media assay. The 
positive results obtained with the use of clinical strains as test organisms enabled the 
observation that the antimicrobial being produced in each case seems to be a broad 
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spectrum agent as it inhibits both Gram positive and negative bacteria as well as type 
cultures and clinical strains. 
The fact that Pseud. aeruginosa and Enterobacter cloacae were not inhibited by any 
isolates might be due to the fact that both of them were clinical isolates. Also Pseud 
aeruginosa is known for its resistance to antimicrobial agents (Larsen et al. 1993; 
Salunkhe et al. 2005). Clinical isolates do not behave the same way as type cultures of 
the same species would, because they have been exposed to different environmental 
pressures, forcing them to find mechanisms for adaptation that type cultures do not 
need (Rutala et al. 1997). 
These results raise the issue of what should be the permitted level of antibiotics in 
honey. Hives can be treated with antibiotics for the treatment of diseases like 
American foul brood disease. At the moment the level of antibiotics allowed in honey 
is 0 mg/kg (FAO and VMO 1993), as an indication of no-treatment of the honey. 
Nevertheless recently this level has been brought into question when low levels of 
streptomycin (3 to 16 ppb) were detected in Zambian honeys (Zambia Bee Products 
Association 2005). Honey from a wide area was affected and it is not likely that hives 
had been treated with streptomycin, because of its prohibitive cost. Since 
Streptomyces growing in the environment is capable of producing this antibiotic, and 
it has been reported to be present in soils (Huddleston et al. 1997), it is possible that 
these low levels of streptomycin have occurred by natural contamination of soil in 
water sacs of foraging bees (Zambia Bee Products Association 2005). 
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With the development of more sensitive techniques for the quantification of 
antibiotics in complex substances such as honey it is possible that honey which had 
previously been considered to be free of antibiotics actually possesses low levels and 
that this is part of the natural production of honey. This work has shown that in the 
honey there are bacteria capable of producing antimicrobial agents. Analytical 
techniques are now needed to show if these antimicrobial agents are present and at 
sufficiently high concentrations to have an effect on wound pathogens. 
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4. A studv of the antioxidant potential of selected honev 
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4.1 Introduction 
It is recognised that honeys from different floral sources and geographical locations 
vary considerably not only in their antibacterial activity but also in their colour 
(Molan 1992) and wound healing potential (Wheat 2004). These properties change on 
exposure to light, heat and time (Dustman 1978). Antioxidants are present in many 
vegetables, fruits, and food products, such as black tea, coffee and honey. These 
agents have been characterised as flavonoids, and phenolic acids (Gheldof et al. 
2002), which may also function as antimicrobial agents. 
Antioxidants are known for their cytoprotective effects by scavenging free radicals. 
Free radicals are reactive molecules that arise from the products of the oxidation/ 
reduction of oxygen and hydrogen. The high oxidative/reductive capability of these 
radicals can damage cell membranes by altering the oxidative state of certain 
components such as DNA and proteins that results in altered conformation (Heim et 
al. 2002; Inoue et al. 2005; Sabu and Kuttan 2002). 
Two of the most physiologically important free radical species are hydroxyl and 
superoxide radicals. These are produced by human immune cells to counteract 
microbial infections, for example from human fibroblasts in response to cytokines like 
interleukin-I or tumour necrosis factor, or by neutrophils and macrophages 
(production by the NADPH-oxidase located in plasma membrane) (Burdon 1995). 
They are also produced by bacterial cells, to allow them easier access to human cells 
for example Pseudomonas aeruginosa, secretes pyocyanin and pyochelin (toxins) that 
act in synergy with hydroxyl radical to damage the endothelial cell wall (Britigan et 
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al. 1992) or in the case of Cryptococcus neoformans that has in its pigments a stable 
free-radical population that makes it more resistant to antibody-mediated 
phagocytosis (Wang et al. 1995). 
One of the most common pathways for the production of hydroxyl radicals is through 
the Fenton reaction: 
Fe 2+ + H202 > Fe 
3+ + OHe+ OH- 
The Fe 3+ can then react further with H202 to produce superoxide: 
Fe 3+ + H202 lo Fe 2++ '02'+ 2H+ 
Superoxide radicals are also generated from the reduction of molecular oxygen as 
occurs in the phagocyte respiratory burst: 
02 + e'+ H+ 10 *02'+ Ir 
Honeys vary in their antioxidant potential (Gheldof et al. 2002; Meda et al. 2005) and 
there is anecdotal evidence that darker honeys possess higher antioxidant potentials 
than lighter coloured honeys (Gheldof et al. 2002). 
Manuka honey is used in commercially available medical products, this honey is 
thought by most researchcrs to havc most of its antimicrobial activity dcrivcd from 
sources other than the hydrogen peroxide generation, although it may produces 
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hydrogen peroxide but in a minute concentration as demonstrated by the difference 
(small) between the peroxide and non-peroxide activity when using a bioassay. 
Nevertheless there are those that claim that the level of hydrogen peroxide production 
in the manuka honey is higher than generally accepted and that the assays currently 
used to test the type of antimicrobial activity not due to the generation of hydrogen 
peroxide are not taking this into consideration. It is suggested that these experiments 
were using a concentration of catalase (breaks down hydrogen peroxide) which was 
too low to inactivate this activity in manuka honey (Weston 2000). 
The aim of this study was to determine the antioxidant potential of three natural 
honeys of differing floral and geographical origins, by the detennination of the free 
radical quenching potential of honey, and on the other hand the determination of the 
production of free radicals via the Fenton reaction using electron paramagnetic 
resonance (EPR) (Fig. 10) spectroscopy. The antimicrobial activity of each honey 
was also determined and relationships between these parameters were investigated. 
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Figure 10. Diagram of EPR spectroscopy method. 
Fe2+ + H202 IP Fe 3+ + OH*+ OH Short-lived unstable molecule 
Add relevant spin trap (molecule with 
high affinity that stabilizes the free 
radical) 
This adduct (free radical + 
DMPO + 
1 
spin trap) will have a 
particular, non-random spin 
that can be detected by 
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4.2 Methods 
Five samples of honey were used. An artificial honey that reflected the main 
components of honey was prepared by dissolving 1.5 g of sucrose, 7.5 g of maltose, 
40.5 g of fructose and 33.5 g of glucose in 17 ml of deionised water. This solution 
was included in the study to evaluate the contribution of the predominant sugars and 
water to the antibacterial and antioxidant characteristics of honey. A clear, runny 
honey (Gale's) obtained from a supermarket was included to represent a heat- 
processed honey. A peroxide generating honey derived from mixed floral source 
(pasture PS9), a non-peroxide, generating honey, and monofloral manuka (M109) 
honey was also used, supplied by Professor Peter Molan of the University of Waikato, 
New Zealand and a local honey obtained from West Wales were also used. 
4.2.1 The determination of the colour of honeys 
As described in section 2.2.2.2. 
4.2.2 Determination of antimicrobial activity 
The method used was that of Allen et aL (1991), described in section 2.2.3. 
4.2.3 Superoxide radical enzymatic quenching assays 
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Superoxide radicals were generated by the xanthine/ xanthine oxidase (X/XO) system 
following a method previously described (Valentao et A 2002a; Valentao et al. 
2002b). 
Xanthine oxidase 
Xanthine 
+ 
uric acid + superoxide 
L-0- 
+ Lucigenin Generates 
A master mixture for each sample was prepared in two 1.5 ml. eppendorf tubes each 
containing 290 pl of 5 mM xanthine (sodium salt), 100 pI of the test solution (positive 
control, 5 0% honey solution or negative control), and 100 ýtl of I mM lucigenin. As a 
positive control, ascorbic acid (1 mM) was used, and for a negative control, the 
antioxidant compound was replaced by sterile deionised water. 
After mixing, 150 gl of this mixture were transferred to a well in a 96 well microtitre 
plate using at least 5 repeats. To each well was added 10 ýLl of xanthine oxidase (0.5 
units/ml) and the plate was incubated for 15 minutes in the dark. The plate was read in 
the lurninometer (MLX Microtiter plate Luminometer, Dynex Technologies). 
4.2.4 Electron Paramagnetic Resonance (EPR) spectroscopy 
This work was undertaken in the Medical Microbiology Department of the University 
Hospital of Wales, with the assistance of Dr. Simon Jackson. 
EPR spectroscopy was employed in two experiments: detection of hydroxyl radical 
(OH9) formation from hydrogen peroxide that may be present in the diluted honey 
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samples and in a second experiement to test for any antioxidant activity in the honey 
by quenching free radicals introduced into diluted honey samples. To detect highly 
reactive radicals, such as OH*, the spin trap 5,5-dimethyl-l-pyrroline-N-oxide 
(DMPO) (Sigma) was used. This compound reacts with OH* to form a stable 
paramagnetic species (the 'spin-adduct' DMPO-OH*) that gives a characteristic 
1: 2: 2: 1 quartet of lines in the EPR spectrum. 
To determine the potential for OH* production by the different honey solutions, Fe 2+ 
was added to the honey to generate 01-19 by Fenton chemistry from any peroxide 
present. As a positive control for trapping this radical, Fe 2+ was used to generate the 
hydroxyl radical from H202- 
In typical experiments 40 IiL of 0.1 M DMPO was added to 100 gL of a fresh 50% 
(w/v) solution of honey in an eppendorf tube and mixed gently by pipetting. To 
initiate the reaction, 20 gL of 0.05 M FeS04 was added and the solution immediately 
drawn into a glass capillary tube that had been sealed at one end. This tube was placed 
in the cavity of an EPR spectrometer (Varian E104 operating at 9.2 GHz microwave 
frequency and 20 mW power) and EPR spectra recorded. Typical spectrometer 
conditions were 100 Gauss (G) scan range, 120-second scan time and 1.0 G field 
modulation. 
In some experiments, the honey samples were also 'spiked' with 30 PI of 30% (v/v) 
H202 prior to addition of the FeS04 and the decay time of the resultant EPR spectrum 
was used to determine the OH* radical 'quenching' or antioxidant potential of each 
honey. 
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4.3 Results 
4.3.1 Determination of the colour and antimicrobial activity of honeys 
The results of the colour determination assay ranged from extra white to amber and 
are shown in table 6. 
Table 6. Results of the colour determination of honeys tested (absorbance at 560 nm 
and its correspondent colour). 
Honey Type Absorbance @ 560 nm Colour Description 
Artificial Honey 0.068 Extra white 
Commercial Honey 0.507 Light amber 
Pasture Honey (PS9) 1.024 Amber 
Manuka Honey (M 109) 1.166 Amber 
West Wales 1.016 Amber 
The antimicrobial activity of each honey is shown in Table 7. Only manuka honey 
demonstrated significant non-peroxide activity. Antibacterial activity in both pasture 
and local Welsh honey was largely due to the generation of hydrogen peroxide, 
whereas artificial and Gales honey had no detectable activity in this assay (therefore 
equivalent to less than 2% (w/v). 
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Table 7. Antimicrobial activity of selected honeys determined using the bioassay 
method. 
Honey type Phenol equivalent % (w/v) 
Total activity Non-peroxide activity 
Artificial Honey 
Commercial Honey 
Pasture Honey (PS9) 
Manuka Honey (M 109) 
Not detectable 
Not detectable 
19 
18.1 
Not detectable 
Not detectable 
Not detectable 
17.3 
Welsh Honey 6.6 Not detectable 
4.3.3 Superoxide radical enzymatic quenching assays 
In the superoxide radical quenching assay, the greater the amount of superoxide 
radical present in the reaction mixture, the more light is detected. Each honey sample 
exhibited different abilities to quench superoxide radical (Figure 11). As expected, the 
greatest light emission was observed with the negative control (sterile deionised 
water) and the least with manuka honey. With the natural honeys, greatest quenching 
activity was observed in manuka (MI09) honey followed by the pasture honey (PS9) 
and the supermarket honey. The artificial honey was less effective than all of the 
experimental honeys, but did show some quenching activity compared to deionised 
water. 
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4.3.4 Electron Paramagnetic Resonance (EPR) Spectroscopy 
In total 58 EPR spectra were collected from the tested samples. The control spectrum 
is shown in Figure 12. The only honey observed to generate radicals via the Fenton 
reaction (Fig. 13) was the pasture honey (PS9). Although the profile was not a typical 
hydroxyl radical profile, it was possible to deduce that this was due to hydroxyl 
radical generation because the signal disappeared when catalase (Fig. 13) was added to 
the reaction mixture. Interaction between hydrogen peroxide and some of the 
components in honey may give rise to unusual profiles. No radicals were detected 
with any of the other honey samples in the presence of iron. 
When hydrogen peroxide was added to each of the honey solutions the expected 
profile for hydroxyl radical was immediately observed and quenched with time. 
Manuka honey profiles are illustrated in Fig. 14, (a) with no hydrogen peroxide 
addition, (b) with added hydrogen peroxide and (c) after incubation, similar profiles 
were obtained for West Wales, commercial and artificial honey. Speed of signal 
quenching of hydroxyl radicals varied between honeys, with manuka being the faster 
quencher, followed by the West Wales honey then by the commercial honey, the 
artificial honey and finally by pasture honey. It was possible to observe that pasture 
honey radical profile disappeared with time (Fig. 15b) to levels similar to those 
verified when catalase was added to the honey solution (Fig. 13b). 
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Figure 12. (a) EPR spectrum of the OH9 radical trapped with DMPO from the 
Fenton reaction (positive control). (b) The same as in (a) but without Fe 2+ or H202 
(negative control). 
Figure 13. (a) typical EPR spectra obtained with a 50% (w/v) solution of pasture 
honey in the presence of FeS04 and DMPO. (b) same as (a) but with the addition of I 
mg/ml catalase. 
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Figure 14. Antioxidant capacity of manuka honey. (a) Typical EPR spectra obtained 
for 50% (w/v) manuka honey, and for 50% (w/v) manuka honey is incubated with 
H202 + FeS04 and DMPO, measured at (b) at time 0 and (c) after 5 minutes following 
addition of H202. 
Figure 15. Antioxidant capacity of pasture honey. (a) Typical EPR spectra obtained 
for 50% (w/v) pasture honey, measured at (b) at time 0 and (c) after I hour. 
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4.4 Discussion 
As discussed in the introduction, one source of antibacterial activity in honey is the 
production of hydrogen peroxide by the enzyme glucose oxidase present in honey. 
The results obtained in this section show that honeys of high antibacterial capability, 
like manuka honey, do not necessarily have a high hydrogen peroxide generation 
capability, and that even the honeys that generate hydrogen peroxide and free radicals 
through the Fenton reaction such as pasture honey also have an antioxidant activity. 
The EPR spectroscopy allowed the detection of any free radicals produced via the 
Fenton reaction in the presence of hydrogen peroxide produced by honey, and the 
results obtained demonstrate that manuka honey did not produce any detectable levels 
of hydrogen peroxide using EPR spectroscopy, but still showed a high antibacterial 
activity, equivalent to 18% (w/v) phenol. Furthermore, the quenching assays, both 
using the EPR spectroscopy and the xanthine oxidase method demonstrated that 
different honey possesses different antioxidant potentials. 
Honey has been shown to elicit the spontaneous synthesis of cytokines by monocytes 
that have the potential to mediate the immune response (Tonks et al. 2001; Tonks et 
al. 2003). Some immunological cells, like neutrophils and macrophages, utilise the 
presence of free radicals like the superoxide and hydroxyl radicals to modulate the 
activity of other cells such as monocytes and platelets, when responding to challenges 
(Burdon 1995). Nevertheless in dealing with a prolonged insult, like a chronic 
infection, such a stimulus may give rise to an excessive response. The ability to 
dampen free radicals may therefore contribute to the complex interaction that helps to 
resolve the state of chronic inflammation that typifies chronic wounds. 
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When Pseudomonas aeruginosa invades human tissue it induces free radical 
formation as a means to enhance invasion and this can lead to cellular damage 
(Britigan et al. 1992; Nunoshiba et al. 1995; Wang et al. 1995). Honey has already 
been shown in vitro to be bactericidal for Pseudomonas aeruginosa (Cooper et al. 
2002a) and has been suggested as a topical treatment for wounds infected with this 
bacterium. This study provides evidence that manuka honey especially has the ability 
to quench free radicals, which could minimise cellular effects of bacterial infection as 
well as chronic inflammation. 
In a previous study of the antioxidant potential of honey, phenolic acid concentration 
was measured (Al-Mamary et al. 2002). A more recent study has indicated that the 
consumption of honey can provide protection to healthy humans by increasing 
antioxidant activity of plasma (Schramm et al. 2003). This study demonstrates that 
different honeys possess varying capabilities to quench superoxide and hydroxyl 
radicals in vitro. This is an important factor when considering using honey in a 
clinical context because both antibacterial activity and antioxidant potential should be 
evaluated. It is important to note that the honey with the highest antibacterial activity 
tested here (manuka honey) did not produce detectable free radicals in the presence of 
the components of the Fenton reaction using this sensitive EPR technique. 
The nature of the antibacterial activity of manuka is unknown. Although activity has 
been demonstrated in vitro in the presence of catalase (Al-Mamary et al. 2002; Allen 
et al. 1991), and the activity therefore been called non-peroxide activity, this activity 
has paradoxically been attributed to hydrogen peroxide on the basis that the levels of 
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catalase utilised in the bioassay were insufficient to inactivate hydrogen peroxide 
(Weston 2000). This idea has since been refuted by (Snow and Manley-Harris 2004) 
using increased amount of catalase (10-fold increase) in relation to the normal 
concentration used and no statistically significant difference was observed. 
It has been shown that the optimal dilutions at which honeys will produce the 
maximum amount of hydrogen peroxide is between 40 and 60% (w/v) (Bang et al. 
2003). In this study the failure to detect hydroxyl radicals using EPR in the presence 
of the reagents needed for the Fenton reaction to take place, indicates that hydrogen 
peroxide was not generated when manuka was diluted by a factor of at least 2 in vitro. 
The results presented here, therefore, confirm previous suggestions that antibacterial 
activity in this honey is caused by components other than hydrogen peroxide. 
Furthermore the production of radicals was observed in pasture honey, a hydrogen 
peroxide generating honey. 
Pasture honey produces hydrogen peroxide upon dilution, and the addition of the 
reagents for the Fenton reaction enabled the detection of a profile in the EPR, 
although it was not the traditional hydroxyl radical profile. It is possible to say that the 
radicals formed are the product of the Fenton reaction because when catalase was 
added this profile disappeared. Probably the hydroxyl radicals, being very reactive 
substances, reacted with organic materials in the honey and created a different profile 
to the one usually attributed to hydroxyl radicals. Artificial and commercial honey 
could not produce any radicals because the first never possessed the enzyme needed 
for its production, and the second had the enzyme inactivated (due to the heat 
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treatment that it had received prior to commercialisation). Hence these honeys, 
together with manuka honey did not show the presence of any radicals. 
When the results of the quenching potential of these different types of honey are 
related to the results obtained for the colour determination, it is possible to verify that 
darker honeys like manuka, West Wales and pasture honeys (amber colour) are more 
effective antioxidants than the lighter honeys, artificial and commercial (extra white 
and light amber, respectively). These results confirm data obtained by Taormina et aL 
(2001) that demonstrated that darker honeys have a higher antioxidant and 
antibacterial potential. Perhaps one of the ways through which honey was selected 
locally for use in Medicine was through the selection of darker honeys. In order for 
the relationship between colour and antioxidant potential to be explored, a greater 
number of honey samples need to be tested. Although sugars alone do not possess as 
high antimicrobial activity as honey, they demonstrate radical quenching potential in 
these assays. This is not uncommon and other researchers have demonstrated this 
(Morelli et al. 2003; Park et al. 2003) 
Honeys with a hydrogen-peroxide-derived antibacterial activity are useful for medical 
purposes for their effective action against infection, nevertheless this work has 
demonstrated that these honeys also possess the capacity of producing free radicals, as 
is the case of Pasture honey. This honey has also shown a high free radical quenching 
capacity in the superoxide enzymatic assay (Fig. 11) and also in the quenching of the 
hydroxyl radicals observed through EPR spectroscopy (Fig. 15). It seems that this 
honey has a modulatory effect on its own production of free radicals as the amount 
detectable decreased with incubation time. It is possible to speculate that this can have 
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a benefit in vivo by acting as an early signal for the recruitment of macrophages and 
neutrophils to the site of infection and as an antibacterial agent at the same time, 
because bacterial cell walls are also susceptible to attack by free radicals (Nunoshiba 
et al. 1995). These results suggest that the use of hydrogen peroxide-generating 
honeys, such as pasture honey, that produce some free radicals, may not be 
detrimental to the wound healing process, as they seem to possess a self modulatory 
capacity that decreases the activity of these radicals. 
This research has investigated the relationship between antioxidant potential and 
different types of honey, as well as the relation between the antibacterial activity and 
the production of hydrogen peroxide in vitro. This is only one of the steps necessary 
to understand the complex action of honey on wounds and other types of infection, 
and there is a need to continue this work with in vivo studies that are vital for the full 
understanding and acceptance of honey as a real alternative to modem antibacterial 
agents 
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5. An investigation into the kinetics of death of Staphvlococcus aureus 
and Pseudomonas aeruainosa 
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5.1 Introduction 
Understanding the mode of action of a new antimicrobial agent is necessary for it to 
be used appropriately and safely. Although honey is not a new antimicrobial agent, its 
use in conventional medicine is recent, with the introduction of the first manuka 
honey impregnated wound dressing on to drug tariff in the UK in March 2004. 
Further research into the mechanism of action of manuka honey on relevant wound- 
infecting pathogens is considered necessary. if honey is to be accepted by healthcare 
practitioners (Molan and Betts 2004). Appropriate evidence on the kinetics of death, 
such as time-to-kill studies, Minimum Inhibitory Concentration and Minimum 
Bactericidal Concentration values has been suggested (Stratton 2003). 
Staphylococcus aureus and Pseudomonas aeruginosa, as representative species of 
common wound infecting bacteria were selected for antimicrobial studies because 
they are among the bacterial species that incur the biggest problems to control and 
eradicate (Howell-Jones et al. 2005). Staph. aureus is the most common wound 
infecting pathogen; it is ubiquitously associated with human skin and may become an 
opportunistic infectious agent when there is a break in the barrier provided by the skin 
(Lowy 2003). With the increase in the use of antimicrobial agents, antibiotic-resistant 
Staph. aureus have increased in incidence, both in hospital and the community, one of 
the most worrying being methicillin-resistant Staph. aureus or MRSA, which have 
increased in incidence in the last decade (Ang et al. 2004b; Howell-Jones et al. 2005), 
the treatment of which is difficult due to the fact that some strains can be resistant to 
more that one antimicrobial agent. Another common wound pathogen known for its 
resistance is Pseud. aeruginosa, due to its ability to form biofilms in wounds that lead 
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to persistent infection due to the difficulty in eliminating all the bacterial cells from 
the wound, and also for its natural resistance to antimicrobial agents both in wounds 
and in nature (Gilbert and McBain 2003b). 
It is important to test new antimicrobial agents against both laboratory reference and 
clinical strains (Cooper et aL 2002a). Strains of bacteria collected from 
enviromnental sources, in this case wounds, have been subjected to cnviromnental 
pressures that may have altered their susceptibility to antimicrobials, and bacteria 
collected from different wounds may respond differently, as they may have been 
subjected to different cnviroruncntal conditions. 
Organisms held in stock cultures, as is the case of laboratory strains, can lose their 
virulence and/or viability during long term storage, be it at room temperature, 
Iyophilised or in frozen stocks. This has been described for many different 
microorganisms ranging from Escherichia coli (Acha et al. 2005), to Clostridium 
dificile (Freeman and Wilcox 2003), Mycobacterium sp. (Nascimento and Leite 2005) 
and amoebae (Gupta and Das 1999). 
Accurate antimicrobial testing is important for the correct determination of the 
usefulness of an antimicrobial agent, in the early years there was no standardization 
between laboratories and the results for the antimicrobial agent differed greatly as 
different concentrations of inocula and antimicrobial agents were used (Piddock 
1990). Since this problem was first recognised in 1952 standardised techniques have 
been developed for susceptibility testing among them are the methods developed by 
the Clinical Laboratory Standards Institute, CLSI (formerly known as NCCLS) in the 
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USA, which publishes revised methods for antimicrobial susceptibility testing every 3 
years (Piddock 1990), and the British Society for Antimicrobials and Chemotherapy 
(BSAC). These methods thoroughly describe inocula size, media and antimicrobial 
dilutions, as well as provide reference tables to assess resistance or susceptibility to a 
particular antimicrobial agent and also quality control protocols. 
The use of a liquid media based antimicrobial susceptibility assay is more practical in 
relation to the solid media tests as it allows for the determination of the MBC, and 
allows the possibility of scale down to a microtiter plate, which in turn allows for a 
bigger number of replicates and assays to be performed with a minimum amount of 
antimicrobial agent (Piddock 1990). If resistance is observed in vitro it is likely to be 
present in vivo, although susceptibility does not have such a clear cut interpretation, as 
in vivo there are more interfering substances than in the standardized laboratory 
assays (Varaldo 2002). 
Time-to-kill, MIC/MBC, time for commitment to death and total cell counts were 
determined here for manuka honey, acting on Pseud. aeruginosa and Staph. aureus. 
An investigation was also undertaken to assess the ability of the bacteria to develop 
resistance to manuka honey, since the rapid emergence of honey-resistant microbes 
would seriously limit the effectiveness of this alternative antimicrobial. 
Recently there has been some debate among the scientific community regarding what 
happens to cells when they cease to be culturable. Cells that could not be cultured 
have been considered to be non-viable, nevertheless it seems that some bacteria can 
enter a dormant state in which they retain metabolic activity but cannot be cultured, 
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and this state has been termed the viable but non-culturable (VBNC) state (Barer and 
Harwood 1999; Byrd et al. 1991; Heim et al. 2002b; Kell et al. 1998; Oliver 2005; 
Roszak and Colwell 1987). The triggers behind the transition from culturable to non- 
culturable are not fully understood. In many bacteria this state is a response to 
starvation, as is the case with Escherichia coli (Nystrom 2003), whilst in others it is a 
response to adverse environmental conditions, such as low temperature, as is the case 
of Vibrio vulnificus (Barer and Harwood 1999). One of the main characteristics of this 
state is that although the culturable counts obtained by plating techniques (previously 
regarded as viable counts) decrease significantly over the course of time, the total cell 
count decreased very slowly over time. The number of viable cells are predicted to 
decrease at a rate between that of the total cell counts and that the culturable counts 
(Kell et al. 1998). 
In order to determine if the honey could be inducing a VBNC state in Staphylococcus 
aureus and Pseudomonas aeruginosa, the total counts were determined and compared 
with the culturable counts. 
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5.2 Methods 
5.2.1 Cultures and honeys used 
Three type cultures were used Pseudomonas aeruginosa ATCC 27853, 
Staphylococcus aureus NCTC10017 and Staphylococcus aureus NCTC 6571, also 10 
clinical isolates (five MRSA and five Pseud. aeruginosa) from a cohort of bacteria 
collected from wounds and held at UWIC. MRSA 18 was isolated from a patient 
successfully treated with manuka honey at a local hospital (Natarajan et al. 2001) 
Three types of honey were used: a hydrogen peroxide-generating honey (pasture 
honey, PS9) and two non-hydrogen peroxide generating honeys (manuka honeys), one 
sterile (SH) (kindly supplied by the New Zealand natural Food Company) and the 
other non-sterile (MI09). Manuka honey provided by Prof. Molan. 
5.2.2 Antibacterial activity of honey 
As described in section 2.2.3. 
The antibacterial activity of M109 was assayed at the start of this project and at 
different time points during the course of this research because anecdotal evidence 
suggested that it changed with time. The activity of M109 was compared to penicillin 
(Sodium salt, Sigma, 1650 Units/mg) by the same method. This bioassay was also 
used to determine the effect of pH and heat on manuka honey. Aliquots of a 50% 
(w/v) solution of M109 manuka honey were adjusted to pH 1,7, and 10 through the 
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addition of HCL (1 M) or NaOH (1 M) before using in the bioassay pH was measured 
using a Chemlab instrument pH 1000 meter previously calibrated using buffers of 
known pH (Fisher). To determine the effect of heat, aliquots of a 50% (w/v) solution 
of M109 manuka honey was heated at 80'C for 30,60 and 120 minutes before using 
in the bioassay. 
5.2.2 Minimum Inhibitory Concentration (MIC) according to the CLSI methods 
and BSAC methods. 
The Minimum Inhibitory Concentration is the lowest concentration of an 
antimicrobial agent (in this case honey) that prevents the growth of a microorganism. 
The CLSI and BSAC method are standards methods for susceptibility testing of 
antimicrobial agents commonly used in hospital laboratories around the world. The 
CLSI microdilution method of detcnnining MIC was described in (Ferraro et al. 
2003). The BSAC method was is based on the CLSI method except that iso-Sensitest 
Broth (Oxoid) was used, BSAC does not possess a defined method for broth 
microdilution assays, nevertheless it uses iso-sensitest agar for use in their antibiotic 
susceptibility test method, which is also similar to the CLSI method. The use of the 
isosensitest broth with a method based on the CLSI method has been described by 
(Koeth et al. 2000). 
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5.2.3 Minimum Inhibitory Concentration (MIC) by tube dilution 
Khan tubes containing 2 ml in total were used. To I ml of double strength nutrient 
broth, was added 1 ml of double the desired final concentration of honey made up in 
the appropriate diluent. The diluents were sterile deionised water to determine total 
activity, 1 mg/ml catalase solution (Sigma) for non-hydrogen peroxide derived 
antibacterial activity, and 90% (v/v) Foetal Calf Serum to determine the effect of 
proteins on the antibacterial activity of honey (Bryant 1972). An overnight broth 
culture of the test organism was used as an inoculum without dilution; each tube was 
inoculated with 10 ýd and incubated at 37'C for 24 hours. TVC of the inocula were 
routinely performed after the tubes were inoculated to determine the population size 
of inocula, to check retrospectively that each tube had been inoculated with 
approximately 106 cells. Growth or no growth was recorded, by noting turbidity and 
appropriate positive (single strength broth and inoculum) and negative controls (broth 
and honey) were included to aid interpretation. Tubes with the lowest concentration 
without growth were recorded as the MIC. 
5.2.4 Minimum Inhibitory Concentration (MIC) in Microtiter plates 
As described above in section 5.2.3 but in a 96-well microtiter plate with flat bottom 
and lid, with a total volume of 200 gl and an inoculum of I pl for each well. The plate 
was incubated at 370C for 24 hours before measuring turbidity at 400 mn in a plate 
reader (Anthos Labtec Instruments). TVCs were performed to determine the 
population size of inocula. Appropriate positive (broth and inoculum) and negative 
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controls (broth and honey) were included. Wells with the lowest concentration 
without growth were regarded as the MIC. 
5.2.5 Minimum Bactericidal Concentration (MBC) 
From the plate wells and the tubes with no growth, 20 gI was removed and plated 
onto nutrient agar (Oxoid) that was then incubated at 37'C for 24 hours to determine 
MBC. The lowest concentration to show no growth was the MBC. 
5.2.6 Time-Kill Curves 
A 40 RI volume of an overnight culture in nutrient broth (NB) (Oxoid) of the bacteria 
was incubated at 37"C with shaking in 20 ml of nutrient broth alone or nutrient broth 
containing 10% (w/v) or 20% (w/v) M109 manuka honey for Staph. aureus and 
Pseud. aeruginosa respectively. Samples were removed at known time intervals (30 
minutes) usually up to 6 hours and total culturable counts were determined using the 
Miles and Misra surface drop count method (Drabu and Blakemore 1990; Levett 
1991; Tweats et al. 1981). Time-kill curves were plotted and trendlines used to 
extrapolate estimated times required to achieve 3 decimal log reductions, which 
demonstrates 99.9% reduction in total number and which is considered to demonstrate 
bactericidal activity (Duarte et al. 2003; Montero et al. 2002). 
5.2.7 Total cell and culturable counts 
A time-to-kill experiment was performed as described in section 5.2.6. 
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Briefly, 40 gl volume of an overnight culture in nutrient broth (NB) (Oxoid) of the 
bacteria was incubated at 37'C with shaking in 20 ml nutrient broth alone or nutrient 
broth containing 10% (w/v) or 20% (w/v) M109 manuka honey for Staph. aureus and 
Pseud. aeruginosa respectively. Samples of 5 ml were removed at known time 
intervals (I hour) up to 6 hours. The samples were filtered through a reusable 0.22 gin 
syringe filter (Millex GV, Fisher Scientific, UK). Using flame sterilised forceps the 
membrane filter was removed and added to 5 ml of sterile nutrient broth (Oxoid), and 
mixed in a vortex mixer at top speed for 60 seconds. 
For the total culturable counts the method used was the Miles and Misra surface drop 
method. To determine the total cell count a bacterial counting kit (Molecular Probes, 
USA) that allowed quantification of the total number of bacteria present using flow 
cytometry was used. In this method I ml of the cell suspension was used and 1 ýd of 
SYTO green dye (Molecular Probes, USA) was added and incubated at room 
temperature for 15 minutes. After this incubation 10 gl of the fluorescent beads 
(Molecular Probes, USA) was added and the solution vortexed at full strength for I 
minutes to disrupt any clumps. This solution was used for flow cytometry using the 
FACS machine (Cytomics FC 500 MPL, Becton-Dickinson). In order to detect which 
signals were bacteria and which signals were beads, solutions of beads in media (no 
cells) and cells in media (no beads) were used and gates used to limit the areas were 
each type of signal would appear, so that when the test samples were applied the 
signals due to the fluorescence of the beads would appear in the gate determined to be 
from the beads and the cells in the remaining gate. At the end of each run 5000 events 
(or 5000 signals) were recorded, the total number of cells was determined by dividing 
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the total number of events in the bacteria gate by the number of events in the beads 
gate. This number was then multiplied by 106 to give the number of cells per ml. 
5.2.8 Resistance training 
Resistance training was attempted by two methods: single concentration exposure and 
rising concentration exposure (Thomas et al. 2000). For resistance training by single 
concentration exposure 20 ml cultures were set up at 37* in the shaking water bath 
using a sub lethal concentration of 2.5% (w/v) sterile honey in nutrient broth (NB) for 
Staph aureus NCTC 10017 and 8% (w/v) for Pseud aeruginosa ATCC 27853. These 
were then sequentially subcultured 10 times by taking 40 RI of 24-hour culture into 
fresh 20 ml honey suspension. 
For resistance training by increasing concentration, cultures were set up as above, 
using a starting concentration of 1% (w/ v) sterile honey in NB for Staph. aureus and 
5% (w/v) in NB for Pseudomonas aeruginosa, and this was increased stepwise by 
0.5% (w/ v) intervals for Staph. aureus and 1% intervals for Pseud. aeruginosa for 10 
subcultures with incubation interval of 24 hours at 37'C in a shaking water bath. 
Throughout the resistance training, the identity of each resistant culture was 
confirined by BBL crystal kits (BD). 
MIC and MBCs of the final isolates obtained from both methods were determined and 
compared with initial MIC and MBCs. Any shown to have an increased resistance 
was subcultured a further 6 times into fresh nutrient broth without honey and the MIC 
and MBC were determined again. The difference between the initial and the final 
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MIC and MBC was analysed using MiniTab 4.0 as the tool for statistical analysis and 
performing the Mann-Whitney statistical test on the results obtained for the MIC and 
MBCs. 
5.2.9 Commitment to death 
Time-to-kill experiments were performed for Staph. aurcus NCTC 10017 and Pseud. 
aeruginosa ATCC 27853 as described in section 6.2.6, but instead of total viable 
counts being determined samples of the honey-treated cells (100 gl ) were collected in 
I hour intervals for 8 hours and then a further sample at 24 hours and added to 10 ml 
of single strength nutrient broth (Oxoid) and incubated over night. Growth (turbidity) 
or no growth (no turbidity) was recorded and time for commitment to death was 
considered the first time point where no growth was detected. 
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5.3 Results 
5.3.1 Antibacterial activity of honey 
PS9 had an average phenol equivalent for total activity of 16.4% (w/v) and no 
detectable non-hydrogen peroxide activity, M109 had an average total activity (Table 
8) equivalent to 18.45% (w/v) and non-hydrogen peroxide-derived activity equivalent 
to 18.36% (w/v) and for sterile honey the average values were 17.3% (w/v) for total 
activity and 16.8% (w/v) for non-hydrogen peroxide-derived activity. 
M109 was received in UWIC in January 2003 and was stored in a cold room in the 
dark kept at 4"C and its potency did seem to change with time (Table 8). Using the 
Mann-Whitney test there is a statistically significant difference between all the time 
points (p<0.05). 
Table 8. Increase in the potency of manuka honey M109 over time as determined 
using the bioassay method. 
Activity related to phenol % (w/v) 2003 2004 2005 
Total activity 17.6 ± 1.9 16.8± 1.1 20.9± 3.7 
Non- peroxide activity 17.2 ± 2.5 16.7± 1.1 21.2± 1.4 
Undiluted manuka honey showed an activity equivalent to 1.1 mg/mI of penicillin 
solution using the same bioassay method developed for the comparison of honey to 
phenol standards. The potency of M109 manuka honey did not seem to be affected by 
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heating at 80*C however activity became undectable on increasing the pH to 10 
(Table 9) 
Table 9. The effect of temperature and pH on the total (peroxide and non-peroxide) 
antibacterial activity of M 109 manuka honey. 
Effects of temperature Effects of pH 
No 
80'C for 80'C for 80'C for 
treatment pH I pH 7 pH 10 
30min 60nin 120min 
Total activity 
related to 
18.7 17.1 20.0 17.8 18.2 16.1 ND 
phenol 
%(w/v) 
ND: Not detectable 
5.3.2 Minimum Inhibitory Concentration (MIC) according to the CLSI methods 
and BSAC methods. 
Determining MIC of M109 against Staph. aureus and Pseud. aeruginosa was not 
consistent for all of the methods used (Table 10). There were statistically significant 
differences (p<0.05) between the different methods used. 
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Table 10. MIC values for M109 against Staph. aureus and Pseud. aeruginosa 
determined by different methods. 
Method Staph. aureus Pseud. aeruginosa 
Microtiter plate 
Tubes 
CLSI 
BSAC 
Median % (w/v) n Range Median% 
(W/V) 
2.9 10 2.5-3.4 9.5 
2.2 4 2.2-2.4 10 
3.5 8 3-4 12 
4.5 8 4.5-5 12 
n Range 
9-11 
8-12 
10-12 
12-12 
4 
3 
4 
4 
5.3.3 MIC and MBC in tubes and microtiter pIates 
The results of the Minimum Inhibitory Concentration (MIC) and Minimum 
Bactericidal Concentration (MBC) determination in tubes and in microtiter plates are 
shown below in Table II and 12 respectively. 
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Table 11. Median MIC and MBC values detennined in tubes with three honey 
samples (M109, SH and PS9) and two type cultures (Staph. aureus and Pseud. 
aeruginosa). 
Pseudomonas aeruginosa ATCC 27853 Slaph. aureus NCTC 100 17 
Mic MBC Mic MBC 
Range n Range n Range n Range n 
(%w/v) (%w/v) (%W/V) (%w/v) 
M109 10 10-12 3 18 16-18 3 2.2 2.2-2.4 4 2.6 2.4-2.8 4 
M 109 + catalase 15 12-20 3 24 26-28 3 6.6 6-6.6 4 7 7-7.5 4 
M 109 + serum 18 15-20 3 14 12-15 12 * 
PS9 22 20-30 3 32 30-34 3 9.5 4-16 12 18.5 17-18.5 4 
PS9 + catalase 32 30-32 3 34 34-36 3 28 14-28 6 30 30-32 3 
PS9 + serum 30 30-35 3 42 40-42 
SH 18 14-26 3 24 22-26 3 3 3-4.5 10 6.5 4-7.5 5 
SH + catalase 30 28-30 3 32 30-32 3 5 3-10 7 6 5.5-6.5 3 
SH + serum 22 20-25 3 30 30-35 3 14 14-16 3 26 24-28 3 
Cells with the symbol (*): result could not be determined due to endospore 
gennination during the test period. 
n= number of replicates 
SD = standard deviation 
M 109 = manuka honey (non-sterile) 
PS9 = pasture honey (non-sterile) 
SH = manuka honey (sterile) 
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Table 12. Mean MIC and MBC values determined in microtitre with three honey 
samples (MI09, SH and PS9) and two type cultures (Staph. aureus and Pseud. 
aeruginosa). 
Pseudomonas aeruginosa ATCC 27853 Staph. aureus NCTC 100 17 
Mic MBC MIC MBC 
Range n Range n Range n Range n 
(%w/v) (O/OW/V) (O/OW/V) (%w/v) 
M 109 9.5 9-11 6 12 11-12 5 2.9 2.5-3.4 10 4.5 3.2-5 7 
M 109 + catalase 16 16-24 10 24 24-26 4 7.8 7.2-8 7 7.9 7.4-8 5 
M 109 + serum 15 15-15 5 13 12-13 7 
PS9 19 14-28 10 22 22-30 6 10 8-10 7 16 14-22 7 
PS9 + catalase 30 22-30 5 32 30-34 2 26 14-26 7 38 24-30 5 
PS9 + serum 25 20-25 5 35 35-35 7 
SH 16 12-18 8 22 16-22 6 3 2-3 5 8 4-10 5 
SH + catalasc 28 22-28 to 30 24-30 8 4 4-8 5 14 12-14 5 
SH + serum 20 20-20 4 25 25-30 5 12.5 15-30 4 25 15-30 4 
Cells with the symbol (*): result could not be determined due to endospore 
germination during the test period. 
n= number of replicates 
SD = standard deviation 
M 109 = manuka honey (non-sterile) 
PS9 = pasture honey (non-sterile) 
SH = manuka honey (sterile) 
As the ratios between the MBC and MIC in all respective pairs were <4, a bactericidal 
mode of action was indicated. Sterile manuka honey (from the New Zealand Natural 
Food Company) was used in the assay of the effect of serum in the antibacterial 
activity of honey because the presence of serum seemed to promote the growth of the 
survival and subsequent growth of the natural microbial flora in pasture and manuka 
honeys. To obviate this difficulty sterile honey was utilised and MBC values were 
successfully obtained. 
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5.3.4 Time-kill studies 
For time-to-kill studies bactericidal concentrations of honey at least twice the the 
value of the calculated MIC values were selected, so that lethal concentrations were 
present. For Staphylococcus aureus 10% (w/v) M109 was used and for Pseudomonas 
aeruginosa 20% (w/v) was used. Although for staphylococci 6 clinical isolates and 
one type culture were tested at least twice, data in Fig. 15 shows representative time- 
kill profiles of only 3 organisms. Similarly Fig. 16 shows representative data of 3 of 
the 7 pseudomonads tested. 
Figure 15. Representative curves of the results obtained in the time-to-kill experiment in 
Staph. aureus strains in nutrient broth with and without 10% (w/v) manuka honey. 
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Figure 16. Representative curves of the results obtained in the time-to-kill experiment 
with Pseud. aeruginosa strains in nutrient broth with and without 20% (w/v) manuka 
honey. 
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Using trendlines, 3 log reduction times and the number of survivors at 24 hours, were 
estimated (Table 13). All strains tested, except MRSA 18 achieved a 103 decimal 
reduction in the number of survivors at 24 hours, but sensitivities among the clinical 
strains varied with estimated sterilization times ranging between 1530 and 391 
minutes for Staph. aureus and between 321 and 92 minutes for Pseud. aeruginosa 
strains. Nevertheless, these observations support a deduction of bactericidal mode of 
inhibition from manuka. honey against the bacteria tested. 
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Table 13. Estimated time for 3 log reduction in viable bacterial counts in the 
presence of honey for the strains of Staph aureus and Pseud. aeruginosa tested in this 
study. 
Staph aureus in 10% (w/v) manuka honey Pseud aeruginosa in 20% (w/v) manuka honey 
Mean estimated Mean estimated 
Isolate Number time for 3 log SD Isolate Number time for 3 log SD 
reduction reduction 
Staph. aureus NCTC Pseud aeruginosa 
427 minutes 101 257 minutes 143 
10017 ATCC 27853 
MRSA 2 573 minutes 84 Pseud aeruginosa 27 275 minutes 231 
MRSA 5 391 minutes 144 Pseud aeruginosa 13 158 minutes 31 
MRSA 8 1012 minutes 374 Pseud aeruginosa 37 274 minutes 234 
MRSA 15 689 minutes 478 Pseud aeruginosa 38 321 minutes 164 
MRSA 18 1530 minutes 638 Pseud aeruginosa 32 92 minutes 32 
mean 770 minutes 495 mean 229 minutes 145 
Note: The numbers given to the clinical strain tested refers to the stock number given 
by Dr. Rose Cooper when the isolates were received. 
5.3.5 Total and culturable counts 
When time-kill experiments were monitored simultaneously by total culturable counts 
or TVC and total cell counts it was realised that trends did not concur. Where as the 
culturability of Staph. aureus and Pseud. aeruginosa in the presence of lethal 
concentrations of M109 (10% and 20% respectively) decreased the total number of 
cells did not reduce at the same rate (Figure 18 and 19). In cultures without M109 
both total and culturable number of cells increased with time (Figure 17 and 18). 
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Figure 17. Staph. aureus total and culturable cell count in nutrient broth alone and 
mutrient broth with 10% (w/v) manuka honey (boxes = total counts and line = 
culturable counts). 
Figure 18. Pseud. aeruginosa total and culturable cell count in nutrient broth alone 
and nutrient broth with 20% (w/v) manuka honey (boxes = total counts and line = 
culturable counts). 
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5.3.6 Resistance training 
No honey-resistant cultures of either bacterium were recovered by resistance training 
with exposure to stepwise increasing concentrations of manuka honey. Neither 
bacterium was recovered above their MIC values (4% (w/v) and 10% (w/v) manuka 
honey for Staph. aureus and Pseudomonas aeruginosa repectively). The results 
obtained in the training by repeated exposure to a sub-lethal concentration of M109 
are shown in Table 14. The MIC for Pseudomonas aeruginosa MIC was significantly 
different from the original value, and this apparently resistant strain was grown for 6 
sub-cultures in honey-free medium and the MIC re-tested. The MIC and MBC after 
this period were not significantly different from the original MIC and MBC (p>0.05). 
Table 14. Resistance training MIC and MBC determination of the test strain before 
and after training. 
Staph. aureus NCTC 10017 Pseudomonas aeruginosa ATCC27853 
Before training After training Before training After training 
Mean n SD Mean n SD p Mean n SD Mean n SD p 
%(w/v) %(w/v) %(w/v) %(W/V) 
SH MIC 2.8 5 0.4 3.8 5 0.8 0.09 15.7 8 2.0 19.7 7 1.4 0.0032* 
MBC 752.8 7.4 5 1.5 1 20.6 6 2.4 21.5 410.083 
SHC MIC 5.2 5 1.8 5.2 510.91 25 10 3.2 26.6 7 2.2 0.31 
MBC 13.6 5 0.9 13.6 5 0.9 1 29.3 3 1.1 32 7 1.6 0.06 
this was found to be significant using the Mann-Whitney statistical test 
SH = sterile honey, and SHC = sterile honey and catalase. 
5.3.6 Commitment to death 
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The commitment to death experiment showed that Staph aureus did not survive after 
8 hours of exposure to 10% (w/v) manuka honey and that Pseud. aeruginosa after 4 
hours exposure to 20% (w/v) manuka honey did not grow. 
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5.4 Discussion 
From the results of the bioassay it is possible to note that the potency of this honey 
has increased with time during storage. Others have commented on the fact that 
antibacterial characteristics of honey change with time, although in some cases it 
increases, whilst in other it decreases in potency (Al Waili 2004c; Bogdanov 1997). 
Honey is an ever-transforming substance; with enzymes present that are able to effect 
transformations such as increase in HMF content with time or heating and constant 
chemical reactions taking place like sugar crystallization that change the honey's 
characteristics (Khismatullina 2005; Gleiter et al. 2006). 
Although honey had been discussed and treated as the alternative to antibiotics, when 
quantifying its antibacterial activity it is generally compared to phenol. Although 
phenol is an effective antiseptic it is not commonly used in the treatment of infected 
wounds. Also the diffusion curves of phenol and honey from wells in bioassay plates 
are likely to differ, and phenol may not be the best reference standard. 
In order to have a better understanding of the potential of honey for the treatment of 
infected wounds, it was compared to a penicillin solution. The results showed that the 
neat honey had a potency equivalent to 1.1 mg/ml of penicillin. When taking the MIC 
for penicillin-sensitive Staph. aureus into account (0.12 [Ig/ral, (Ferraro et aL 2003), 
a 3% solution (MIC calculated in microtiter plates, Table 12) has a potency of 0.033 
mg/ml (equivalence to penicillin) which is still at least 275 times stronger than the 
MIC reported for sensitive species. This is a result to which practitioners might be 
able to relate easier than to phenol value. 
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Recently a new method has been put forward on the testing of the antibacterial 
activity of honey, that uses a spectrophotometric method (Patton et al. 2006) instead 
of the traditional agar diffusion assay described in this thesis. In this new method the 
MIC are determined using a microtiter plate. This new method has the advantage of 
using less materials, being less expensive and allowing full automation and real-time 
monitoring (Patton et al. 2006). 
There was a significant difference between the MIC when different methods were 
used (p<0.05). In the methods described by CLSI and BSAC defined media such as 
Iso-Sensitest broth and Mueller-Hinton broth are used, these are defined media that 
are advised for the testing of the susceptibility of different organisms to conventional 
antibiotics. The use of defined media in these cases is preferred because some ions 
such as calcium can decrease the activity of some antibiotics, and other increase it 
(Ferraro et aL 2003). In the present study nutrient broth was used. This can be 
justified because the wound environment is not defined and contains many products 
that could interfere with the action of an antimicrobial agent; furthermore, honey itself 
is not a defined substance like penicillin, and different honeys possess different 
compositions. Therefore using a defined medium would not necessarily reflect the 
environment in which the honey would to be used clinically. 
The MIC/MBC determination showed that the results obtained using the microtitre 
plate and the tube dilution methods were not significantly different (p>0.05). In this 
case the MICs and MBCs calculated with the microtitre plate method were higher for 
both bacterial strains than the values calculated in the control, because growth or no 
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growth in the microtiter plate method is determined by comparing readings of optical 
density it can be more sensitive than the visual observation of turbidity in tubes using 
the naked eye. In this work the microtiter plate method was the one of choice due to 
the combined convenience of using less antimicrobial agent and allowing for more 
repeats under the same conditions (Table 10). 
Antimicrobial agents with bactericidal activity are generally preferable to agents with 
bacteriostatic activity. By killing bacteria a barrier to the progression of healing might 
be removed, whilst the inhibition of growth without death has the disadvantage that 
once antimicrobial treatment is stopped the bacteria might grow again (Stratton 2003; 
Dzidic and Bedekovic 2003). 
The MBC/ MIC ratio has previously been used as an indicator of mode of inhibition 
(bactericidal or bacteriostatic activity of antimicrobial agents) (Andreoni et al. 1985; 
Perez et al. 1999). When it is less than 4 the antimicrobial agent being tested is 
considered to have a bactericidal mode of action whilst if this ration is >4 the activity 
of the antimicrobial agent is considered to be bacteriostatic. All of the honeys tested 
had an MBC/MIC ratio <4, and were therefore considered to have a bactericidal mode 
of action, confirming the results of the time-kill studies. 
Serum proteins are also known to interfere with the action of many antimicrobial 
agents, and so it was important to determine whether honey maintained bactericidal 
activity at achievable concentration in the clinical context (Polasa and Krishnaswamy 
1987). The presence of serum increased the MIC values for all the honeys and 
bacteria tested, but honey still remains effective at clinically achievable 
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concentrations and remained bactericidal as demonstrated by the MIC/MBC ratios 
(Andreoni et al. 1985; Perez et al. 1999). 
From the determination of the MIC/MBC in the presence of 90% Foetal Calf Serum, 
it was seen that M109 retained bactericidal activity (Bryant 1972) (Table 12), also the 
results showed that the MIC against Staph. aureus was much more affected by the 
action of the serum proteins in the honey than for Pseud. aeruginosa. This suggests 
that the mode of action of manuka honey on these two bacteria might be different 
(Table 12). 
Wound exudates contain serum that has high concentrations of enzymes, such as 
catalase that can destroy the peroxide activity of a honey, thus honeys with high non- 
peroxide activity are more suitable for wound treatment as they retain their activity 
even after dilution with catalase containing fluids 
Although there was variation in rates of inhibition between each isolate (clinical and 
type cultures) (Figures 15 and 16), bactericidal mode of action was confirmed in most 
cultures tested, with type cultures being more sensitive than clinical strains, as 
expected, as the clinical isolates have been subjected to environmental stress that can 
switch on resistance mechanisms. 
MICs obtained in this study were similar but not identical to values previously 
reported (Cooper et al. 1999; Cooper et al. 2002a; Cooper et al. 2002c). This is not 
unexpected as honey is a natural product and samples are never consistent, 
furthermore the honeys used in these studies had a sligthly lower potency (from 16 to 
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17 % w/v). Both MBC and time to kill studies confin-ned that manuka honey was 
bactericidal for Staph. aureus and Pseud. aeruginosa. Although MICs indicated that 
Staph. aureus were more susceptible to manuka honey than Pseud. aeruginosa, time- 
kill curves showed that Staph. aureus at manuka concentrations approximately three 
times MIC were killed at a slower rate than Pseud. aeruginosa at concentrations twice 
the MIC. This difference between the rates of kill for the two bacterial species tested 
could be an indication of a different mode of action for manuka honey with Gram 
positive bacteria when compared to Gram negative bacteria. Further tests are needed 
with a wider range of bacteria. 
Unexpectedly, the total number of cells did not decrease at the same rate as the 
number of culturable cells of Staph. aureus and Pseud. aeruginosa when exposed to 
10% (w/v) and 20% (w/v) manuka respectively. Similar total and viable count profiles 
can be obtained for cells in the Viable-but-non-culturable (VBNQ where cells are 
alive but cannot be cultured (Roszak and Colwell 1987). This is thought to be a 
physiological adaptation of non-spore forming cells so they can cope with 
environmental stress (starvation, temperature, osmotic concentration, oxygen 
concentration or exposure to light) and it was first identified in Vibrio cholerae and 
Escherichia coli (Xu et A 1982). Since its characterization, about 60 different 
bacteria have been reported to enter this state (Oliver 2005) among them are some 
human pathogens like Enterococcusfaecalis and Pseudomonas aeruginosa.. 
Training experiments showed that Staph. aureus developed no resistance to manuka 
honey, but it is possible that a longer period of adaptation may be needed for 
resistance to develop. For these experiments 10 sub culturing steps were chosen to 
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mimic 10 wound dressing changes, as the average treatment time for sterilization of 
infected wounds has been reported to be between 7 and 9 days (Natarajan et al. 2001). 
On the other hand Pseud. aeruginosa showed a significant increase in the MIC for 
total honey activity when the single exposure to a sub-lethal concentration of honey 
was used. This resistance was thought to be due to a phenotypic adaptation and not a 
genetic mutation, as the susceptibility levels returned to normal after culturing in 
media without honey. This has been observed in Bacillus sp. in response to 
enviromnental factors and in bacteria that live in biofilms in response to disinfectants 
(Haque and Russell 2004; Russell 1999). 
Honey is a complex substance and microorganisms might be inhibited by a 
combination of antimicrobial factors present in honey, if so, the probability of 
resistance arising, would be expected to be reduced because microorganisms would 
have to develop simultaneous resistance to more than one antimicrobial factor. 
Nevertheless this does not mean that honey should be used indiscriminately, honey 
should still be utilised carefully to avoid the risk of developing resistance. Further 
work is needed to the test the possibility of resistance arising in these and other 
bacteria relevant to wound infection. Furthermore, there is a need for accurate in vivo 
studies that aim to verify all of this in vitro data. 
The commitment to death experiment showed that cells exposed to manuka honey 
reached a point at which viability was irreversibly lost at, sooner in Pseud. aeruginosa 
than in Staph. aureus. This might have been due to the concentration difference of 
honey used, or to the difference in susceptibility of the bacteria themselves. Further 
combinations of concentrations need to be tested. 
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6. A study of the morphological effects of honey on bacterial cells 
(Staphvlococcus aureus and Pseudomonas aerurzinosa) 
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6.1 Introduction 
Different antimicrobial agents act in different ways. Beta-lactam antibiotics, like 
penicillin and cephalosporin, interfere with bacterial growth by inhibiting the 
formation of cross-linkages in peptidoglycan molecules within bacterial cell walls. 
The aminoglycosides (eg. gentamicin) act by interfering with protein synthesis, often 
by binding to a ribosomal subunit or interfering with peptide bond formation. 
Quinolones inhibit DNA synthesis by binding to DNA gyrase, which is an enzyme 
needed for unwinding supercoiled DNA prior to replication (O'Meara et al. 2000). In 
all of these cases mode of action of the antimicrobial molecule was discovered after 
the identification and characterization of the active compound. 
For most antibiotics the action of the antimicrobial agent is usually specific, by 
affecting a narrow range of substrates or enzymes, which in turn are only available in 
a limited number of target sites within a bacterial cell. For example, cephalosporin, a 
broad spectrum antibiotic effective against Gram positive and negative bacteria, is 
only capable of incapacitating the cells by interfering with cell wall synthesis, by 
interfering with peptidoglycan synthesis in the final transpeptidation needed for the 
cross-linking of the peptidoglycan molecules (O'Meara et aL 2000). 
In some honeys, an important source of the antibacterial action has been identified as 
the generation of hydrogen peroxide, where it supplements the physical action of 
osmotic pressure (Cooper 2005c). Nevertheless taking into account the complexity of 
honey, it is possible that many other components have a role to play in the 
antibacterial activity of honey. Those honeys, whose activity is reduced by the 
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addition of catalase, are termed peroxide honeys, because the generation of hydrogen 
peroxide contributes to their activity. In the case of honeys that retain high activity in 
the presence of catalase the honey is a non-peroxide honey. Manuka honey is an 
example of such a honey. Furthermore, the non-hydrogen peroxide-derived activity in 
honey might be due to the combined action of some of the many different 
antibacterial components present in honey (acting in synergy) upon the bacterial cells. 
Most of the attempts to identify the antibacterial factors in honey have been 
concentrated in the analysis of the chemical composition of honey (Bogdanov 1997; 
Snow and Manley-Harris 2004). Several attempts have been made at fractionating 
honey to try to isolate the extra antimicrobial factors (Bogdanov 1997; Colombara and 
Clark 2001; Wahdan 1998; Weston et al. 2000; Zaghloul et al. 2001). A completely 
different approach is to use electron microscopy to observe the type of physical 
damage inflicted on the bacterial cells treated an agent, in the hope that changes to 
structure might allow a more informed search for the antimicrobial substance 
responsible for such effects. 
Electron microscopy has previously been used to determine the physical effect of 
antimicrobial agents on bacterial cells. Silva and colleagues (Silva et al. 1979)used 
electron microscopy to determine the effect of phenethyl alcohol on the morphology 
of Bacillus sp. and Streptococcus sp. This approach has also been used for the 
determination of the effects of biocides on bacterial cells (Hugo and Longworth 1965; 
Johnston et al. 2003). Recently it was also used for determining the effects of tea tree 
oil on Escherichia coli (Gustafson et al. 1998). In these cases electron microscopy 
was mainly used to determine membrane integrity and electron density of the 
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cytoplasmic space because loss of electron dense material was used to indicate loss of 
membrane constituents (Gustafson et al. 1998). 
Depending on the targets of the antimicrobial agents in question, stationary and 
exponential phase cells can have different sensitivities to the antimicrobial agent. This 
is because during the exponential phase of growth there is a rapid cellular growth, 
which is accompanied by the synthesis of many proteins and enzymes that are targets 
for the antimicrobial agent. These biosynthetic routes are of lesser significance in 
stationary phase, when the cells are growing slowly or not at all and secondary 
metabolisms starts producing a different range of molecules that can act as potential 
targets. Hence stationary phase cells tend to be more resistant to antimicrobial action. 
Eukayotic cells possess different phases in their cell cycle that include checkpoints at 
the end of each phase of growth in which the cells verify if growth and division is 
possible and should continue which are well understood, but the bacterial cell cycle is 
poorly understood. Bacteria mainly divide through binary fission (Fig. 19). Following 
the daugther cells separation, the cells enlarge in what is called the I-period, and 
mature. After this period the chromosome replication starts in the a period called the 
C-period, and after the replication of the chromosome is complete the next period is 
termed the D-period and it is the time between chromosome replication and cell 
division or cytokinesis (Edwards 198 1). 
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Figure 19. Example of bacterial cell cycle from Ohio State University, Mansfield, 
http: //www. mansfield. ohio-state. edu/-sabcdon/009bnfis. gif (20/02/2006). 
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In bacterial cell cycle one point that is of special interest to many scientists is the 
regulation of cytokinesis, as bacterial cells are diverse in shape and possess their DNA 
in the cytoplasm, and not inside a nucleus like eukaryotic cells. After DNA replication 
there are two types of signals that initiate the DNA prior to cell division: the Min 
system (the family of proteins, including the MinD protein produced by the cell are 
negative regulator of the formation of the division plate) and the nucleoid occlusion 
(the division plate will only form in areas that do not contain nucleic acids). These 
two systems form "inhibition7' zones in the cells, areas where the DNA will not 
segregate, this allows for an empty zone in the cells where the new cell wall for 
division during cytokinesis is going to be formed (Errington et al. 2003) (Fig. 20). 
There is more information about the formation of the division plane for rod-shaped 
bacteria like Bacillus subtilis, than for cocci-shaped bacteria like Staphylococcus 
aureus, although it is thought that the processes are similar (Koch 2000). 
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Figure 20. Selection of division plane in rod-shaped bacteria based on diagram by 
(Jacobs and Shapiro 1999) 
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The new cell wall is formed with the help of the action of the FtsZ protein, this is a 
cytosolic protein that when DNA is segregated to the poles of the cells, forms 
between them and through its polymerization it forms a ring in the cell which acts as 
the division plane for the formation of the two new daughter cells. Once this ring is 
formed it acts as the scaffold for the new cell wall and it is thicked by the deposition 
of cell wall components like peptidoglycan. Also murosomes (vesicles containing 
enzymes capable of separating the two daughter cells, autolysins) are secreted into 
this ring. The actual regulation of all these steps is of great interest to microbiologists, 
as is the activity of different antimicrobial agents upon the cell cycle of bacteria 
(Anderson et al. 2004; Errington et al. 2003; Gueiros-Filho and Losick 2002; Sun and 
Margolin 2001). 
The aim of this study was to understand the physical effects of exposure to honey on 
bacterial morphology, and to differentiate between changes induced by honey 
treatment in Gram positive and Gram negative bacteria in both exponential and 
stationary phases of growth. Therefore, Staph. aureus and Pseud. aeruginosa in both 
these phase of growth were studied. 
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6.2 Methods 
Cultures of Staph. aureus and Pseud. aeruginosa in different phases of growth 
(exponential and stationary) were incubated in manuka honey contained in buffer 
solutions between 4 to 8 hours, and morphology was compared to untreated cells 
using scanning and transmission electron microscopy. Throughout the rest of this 
thesis Tris buffer (0.05 mM, pH 7.2) was used for suspension of Staphylococcus 
aureus and MOPS buffer (0.2 M, pH 7.2) for suspension of Pseudomonas aeruginosa 
unless otherwise stated. 
6.2.1 Growth curves 
Growth curves for each of the two type cultures ued in this experiment (Staph. aureus 
NCTC 10017 and Pseud. aeruginosa ATCC 27853) were performed by inoculating 
20 ml of Isosensitest broth with 100 gl of an overnight culture and removing 2 ml of 
culture at known time intervals to determine absorbance at 520 nm Cecil 
spectrophotometer. Optical density versus time was plotted and exponential and 
stationary phases were identified so that cells at appropriate phases of growth were 
collected in the following experiments. 
6.2.2 Collection of stationary phase cells 
Cultures were grown overnight in two 20 ml volumes of Isosensitest broth (Oxoid) in 
a shaking (100 revs/min) water bath at 37'C to achieve stationary phase cells. The 
total volume of culture was spun down at 3000 g for 30 minutes (MSE harrier 15/80 
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centrifuge, Sanyo) and re-suspended in 20 ml of 0.05 mM Tris buffer (pH 7.2) with 
and without 10 % (w/v) manuka honey (in the case of Staph. aureus) for 4 hours, or 
MOPS buffer (pH 7.2) with and without 20 % (w/v) manuka honey for 8 hours in the 
case of Pseud. aeruginosa. 
For scanning electron microscopy (SEM), 4.5 ml of cell suspension were harvested, 
washed and resuspended in I ml of buffer, whilst for transmission electron 
microscopy (TEM) 3 ml of cell suspension was similarly concentrated into 1 ml of 
buffer. Washed cells were fixed in 750 gl of 3% glutaraldehyde (Fluka) for one hour 
at 4C, then washed twice with 1.5 ml of sodium phosphate buffer (0.1 M, pH 7.4) 
and resuspended in 1 ml of the same buffer. The solutions were stirred in the dark and 
at 4`C ovemight. 
6.2.3 Collection of exponential phase cells 
Stationary phase cultures (1 ml) were used to inoculate 100 ml of Isosensitest broth 
(Oxoid) and incubated for 3 hours in a shaking water bath at 37"C at 100 rpm. The 
samples were then processed as described in section 6.2.2 
6.2.4 Preparation of cells for electron microscopy 
Cells were examined by scanning and transmission electron microscopy following the 
method described by Lemar et al. (2002) except that TEM cells were embedded in 
Araldite resin and not Spurr. A brief description of the method follows. 
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Briefly, gluteraldehyde fixed cells were resuspended in buffered 1% (v/v) osmium 
tetroxide (OS04) in phosphate buffer (0.1 M, pH 7.2) for I hour at 41C. This 
additional fixation stage prepared the lipids in the bacterial membranes for electron 
microscopy. 
After fixation the cells were spun down in a microcentrifuge (Eppendorff 5414) and 
osmium. tetroxide was decanted. This was replaced with 30 % (v/v) ethanol, and 
incubated for 5 minutes. The cells were once again spun down, the 30% ethanol 
removed and re-suspended in 50% (v/v) ethanol. This solution was incubated for 5 
minutes. The same procedure was repeated for 50%, 70%, 90% and 100% (v/v) 
ethanol. If the samples could not be fully processed on the same day they would be 
left in 70% (v/v) ethanol and kept at 4T. 
6.2.5 Scanning electron microscopy 
The samples were added to small plastic containers (labelled by cutting a roman 
numeral into it) that were fitted with a 0.4 gin filter membrane (Nucleopore Track- 
Etch membrane 13 mm, Whatinan) attached to blotting paper to trap cells for critical 
point drying (Fig 21). Any ethanol in the sample was allowed to dissipate to the air 
and into the blotting paper, and 100% ethanol was added and allowed once again to 
evaporate taking care not to let the sample completely dry (this procedure was 
repeated twice). After the final wash a small volume of ethanol was added to the 
containers (this will be displaced in the critical point dryer). 
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Figure 21. Diagram of the containers holding samples for critical point drying. 
SamPle in 100% ethanol 
L6L=---* 
Membrane 
The samples are added to the critical point drying machine (CPD 030; Balzers, 
Lerchtenstein) and dried to critical point. Then the samples were mounted using 
double sided adhesive tape onto an aluminium slab (10 x 10 mm Jeol type, Agar 
Scientific). Sputter coating (gold coating) was performed in a sputter coater (S150B; 
Edwards, West Sussex, UK) and the images were viewed using a scanning electron 
microscope (20.0 kV, XL 20, XL series, Philips). 
In total 8 samples were prepared for Staph. aureus and 10 for Pseud. aeruginosa. For 
each sample a minimum of 6 images were collected (2 high magnification and 4 low 
magnification) and a maximum of 14 (4 high magnification and 8 low magnification). 
At least 600 different cells in randomly selected fields of view were examined for 
each treatment and the number of damaged (holes in the cell, debris, distorted 
morphology) and undamaged (normal cells shape) cells was recorded. 
6.2.6 Transmission electron microscopy 
Following ethanol replacement (the suspension steps in increasing concentrations of 
ethanol) was complete, pellets were released into a fresh 10 ml glass container using a 
squirt of 100% ethanol and a cocktail stick. The pellet was allowed to stand 15 
minutes in 100% ethanol, and then transferred to fresh 100% ethanol for a further 5 
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minutes. Then the pellet was transferred to 5 ml propylene oxide and left for 15 
minutes in order to displace the ethanol inside the pellet of cells. 
The pellets were transferred to Araldite resin (5 g of araldite CY212 and 5g of DDSA 
are preheated, mixed together and 0.3 g of BDMA, Agar Scientific) / propylene oxide 
(50: 50), about 9 ml per sample and left overnight in the orbitator (Agar Scientific) 
that rotated the samples at an angle for better infiltration of the resin into the pellet 
and for the propylene oxide to evaporate. The infiltrated pellets were then transferred 
into 5 ml of fresh resin (no propylene oxide), and left for 12 hours in the orbitator 
(Agar Scientific) Once this incubation was finished the pellets were transferred into 
moulds previously filled with full strength resin taking care to place the pellets near to 
the edge. The moulds were then incubated in the oven for 3 days at 60'C. 
For the ultra-thin sectioning glass knives were used for the trimming and for the 
sectioning and an Ultratome III (LKB, Stockholm, Sweden). Before the samples could 
be sectioned they had to be trimmed in order to remove the excess resin around the 
samples and expose the pellet of cells. The sections were then mounted (placed) onto 
an uncoated 3.00 mm copper grid (Agar Scientific). 
A measure of Nesco film was added to the tile of the designated staining area and 
labelled on the top with the reference names of the samples to be stained. A drop of 
uranyl acetate was then added on top of the film underneath the respective labels and 
2 grids were added to the drop with the side containing the ultra-thin section facing 
down, and were incubated in the dark for 10 minutes. A drop of lead citrate was added 
to the film for each of the samples and the grids were transferred to the lead citrate 
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and incubated for 5 minutes. After this staining the grids were washed 3 times using 
the same procedure, but with drops of filter sterilised water. 
For TEM 10 resin blocks with Pseud. aeruginosa were prepared and from each block 
at least 5 grids were prepared. Two were stained, and examined by TEM and 
photographed. In the case of Staph. aureus, 8 resin blocks were prepared and from 
each block a minimum of 6 grids were prepared, of which 2 were stained for 
visualization with TEM. The microscopy was performed in a transmission electron 
microscope (1210; Jeol). 
Throughout these experiments cells that were not treated with honey, are referred as 
control cells and cells treated with honey are test cells. Electron micrographs were 
examined for structural changes; usually more than 600 cells were observed each for 
normal and abnormal appearance (such as holes, different shape, debris and septa) in 
both SEM and TEM images. Also, numbers of cells with complete septa were 
recorded in TEMs of Staph. aureus. Results were analysed for statistically significant 
differences using the Mann-Whitney test in MiniTab Statistical computing package 
(Version 14). 
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6.3 Results 
6.3.1 Growth curves 
The exponential cells were collected after 3 hours incubation at 37 'C in nutrient broth 
as indicated by the arrows in Figure 22 and 23. 
Figure 22. Pseud. aeruginosa growth curve in nutrient broth. 
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Figure 23. Staph. aurcus growth curve in nutrient broth. 
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6.3.2 Staph. aureus electron microscopy 
Using the scanning electron microscope control cells (Figure 24) showed cells with 
normal morphology (regular cocci) whilst Staph. aureus samples incubated with 10% 
w/v manuka honey for 4 hours cells, some physical damage (ruptured walls and 
irregular shape) were observed (Figure 25 and 26). The most interesting changes were 
observed in thin sections by transmission electron microscopy, where an increased 
number of septated cells (Figure 28) and cells with electron dense material (Figure 
29) in honey treated samples were noted in comparison to control cells (Figure 27). 
For Staph. aureus an average of 6 TEM micrographs with a magnification of 10 000 
times (for septum count) and 80 000 times for detail view for each of the 8 (4 
exponential and 4 stationary) samples. For SEM an average of 8 micrographs were 
taken with a magnification of 10 000x (for the assessment of damage) on each of the 
8 samples (4 exponential and 4 stationary) for analysis. The amount of cellular 
structural damage (debris, ruptured cell walls and irregular shape), observed by SEM 
and the number of septated cells (cells with a complete septum present), observed by 
TEM was determined (Table 15). The criteria for including cells in the analysis were 
as follows: 
1) The field of view in the photo should contain the lowest possible number of 
clumped of cells (when clumps were present the cells in the clumps were 
disregarded). 
2) Only whole cells (cells that were entirely in the micrograph) were counted. 
3) For the septum determination, cells with a complete septum were counted 
and compared to those with partial or no septa. 
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4) To assess structural damage, cells with debris, irregular shape and rupture 
walls were recorded, and compared to numbers of cells without these changes. 
5) The fields selected for capture were selected on the basis of medium cell 
density. An image with an average of about 400 cells was used (too many cells were 
difficult to count and few cells would have made it necessary to take more photos) 
The amount of damaged cells present in Table 15 was determined using SEM and the 
amount of cells with fully formed septa was assessed using TEM. 
Table 15. Staph. aureus electron microscopy results (damage and full septa). 
Treatment Exponential phase cells Stationary phase cells 
% Damage % Septa % Damage % Septa 
No honey 1 (n = 612) 20 (n = 1025) 1 (n = 599) 10 (n = 1178) 
10% (w/v) honey 10 (n = 610) 30 (n = 1135) 10(n=634) 20(n=1235) 
Stat. Sign. p=0.014 p=0.05 
n= number of cells counted 
It was not possible to perforn statistics on the amount of damaged cell counts were 
accumulative, and not separated into fields of view, as in the septum formation. 
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Figure 24. SEM micrograph of Staph aureus cells after 4 hours incubation in Tris 
buffer (50K x magnification). 
Figure 25. SEM micrograph of Staph aureus cells after 4 hours incubation in Tris 
buffer containing 10% (w/v) manuka honey (I OK x magnification). 
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Figure 26. SEM micrograph of Staph aureus cells after 4 hours incubation in Tris 
buffer containing 10% (w/v) manuka honey (detail) (80K x magnification). 
Figure 27. TEM micrograph of Siaph aureus cells after 4 hours incubation in Tris 
buffer (60K x magnification). 
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Figure 28. TEM micrograph of Staph aureus cells after 4 hours incubation in Tris 
buffer containing 10% (w/v) manuka honey (20K x magnification). 
MW 
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Figure 29. TEM micrograph of Staph aureus cells after 4 hours incubation in Tris 
buffer containing 10% (w/v) manuka honey (electron dense cells) (60K x 
magnification). 
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6.3.3 Pseud. aeruginosa electron microscopy 
For Pseud. aeruginosa an average of 12 TEM micrographs of each of the 10 samples 
(5 exponential and 5 stationary) with magnification ranging from (10 000 to 40 000x), 
and an average of 8 SEM micrographs with a magnification of 10 000x of the 10 
samples (5 exponential and 5 stationary) were analysed. 
In this study two different buffers were used. Initial attempts to analyse structural 
changes in Pseudomonas sp. employed cells suspended in Tris buffer (0.05 MM, pH 
7.2), but then it was realised that Tris buffer, has been shown to alter membrane 
permeability in Grain negative bacteria (Irvin et al. 1981). Therefore this was replaced 
by MOPS buffer (0.2 M, pH 7.2). Electron micrographs obtained by TEM and SEM 
for Pseud. aeruginosa suspended in Tris buffer can be seen observed in figures 30-35. 
In SEM and TEM controls there did not appear to be obvious damage nevertheless 
SEM of honey treated cells showed cells with holes and irregular shape (Fig. 34), 
TEM of treated cells present gaps in the cytoplasmic space (Fig. 3 1) and both control 
and test samples are less electron dense (Fig 31 and 32). As there was some damage 
observed with TEM (less electron dense) the rest of the work was carried out using 
MOPS which is not a buffer known to induce membrane permeability in Gram 
negative bacteria (which can also be confirmed by the absence of membrane damage 
in the electron microscopy micrographs of MOPS treated cells). 
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Figure 30. TEM micrograph of Pseud. aeruginosa cells in Tris buffer (20K x 
magnification). 
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Figure 31. TEM micrograph of Pseud acruginosa cells inTris bufter containing 20% 
(w/v) manuka honey for 4 hours (20K x magnification). 
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Figure 32. TEM micrograph of Pseud aeruginosa cells in Tris buffer for 4 hours 
(20K x magnification). 
Figure 33. SEM micrograph of Pseud. aeruginosa cells in Tris buffer (80K x 
magnification). 
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Figure 34. SEM micrograph of Pseud aeruginosa cells in Tris buffer containing 20% 
(w/v) manuka honey for 4 hours (65K x magnification). 
Figure 35. SEM micrograph of Pseud. aeruginosa cells in Tris buffier for 4 hours 
(50K x magnification). 
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In the case of the Pseud. aeruginosa suspended in and visualised by SEM regular rod 
shaped cells for the controls with no surface changes observed (Fig. 36) (cells 
incubated in MOPS buffer for 8 hours) were observed. After exposure to MOPS 
buffer with 20% (w/v) manuka honey the number of cells presenting irregular shape 
(Fig. 37 and 38), blebs (membrane damage) (Fig. 38) and debris around them 
(membrane rupture) (Fig 37 and 38) increased. The statistical analysis of the damages 
observed after exposure to honey are summarized in Table 16. 
Using transmission electron microscopy, control cells presented some electron dense 
material and the occasional mineral deposit. Electron micrograph of honey-treated 
cells presented electron dense deposits, possibly minerals, and some empty vacuoles 
inside the cells (Fig. 40 and 41) were observed in cells exposed to honey. Some empty 
cells (shells of cells that had a membrane rupture) were also observed (Fig. 40 and 
41). It is possible that the empty spaces inside the cells could have been mineral 
deposits that were lost during ultra-thin sectioning. Another characteristic of honey 
treated cells was the fact that they appeared to have a darker cytoplasm, which is 
indicative of an increase in electron dense material. Septated cells were not observed 
using TEM in Pseud. aeruginosa. 
Table 16. Pseud. aeruginosa damaged cells observed by SEM at 8 hours incubation 
MOPS buffer with or without 20% (w/v) manuka honey. 
Treatment Exponential phase cells Stationary phase cells 
No honey 2% (n =1568) 2% (n =2414) 
20% (w1v) honey 80% (n =1 100) 60% (n--283) 
Stat sig. p=0.0003 P=0.0001 
n=number of cells observed 
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Figure 36. SEM micrograph of untreated Pseud aeruginosa cells (IOK x 
magnification). 
Figure 37. SEM micrograph of Pseud aeruginosa cells after 4 hours incubation in 
MOPS buffer containing 20% (w/v) manuka honey. A) debris, b) irregular cells shape 
c) short rods (I OK x magnification). 
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Figure 38. SEM micrograph of Pseud aeruginosa cells after 8 hours incubation in 
MOPS buffer containing 20% (w/v) manuka honey. a) debris, b) irregular cells shape 
c) cells blebbing (I OK x magnification). 
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Figure 39. TEM micrograph of untreated Pseud aeruginosa cells (IOK x 
magnification, size bar =5 [tm). 
p Ilp 'or qw 
ID 
ja 
.0 
Le .0 
I. 
4 
-c 
168 
Figure 40. TEM micrograph of Pseud aeruginosa cells after 8 hours incubation in 
MOPS buffer and 20% (w/v) manuka honey (20K x magnification, size bar-- 2.5 [im). 
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Figure 41. TEM micrograph of Pseud aeruginosa cells after 8 hours incubation in 
MOPS buffer and 20% (w/v) manuka honey (25K x magnification, size bar =2 [im). 
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The results for the EM of Staph. aureus (darnage and septa formation) and Pseud. 
aeruginosa (damage) in the different phases of growth, stationary and exponential 
phases of growth (Table 15 and 16) were significantly different (P=0.0003 for Pseud 
aeruginosa and p=0.028 for Staph. aureus). Exponential cells presented significantly 
more damage and/or septa that stationary phase cells. 
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6.4 Discussion 
Analysis of the images obtained by electron microscopy showed that both of the 
bacteria underwent morphological changes in the presence of honey, and that the type 
of damage observed was different in each species. The criteria for counting damaged 
cells excluded cells in clumps because the whole cell was difficult to visualize, and it 
was impossible to accurately estimate the extent of cell damage. For example, one 
edge of the cell might show no damage, but the other, which was inside a clump of 
cells, might have been damaged. Also only cells with fully formed septa were 
considered in this study as cells with a partial septum were rare it was impossible to 
judge whether these septa would develop later or not and lead to cytokinesis. 
Using SEM with Staph aureus it was observed that honey induced physical changes 
in cells (Table 14), with an increase in the number of cells demonstrating irregular 
shape and increased incidence of cellular debris (Fig 26). However, the most striking 
change was an increase in the number of septated cells (Fig. 28) present in the honey 
treated cultures that was observed using TEM. In both phases of growth (p=0.014 for 
exponential phase cells and p=0.05 for stationary phase cells), increased septation was 
significant. Septa are formed immediately before cell division therefore, if the cells 
were healthy, this could be an indication that the cells were about to divide. If this true 
there would be an increase in the number of cells present, nevertheless in chapter 6 it 
was shown that the culturable cell count decreased almost immediately after exposure 
to honey. Contrary to expectation from time-kill curves (Fig. 15 and 16) the total 
number of cells did not decrease in parallel with the number of culturable cells (Fig. 
18 and 19). It is possible to speculate that the cell division stage of the bacterial cell 
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cycle was interrupted just prior to cytokinesis, or that the cells were prompted to form 
cross wall too soon in the cell cycle and could not finish the cell division process for 
lack of maturity. 
It is possible that the cells could have entered a viable-but-non-culturable (VBNC). In 
this state, cells are normally alive but cannot be cultured. This could be of importance 
in a clinical context because cells would be unable to multiply in the wound allowing 
time for the immune system to act upon an infected wound effectively. Attempts were 
made to determine whether the Staph. aureus cells increased in size, but this was not 
achievable. Staph. aureus are spherical so an increase in volume is difficult to identify 
because it translates into small changes in cell diameter. The presence of electron 
dense material is one of the characteristic of starvation responses in bacteria (Watson 
et al. 1998) and this can lead to a VBNC - type of response (Oliver 2005). 
In the case of Pseud. aeruginosa, SEM images showed an increase in the number of 
cells with damage (Table 16) to their cells walls, as illustrated by the irregular shape, 
blebs and increase in debris (Figs 37 and 38). When considering some of the 
components in honey that are responsible for its antibacterial activity, such as the 
sugar concentration (increased osmotic pressure) (Vijaranakul et al. 1995) and pH 
(Tuttle et al. 1977), one would expect membrane damage to become apparent in the 
first instance due to the efflux of water from the inside of the cells (leading to 
decrease in turgor pressure, plasmolysis and cells shrikange) (Vijaranakul et al. 1995) 
and in the case of pH inactivation of enzymes essential in the cells wall turnover 
(Tuttle et al. 1977). This would lead to a decrease in the cell volume which is 
observed in the SEM micrographs, by comparing the length of the rods in figure 37 
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with the length of the rods in Figure 39, in the latter the rods are visibly shorter, 
denoting a decrease in cellular volume. 
A reduction of the honey-treated cell size could be observed with SEM in Pseudo. 
aeruginosa, in this case the honey-treated cells have assumed an almost coccal shape, 
which is an indication of a stress response (Oliver 2005). 
The TEM images of Pseud aeruginosa, showed an increase in electron dense (dark 
colour) materials within the cytoplasm of honey treated cells (Fig. 40), compared with 
the control (Fig. 39). Also rough cell walls (Fig. 41, letter a) and vacuoles within cells 
were observed (Fig. 40 and 41, letter b) and these could have been sites of mineral 
deposits that were lost during ultra-thin sectioning. This is supported by the presence 
in some cells of black circular deposits inside the cells (Fig. 40, letter c), which could 
represent minerals that were lost during sectioning from the cells with empty pockets 
inside. 
Increased septation was not observed in honey-treated Pseud. aeruginosa, but this 
does not mean that it was not present, because this is a rod-shaped cell, there are more 
planes of sectioning decreasing the chances of sectioning exactly where the septum 
has formed. Since this study was completed, further work has been conducted by a 
research assistant in UWIC that has demonstrated that at 24 hours the proportion of 
septated MRSA cells increased to almost 100% (Cooper, personal communication). 
These observations of morphological changes in both the Pseud. aeruginosa and 
Staph. aureus suggest a possible entry into the VBNC state. In order to verify this an 
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accurate estimate of the number of viable cells would have to be obtained, this is 
usually obtained through flow cytometry analysis of cultures with specific viability 
dyes like oxonols. Several attempts have been made to quantify the number of viable 
cells in honey treated cultures with using DiBAC4 (3) (Sigma) and SYTO 3 dyes by 
flow cytometry (Molecular Probes). To date limited success has been achieved, as the 
cells seemed to become impermeable to these dyes and inconsistent results have been 
obtained. Previous studies at UWIC (Cooper, personal communication) have failed to 
stain honey-treated cells with propidium iodide and ongoing student projects are 
investigating this problem. It appears that dead cells do not accumulate in cultures 
exposed to honey. It is possible that lysis quickly follows loss of viability. 
Although fluorescent dyes might possibly be used to explain the difference between 
the total and culturable cells counts, they are unlikely to help to explain the increase in 
the number of septated cells observed in the honey treated Staph. aurcus cultures. It 
seems that manuka. honey induces interruption of the bacterial cell cycle just prior to 
division. One way of investigating this phenomena further would be to investigate the 
effect of honey on the expression, synthesis or activity of the enzymes murein 
hydrolase and peptidoglycan hydrolase, which are both, coded for in the ad gene. 
These enzymes are responsible for the separation of daughter cells, as well as the cells 
wall turnover; if they were incapacitated the cells would not be able to divide (Foster 
1995; Takahashi et al. 2002). 
The main conclusion to be drawn from these experiments is that Gram negative and 
Gram positive bacteria respond in different ways to honey treatment. In Pseud. 
aeruginosa the damage seems more physical in nature, whilst in Staph. aureus there 
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seems to be a physiological response to the exposure to honey that leads to its loss of 
viability. 
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7. A study of the phvsiological effects of honey on bacterial cells 
(Staphvlococcus aureus and Pseudomonas aeruainosa) 
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7.1 Introduction 
Electron microscopy (Chapter 6) showed that following incubation of Staph. aureus 
with honey for 4 hours, the proportion of cells with a complete septum increased. It is 
possible that an interruption in the daughter cell separation step of the cell cycle that 
in bacteria is mediated by the products of the atl gene (Takahashi et al. 2002; Foster 
1995) and one way this hypothesis could be verified would be to screen genetic 
mutants for changed sensitivity to manuka honey. Using the data collected through 
electron microscopy it seems that the effects on Pseud. aeruginosa seem to be more 
of a physical nature, whilst the effects in Staph. aureus seem to be more of a 
physiological nature. 
In order to better understand the effects of honey upon the cytokinesis process and 
upon the stress response of the bacterial cells, which is responsible for the survival of 
cells in response to starvation, two Staph. aureus mutant strains deficient in the atl 
gene (responsible for the precursor that generates the enzymes responsible for 
cytokinesis) and sigB gene (responsible for the expression of the Sigma factor B 
which protects cells from stress, by helping in the correct folding and translocation of 
proteins, among other tasks), will be assayed for changes in susceptibility to honey in 
comparison to the parental strains. 
The antimicrobial activity of honey has different effects in Gram positive and Gram 
negative bacteria. In order to have a better understanding of the physiological changes 
that led Staph. aureus to an increase in the number of septated cells a better 
understanding of how the cellular protein profile (proteome) changes in the presence 
177 
of honey. Furthermore, there is a need to further understand the physiological changes 
that are brought about in Gram negative bacteria, like Pseud aeruginosa, in order to 
compare to those observed in Gram positive bacteria. This information would allow a 
better understanding of the manuka honey mode of action. 
Biocidal agents can be divided into 6 classes: oxidizing agents (eg. hydrogen peroxide 
and hypochlorite), alkylating agents (eg. formaldehyde and glutaraldehyde), metal ion 
binding agents (eg. EDTA), nucleic acid binding agents (eg. acridine dyes), protein 
denaturing agents (eg. phenols and alcohol) and agents that interact with proteins (eg. 
cationic detergents). Their potency is dependent upon their capacity to reach their 
intracellular target, so uptake of a biocide is vital. In order to study the mechanism of 
action of biocides different methods can be employed, these can include analysis of 
the surface binding and uptake characteristics, detection of membrane damage by 
leakage of cytoplasmic constituents and inhibition of key metabolic functions like 
respiration (Lambert 2004). 
When bacteria are exposed to antibacterial agents bacteria can respond by altering 
their physiological activity (Gilbert and McBain 2003), by activating previously 
unexpressed genes (Gilbert and McBain 2003; Martinez and Baquero 2002), and in 
the case of physical damage, by leaking of molecules into the surrounding media 
(Tuttle et al. 1977; Gilbert and McBain 2003). If the cells incur gross membrane 
damage, large holes may be formed allowing ATP and even large molecules like 
proteins, to be leaked into the surrounding media, whereas of minor membrane 
damage, only small molecules will be able to exit the cell, such as inorganic 
phosphate and potassium ions (Johnston et al. 2003). In order to study the effects of 
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manuka honey on membrane integrity, leakage of materials such as inorganic 
phosphate, protein and ATP will be studied by assaying their concentration in the cell 
free supernatant after honey treatment. 
The electron transport chain, because of its central metabolic role is a suitable target 
for many antimicrobial agents, and as such it is considered important when trying to 
understand the action of honey on microbial cells to investigate the effect of 
inhibitory agents on respiration and ATP synthesis (Cabral 1993; Murray and Murro 
1991). An oxygen electrode will used to determine the capacity of honey treated cells 
to respond to nutrient stimuli, to assess their rate of endogenous oxygen consumption 
and determine whether energy conservation is coupled to the electron transport chain, 
by using the uncoupling agent CCCP. 
An investigation into the effects of Medihoney on Escherichia coU K12 (Blair 2004) 
using microarray technology, revealed that honey produces a general down regulation 
of genes involved in protein synthesis. No further work has been developed into using 
this technology to study the effects of honey on Gram positive bacteria. In UWIC 
microarray technology is not available so a different approach was used to the effects 
of manuka honey on Gram positive bacteria protein profile (proteome). 
Whilst the microarray technology allows for the study to protein profile by an analysis 
of the translation of the genes conding for them, Two-dimensional protein 
electrophoresis allows for the study of the final protein complement of the cell at any 
one time. This technique combines two steps of protein separation, the first of which 
separates the proteins based on a pH gradient in special strips, which are then inserted 
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into polyacrylamide gels where they are separated once more along an electric 
gradient. This allows for the proteins to be separated and a profile or proteorne 
obtained. This can then be compared with proteomes for the same bacteria under 
different condition to determine the effects of an antimicrobial agent. One of the main 
advantages that two-dimensional protein electrophoresis besides the lower cost when 
compared with microarray technology, is that any bacteria can be tested using this 
technique (including clinical strains), whilst with the microarray technology any assay 
is dependent on the commercial availability of microarrays for the specific bacteria to 
be studied or will involve the development of in-house microarrays that can take up a 
great amount of time and cost. 
The aim of this work is to try to clucidatc the physiological changcs that occur in 
Pseud. aeruginosa and Staph. aureus when exposed to manuka honey. 
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7.2 Methods 
Throughout this chapter Tris buffer (0.05mM, pH7.2) and MOPS buffer (0.2M, pH 
7.4) were used as well as Staphylococcus aureus NTCC 10017 and Pseudomonas 
aeruginosa ATCC 27853. 
7.2.1 Mutant screening altered sensitivity to manuka honey 
Two Staph. aureus mutants tested for a change in the sensitivity to manuka, honey 
were a SigB mutant (in SH 1000, TET 5, reference number 1028) and its parental 
strain (SH 1000, reference number 682 ) and an atl mutant (in 8325-4, ERY 5, 
reference number 187) and its parental strain (8325-4, reference number 57), which 
were created in Professor Simon Foster's laboratory in Sheffield University. The 
cultures were kindly provided by Professor Foster for this study. 
For these 4 cultures the MIC and the MBC against M109 was tested using the 
microtiter plate method described in section 3.2. Statistical analysis was performed 
using the Mann-Whitney test in Mini-Tab 4.0, to determine whether the differences 
were significant. 
7.2.2 The effect of manuka honey on the respiration of bacteria 
Cultures of 50 ml of Staph. aureus and Pseud. aeruginosa were incubated overnight 
in Iso-sensitest broth and the total culturable count determined using the method 
described in section 6.2.6 before harvesting. Aliquots with 20 ml of the overnight 
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culture are spun down (15 minutes at 3 000 g) and re-suspended in either Tris/ MOPS 
buffer (control) or Tris/ MOPS buffer and 10 or 20 % honey (manuka, Gale's or 
artificial, previously described in chapter 5) respectively. 
At known time intervals 3 aliquots of 1 ml of samples (of both the test and control 
suspensions) were collected by centrifugation at 13 000 g and cells were washed 
twice in I ml of the appropriate buffer, Tris (0.05 M, pH 7.2) for Staph. aureus and 
MOPS (0.2M, pH 7.4) for Pseud aeruginosa. After washing, 1 ml of washed cells 
suspended in buffer were added to a Clarke type oxygen electrode chamber (teflon 02 
permeable membrane, silver anode/platinum cathode with magnetic stirring) (Rank 
Brothers oxygen electrode) with mixing. 
In order to determine the effect of honey incubation on the endogenous rate of 
respiration after the cell suspensions were added to the chamber the rate of oxygen 
consumption was recorded for a minimum of 2 minutes, both for cells incubated in 
buffer alone and in buffer with honey. After this time 40 gI (for Staph. aureus) or 100 
ptl (for Pseud. aeruginosa) of Isosensitest broth was added to stimulate respiration and 
the rate was recorded for 10 minutes (Tincu et al. 2003) in order to observe the effects 
of honey incubation on the response to the media stimuli. 
The effect of manuka honey on cells which had not been incubacted in honey was 
tested by recording the oxygen consumption rate after the addition of medium for 5 
minutes and by adding 100 gI of a neat manuka (MI09) solution (made less viscous 
by incubation at 50*C for 30 minutes). Changes in oxygen consumption were 
recorded for a further 8 minutes (total of 15 minutes). 
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The bacterial cultures were also treated with uncoupling agent CCCP (Sigma) (stock 
concentration of 0.1 mg/ml, 500 IiM) to determine if the electron transport chain was 
coupled to ATP synthesis. Briefly, a titration curve was made to determine the 
optimum amount of uncoupling agent to add to the chamber in order to get the 
maximum stimulation of respiration (Fig. 42). For this the cells incubated in buffer 
were added to the oxygen electrode chamber and after recording the endogenous rate 
of oxygen consumption, the appropriate volume of isosensitest broth was added (40 gl 
for Staph aureus and 100 gl for Pseud aeruginosa). The respiration rate of the 
cultures was recorded for up to 2 minutes, after which different volumes of the 
uncoupling agent CCCP was added to the chamber. Once this concentration was 
determined, the endogenous and respiration rates were recorded both for cells 
incubated in buffer alone and in buffer with manuka honey for different periods of 
time and the uncoupling agent was added and the effect recorded. 
Figure 42. Determination of the optimal concentration of CCCP uncoupler in Staph. 
aureus culture grown in isosensitest broth. 
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An average of 10 repeats per time point were recorded, using a data recorder. This 
recorded the data as percentage saturation (arbitrary units) of oxygen. In order to 
estimate the oxygen respiration rate in each experiment, a calibration curve was 
produced as follows. Maximum 02 saturation at 37'C was taken to be 10.56 g mol/ml 
(Gnaiger 2004) the respiration rates corresponding to a series of angles of electrode 
trace (Fig. 43) were calculated, and used to construct a calibration curve (Fig. 44). 
The angle, and therefore the respiration rate, for any individual experiment could then 
be read off the graph or calculated from the equation. 
Figure 43. In order to calculate the rate of respiration, the angle of the respiration 
curve was determined as shown in this figure and used in the equation shown in 
Fig. 44. 
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Figure 44. Calibration curve for determination of oxygen consumption rates based on 
the measurement of the angle of the respiration curves. 
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7.2.3 Leakage studies 
Initially these studies were performed with cells grown in broth alone and in broth 
containing manuka honey, and cell-free supernatants were collected to test for the 
leakage of inorganic phosphate, ATP and proteins. However it was found that it was 
not possible to detect changes even between the different concentrations of standards. 
The next approach was to use suspended cells in buffer alone or buffer with honey, 
and to test the culture supernatants for leaked metabolites, but is was found that honey 
was the interfering substance. Therefore, it was decided to use cells that were treated 
in buffer alone or in buffer with honey for known intervals before cells were 
resuspended in honey free buffer, and supernatants from these cell suspensions were 
used for the determination of leaked metabolites (Cox et al. 1998). 
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Hence two litre cultures of either Staph. aurcus NCTC 10017 or Pseud. aeruginosa 
ATCC 27853 in Isosensitest broth (Oxoid) were incubated overnight at 37T with 
shaking (100 rpm). Cells were harvested by centrifugation for 5 minutes at 10 000 g 
(Sorval RC-5b Refrigerated Superspeed Centrifuge, Du Pont Instruments) and 
resuspended in I litre of Tris buffer (0.05 mM, pH 7.2) alone or Tris buffer with 10% 
(w/v) manuka honey in the case of Staph. aureus, or MOPS alone or MOPS (0.2M, 
pH 7.2) with 20% (w/v) manuka honey for Pseud. aeruginosa. 
The suspensions were incubated at 37C with shaking and every 30 minutes (up to 2 
hours), 200 ml of cells from either the cells in buffer or cells in buffer and honey were 
collected and spun down for 2 minutes at 10 000 g (Sorval RC-5b Refrigerated 
Superspeed Centrifuge, Du Pont Instruments). Pellets were resuspended in 9 ml of 
buffer (Tris for Staph. aureus and MOPS for Pseud aeruginosa) and aliquotted in 1.5 
ml portions into 6 eppendorf tubes. Each pellet was washed twice in 1.5 ml of buffer 
and washed cells were resuspended in 1.5 ml of their respective buffers. For 3 of the 
tubes the cell suspension was immediately spun down and the supernatant removed to 
a fresh eppendorf (labelled time 0 minutes) and the remaining 3 tubes were allowed to 
stand at room temperature for 15 minutes (time 15 minutes). After the 15 minutes 
incubation the cells were spun down and the supernatant transferred to a fresh 
eppendorf. Once all of the supernatants had been collected assays for inorganic 
phosphate, protein and ATP leaked to the buffer were performed. Summary of this 
method can be seen in Figure 45. 
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Figure 45. Schematic representation of the leakage studies methodology. 
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7.2.3.1 Determination of inorganic phosphate in the cell free supernatant of cells 
with and without manuka honey treatment 
For the determination of inorganic phosphate the method of Fiske and Subbarow 
(1925) was used. Briefly a standard solution of KH2PO4 containing I gmole/ml that 
was used to prepare a range of dilutions between 0.1 and 1.0 9mole phosphate in 1 
ml. To each dilution was added 1.0 ml of 10 M H2SO4 followed by 1.0 ml of 2.5% 
(w/v) ammonium molybdate solution. After mixing, 0.1 ml of a freshly prepared 
solution of reducing agent (0.2% w/v 1-amino-2-naphthol sulphonic acid, 1.2% w/v 
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sodium metabisulphite and 1.2% w/v sodium sulphite) was added and the mixture 
allowed to stand at room temperature for 30 minutes. Extinction at 660 run was 
measure against a blank reagent containing 1.0 ml of water instead of diluted 
phosphate. One ml samples of culture supernatant were processed in the same way. 
7.2.3.2 Determination of protein in the cell free supernatant of cells with and 
without manuka honey treatment 
Culture supernatants were tested for protein as described in section 2.2.2.3. 
7.2.3.3 Determination of ATP cell free supernatant of cells with and without 
manuka honey treatment 
For ATP determination the UniLiteo kit from Biotrace Ltd (Bridgend) was used. 
Reagent A was reconstituted in Reagent B immediately before use (to provide a 
stabilised luciferase solution). Samples (100 ýtl) were added to ATP free tubes, 40 gl 
of the swabbing solution (a releasing agent) was added and then 40 ý11 of the 
luciferase solution. The tube was mixed for 5 seconds and the resulting light measured 
using the BioTrace portable luminomenter. ATP (Sigma) standards were diluted and 
measured immediately wih Biotrace luminometer and a calibration curve was plotted 
to read the results from the test samples (Fig. 46). This method is based on the 
manufacturers manual. 
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Figure 46. Example of a calibration curve for ATP standard curve in Biotrace 
luminometer (RLU = relative light units). 
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7.2.4 2D protein electrophoresis protocol for Staph. aureus cells 
When Staph. aureus cells were treated with manuka honey it was found that they 
leaked protein. The optimal time to extract maximum levels of protein for both test 
and control samples was determined with a timed extraction of proteins from Staph. 
aureus. 
Two litres of overnight culture of Staph. aureus NCTC 10017 cells in Isosensitest 
broth (Oxoid) were prepared by overnight incubation at 37'C and shaking (100 rpm). 
The overnight culture was divided in two equal portions and harvested at 10000 g for 
5 minutes (Sorval RC-5b Refrigerated Superspeed Centrifuge, Du Pont Instruments). 
One of the portions was resuspended in Tris buffer (0.05mM, pH 7.2) alone and the 
other in 10% (w/v) manuka honey in Tris buffer. Both were incubated at 37'C with 
shaking (100 rpm). One hundred ml of each sample were collected every 10 minutes 
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for the first hour and every 30 minutes up to 2 hours and spun down at 10 000 g for 2 
minutes. Once the cells were collected they were processed for protein extraction 
Due to time constraints this experiment was only performed in Staph. aureus. 
7.2.4.1 Protein extraction from Staph aureus cells incubated with and without 
manuka honey. 
This method was based on the method by Kohler (2003). The pelleted cells from 7.2.4 
were washed twice in 2.5 ml of ultrapure water and then resuspended in the same 
volume of tris EDTA buffer with 2 mM phenylmethylsulfonyl fluoride (protease 
inhibitor). A volume of 250 gl of I mg/mI lysostaphin (Sigma) was added and the 
solution incubated for 60 minutes at room temperature. 
After the incubation the cells were sonicated (MSE Soniprep 150) at full strength for 
3 periods each of one minute (note that the cells were kept in disposable 25ml 
centrifuge tube inside a beaker with ice to prevent overheating). Lysis was verified 
under a light microscope (Olympus CH-2). The resulting liquid was spun down at 
21,000 g for 30 minutes at 4"C (Sorval RC-5b Refrigerated Superspeed Centrifuge, 
Du Pount Instruments) to remove insoluble and aggregated proteins that would 
interfere with the first step of two-dimensional protein electrophoresis, which is the 
IsoElectric Focusing (IEF). 
Protein content was determined using the method described in section 2.2.2.3 and the 
cell free extract was either used immediately for IEF or frozen at -20*C until used. 
190 
7.2.4.2 Protein sample preparation for two dimensional protein electrophoresis 
The sample rehydration buffer (1.2x) was prepared by adding 14.4 g of urea (Sigma), 
0.6 g CHAPS (Sigma), 150 ýtl of 3-10 ampholytes (Invitrogen) and 0.6 ml of 0.1% 
(w/v) bromophenol blue solution to 15 ml of deionised water. The volume was 
adjusted to 25 ml and the resulting solution was separated in lml aliquots and frozen 
for future use. Prior to using this buffer, dithiothreitol (DTT) (Sigma) was added to a 
final concentration of 20 mM. 
The solution for rehydration of the strips consisted of 85 Pg of protein (maximum of 
35 gl volume), was added to 120 [d of 1.2x rehydration buffer to give a total volume 
of 155 gl. 
7.2.4.3 Rehydrating ZOOM'ý Strips 
The ZOOM9 IPGRunner cassette (Invitrogen) was set on a level surface with the 
sample loading wells facing upwards and 155 gl of sample rehydration buffer 
containing the protein sample loaded into each sample loading well located at the 
rounded edge of the ZOOM'5 IPGRunner cassette. The ZOOMO strip card (pH 3-10 
Non-linear) (Invitrogen) was removed from its pouch and a strip was peeled away 
from the card backing. The protective strip cover remained on the card. Each strip had 
a gel side and a side with printed marking on it. The ZOOMO strip was held at the 
basic end (-) using forceps with the printed side facing down. Then using the fingers 
to guide the strip, the acidic end (+) of the strip was inserted into the enclosed channel 
through the sample loading well at the curved end of the ZOOMO IPGRunner cassette 
until acidic end (+) of the strip touched the end of the channel slot (IMPORTANT: 
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avoid large air bubbles, small bubbles will not affect rehydration). This procedure was 
repeated for as many strips as the number of samples to be run. 
All sample loading wells, including unused wells, were sealed using the sealing tape 
provided making sure that the tape fully seals the wells and the ZOOMO IPGRunner 
cassette was incubated for 8-16 hours (overnight) at room temperature. 
After the overnight incubation the sealing tape and the two sample loading devices 
were removed from the ZOOM'5 IPGRunner cassette. An electrode wick was placed 
at each end of the ZOOMO IPGRunner cassette over the adhesive and 750 gl of 
deionised water was evenly applied to each of the electrode wicks, any excess water 
was blotted off using filter paper. The ZOOMO IPGRunner Core and the IPGRunner 
cassette containing the rehydrated strips were placed on a flat surface in the upright 
position and the ZOOMO IPGRunner cassette was pushed towards the electrodes of 
the ZOOM'5 IPGRunner Core until the electrode wicks of the ZOOMO IPRGRunner 
cassette were in contact with the electrodes of the IPGRunner core. If two cassettes 
were used the procedure was repeated, if not the buffer dam was used in place of the 
second IPGRunner cassette. 
The sandwich containing the ZOOM'5 rPGRunner core and ZOOM'5 rPGRunner 
cassettes (or buffer dam) was held tightly together and inserted into the mini-cell 
chamber of the ZOOMO IPGRunner, followed by the gel tension wedge. The negative 
electrode must fit into the opening in the gold plate on the Mini-cell chamber. 
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The gel tension lever was pulled toward the front of the ZOOMO IPGRunner mini-cell 
until lever came to a firm stop and the ZOOM'5 IPGRunner sandwich is fixed. The 
outer chamber was then filled with 600 ml of deionised water by pouring the water 
through the gap between the gel tension wedge and the back of the outer chamber and 
taking care that water does not spill into the inner chamber. 
The ZOOM'5 IPGRunner cell lid was placed on the ZOOM'5 IPGRunner core, and the 
system was connected to the power supply. Isoelectric focusing (IEF) was performed 
by running the electrophoresis using the PowerEase 500 power pack (Invitrogen) at 
500 V for 5 hours (settings per strip: 500 V, I niA and 0.5 W). 
Once IEF was finished, the lid was removed and the water from the outer chamber 
poured off. The gel tension wedge was unlocked and the IPGRunner sandwich 
removed from the mini cell and laid flat on the bench (note: the cassettes can be 
stored at -80*C until required for second dimension electrophoresis). 
7.2.4.4 Performing SDS-PAGE using ZOOMegels 
The film cover from the cassette was peeled off and the ZOOMO strip removed from 
the WOW' IPGRunner cassette using forceps and prepared for SDS-PAGE by 
equilibrating the strips.. 
A solution of IX NuPAGE LDS (Invitrogen) sample buffer was prepared by diluting 
4X NuPAGE LDS stock solution with deionised water (10 ml for each sample). To 
4.5 ml of the IX NuPAGE LDS sample buffer 500 [d of the WAGE sample 
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reducing agent (I Ox) (Invitrogen) was added in a 15 ml conical tube and the ZOOMO 
Strip was placed in this tube and incubated for 15 minutes at room temperature (the 
solution was decanted when incubation finished). 
An alkylating solution (125 mM) was prepared by dissolving 116 mg of fresh 
iodoacetamide in 5 ml of IXNuPAGE LDS sample buffer (need 5 ml of this solution 
per strip) and incubating the ZOOMO strip in it for 15 minutes at room temperature 
(this solution was decanted when incubation finished). 
7.2.4.5 SDS-PAGE 
Before starting the SDS-PAGE a 0.5% (w/v) agarose (Sigma) solution was prepared 
in the appropriate running buffer and kept warm (55-65*C). The ZOOMOý Bis-Tris 8- 
12% (Invitrogen) gel cassette was removed from the pouch and the tape covering 
peeled off. 
The plastic ends of the IPG strip were cut and the strip inserted into the ZOOM9 gel 
well. The IPG strip was aligned in the ZOOM'5 Gel using a thin plastic ruler or a 
weighing spatula avoiding air bubbles. Once the strip was in place -400 ýd of 0.5% 
(w/v) molten agarose solution was added into the ZOOM8 Gel well containing the 
IPG strip taking care not to allow it to overflow into the molecular weight marker well 
and the agarose was allowed to solidify. The size marker Magic western marker (2.5 
pl) (Invitrogen) was added to the marker well. 
194 
The gel cassette/Buffer core sandwich/ gel tension wedge was assembled, once this 
was firmly in place the lower buffer chamber and upper buffer chamber was filled 
with the IL of MOPS running buffer (Invitrogen). The electrophoresis was then run 
at 200 V for 55 minutes. 
7.2.4.6 Staining of polyacrylamide gels from two dimensional protein 
electrophoresis 
When the electrophoresis was completed the sandwich containing the ZOOM'5 Get 
was disassembled and the gel removed from its protective case in order to be stained. 
In this case two consecutive stains were used: SimplyBlue (a Coomassie blue based 
stain from Invitrogen) and silver stain. 
For the SimplyBlue stain the gel was washed 3 times for 5 minutes in ultra-pure water 
and then left in 20 ml of Simplyblue stain overnight. After the overnight stain, the 
stain was removed by washing with ultra-pure water for 2 hours, changing the water 
every 15 minutes. Photographs of the results were taken using the UVP AutoChemi 
system (UVP). 
The gel was then washed for a further 30 minutes in ultra-pure water, after which it 
was stained with a silver stain method based on Morrisey (1980). Briefly, the gel was 
incubated at room temperature in a 50% methanol - 50% acetic acid solution for 30 
minutes, after which it was incubated for a further 30 minutes in a 5% methanol and 
7% acetic acid solution. At the end of this it was rinsed thoroughly with ultra-pure 
water. The gel was then fixed for 30 minutes in 5% glutaraldehyde solution and rinsed 
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3 times with ultra-pure water (15 minutes washes). The gel was then incubated in a5 
pg/ml solution of DTT for 30 minutes followed by 30 minutes incubation in 1% silver 
nitrate. The gel was then rinsed once in ultra-pure water and then in developer (1.5 g 
of sodium carbonate in 50 ml of ultra-pure water + 25 gI of formaldehyde) solution 
with no formaldehyde. Finally, the gel was developed by adding the developer with 
formaldehyde, the gel was agitated gently until the bands started to appear (5 to 10 
minutes) and the reaction stopped at an appropriate time by the addition of 1g of solid 
citric acid. 
Photographs of the gels were then taken using the LJVP AutoChemi imaging system 
(UVP) using the LabWorks UVP software, and the results were analysed by 
Nonlinear dynamics using the software tool Progenesis PG200. This software 
detected the number of different spots in each gel photograph and their intensity, and 
compared the profiles between the different gels. Spots were identified as those that 
were either upregulated or downregulated compared with control. A possible identity 
for some spots was proposed based on size determination and literature searches, but 
definitive identifications were not possible without further analytical techniques on 
isolated protein spots. 
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7.3 Results 
7.3.1 Mutant screening altered sensitivity to manuka honey 
The MIC and MBC determination for the mutant strains showed that the honey had 
bactericidal activity on all strains tested, but the atl mutant seems to be more sensitive 
to M109 (Table 17). 
Table 17. MIC for the mutant and parental strains (autolysin and stress mutants) in 
the presence of manuka honey. 
Parental ad ad mutant Parental SigB SigB mutant 
1 0.8 1.2 1.8 
1.4 0.6 1.6 1.8 
1.8 0.2 1.8 1.8 
1.8 0.2 2.6 1.4 
1.6 0.8 2 1.8 
1.6 0.6 2 1.2 
1.4 0.4 1.2 1.6 
1 0.4 2.2 2 
Mean 1.45 0.5 1.825 1.675 
SD 0.316228 0.239046 0.483292 0.260494 
Statistical analysis was performed on this data using the Mann-Whintey test. This 
showed that the difference between the parental and mutant atl strains was significant 
(p = 0.0009) whilst the difference between the parental and the mutant SigB mutant is 
not significant (p = 0.4524). 
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7.3.2 The effect of manuka honey on the respiration of bacteria 
Cells kept in buffer alone (control cells) always demonstrated an increased rate of 
oxygen consumption on addition of isosensitest broth with time of incubation in 
honey and still responded to the addition of the uncoupling agent (Fig. 47). Staph. 
aureus cells treated with honey showed an increase in the endogenous oxygen 
consumption rate with time (Fig. 47). This was found not to be due to the uncoupling 
as the cells still responded to the the addition of uncoupler CCCP (40 gM) (Fig. 42). 
However in the case of Pseud. aeruginosa the endogenous oxygen consumption rate 
of cells incubated in honey decreased, and the cells were also remained coupled (Fig. 
49). 
Figure 47. Example of an oxygen electrode profile (y axis =% saturation of oxygen, 
x axis = time in minutes). 
I1 100 gl of isosensitest broth I 
40 gM of CCCP 
C. 
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Figure 48. Effect of incubation in 10% (w/v) manuka honey on Staph. aureus 
respiration (respiration rate minus endogenous rate). Error bars indicate range of 
results obtained in an average of 4 independent experiments. 
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Figure 49. Effect of incubation in 20% (w/v) manuka honey on Pseud. aeruginosa 
respiration (respiration rate minus endogenous rate). Error bars indicate range of 
results obtained in an average of 4 independent experiments. 
0.1000 
0.0800 
cells In buffer 
U 0.0600 
cells In 20% 
(wtv) manuka 
0.0400 L ho ney 
E 
N j- ....... 
Linear (cells 
In 20% (w/v) 
0.0200 manuka 
E ho ney) 
C I-Inear(cells 
0.0000 
- 
' 
50 1DO 150 200 
1250 
30 
-0.0200 
Time m In) 
199 
The attempts to determine the effect of adding manuka honey to control cells in the 
oxygen electrode failed, as the honey added directly to the electrode settled at the 
bottom of the oxygen electrode chamber, even with the magnetic flea at full speed, 
and blocked the electrode. When other types of honey were used such as Gale's and 
artificial honey, both Staph. aureus and Pseud. aeruginosa responded in the same way 
as with manuka honey. For Staph. aureus treated with any type of honey the 
endogenous rate of oxygen consumption increased, whilst oxygen consumption rates 
for non-honey treated cells decreased (Fig. 50). Pseud. aeruginosa incubated with any 
of the honeys the endogenous rate of oxygen consumption was decreased, whilst non- 
honey treated cells maintained a stable oxygen consumption rate (Fig. 5 1). 
Figure 50. Endogenous respiration rates of Staph. aureus cells incubated in buffer 
containing 10% (w/v) manuka, artificial or Gale's honey. 
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Figure 51. Endogenous respiration rates of Pseud. aeruginosa in buffer containing 
20% (w/v) manuka, artificial or Gale's honey. 
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7.3.3 Leakage studies 
After the cells were exposed to either buffer alone or buffer with honey, the cells were 
washed and resuspended in buffer alone, measurements were taken of the initial levels 
of ATP, proteins and inorganic phosphate (represented by the columns labelled 0 
minutes in figures 52-63) and levels of these products were once again determined 
after 15 minutes of incubation at room temperature in the buffer alone (represented by 
the columns labelled as 15 minutes in figures 52-63). 
For Staph. aureus there did not seem to be any leakage of any of the metabolites 
studied in the control cells (Fig. 52,54 and 56), in the treated cells there seemed to be 
leakage of ATP (Fig. 57) (at 120 minutes), but not of proteins (Fig. 55). There seems 
to be some leakage of inorganic phosphate when the profile obtained for control cells 
(Fig. 52) is compared to that obtained for honey-treated cells (Fig. 53). 
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Figure 52. Inorganic phosphate leakage from Staph. aureus cells incubated in Tris 
buffer at 37T with shaking (100 rpm) (error bars show the range of results). 
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Figure 53. Inorganic phosphate leakage in Staph. aurcus cells in Tris buffer with 
10% (w/v) manuka honey at 37"C with shaking (100 rpm) (error bars show the range 
of results). 
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Figure 54. Protein leakage from Staph. aureus cells incubated in Tris buffer at 37'C 
with shaking (100 rpm) (error bars show the range of results). 
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Figure 55. Protein leakage from Staph. aureus cells incubated in Tris buffer with 
10% (w/v) manuka honey at 37T with shaking (100 rpm) (error bars show the range 
of results). 
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There was no apparent difference between the protein released from the cells kept in 
buffer (Fig. 54) in comparison with the cells treated with honey (Fig. 55), as the 
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maximum values were found to be higher for the non-treated cells (Fig. 54) than for 
treated cells. 
Figure 56. ATP leakage from Staph. aureus cells incubated in Tris buffer at 37C 
with shaking (I OOrpm) (error bars show the range of results). 
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Figure 57. ATP leakage from Staph. aureus cells incubated in Tris buffer with 10% 
(w/v) manuka honey at 37'C with shaking (100rpni) (error bars show the range of 
results). 
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The profiles of ATP release in treated and non-treated cells were similar, nevertheless 
the maximum amount of ATP released from the non-treated cells (Fig. 56) was lower 
than in the treated cell group (Fig. 57), which suggested cellular damage had allowed 
leakage of ATP. 
Although the inorganic phosphate recorded for Pseud. aeruginosa cells exposed to 
honey treatment showed a trend to increase (Fig. 59) the total values did not appear 
different from those obtained in cells incubated in buffer alone (Fig. 58). In the case 
of Pseud. aeruginosa, there seemed to be release of proteins into the media (Fig. 61) 
with at least a two-fold increase in the amount of recorded protein for the honcy- 
treated cells in comparison with control cells (Fig. 60). There is also an increase in the 
amount of recorded ATP in the buffer for treated cells, with an increase of more than 
I 0-fold between the cells kept in buffer alone (Fig. 62) and the cells kept in buffer and 
honey (Fig. 63). 
Figure 58. Inorganic phosphate leakage from Pseud. aeruginosa cells incubated in 
MOPS buffer at 37'C with shaking (100 rpm) (error bars show the range of results). 
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Figure 59. Inorganic phosphate leakage from Pseud. aeruginosa cells incubated in 
MOPS buffer with 20% (w/v) manuka honey at 37T with shaking (100 rpm) (error 
bars show the range of results). 
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The honey-treated cells showed an increasing trend in the arnounts of released 
inorganic phosphate (Fig. 59), although the levels of phosphate detected were similar 
to those recorded for non-treated cells (Fig. 58). The maximum levels of inorganic 
phosphate recorded in the honey-treated cells was actually lower than the highest 
concentration of phosphate recorded in the non-treated cells. This observation 
together to the results obtained for inorganic phosphate leakage in Staph. allrells cells 
might indicate that the technique was not sufficiently sensitive for the detection of the 
concentrations of phosphate being leaked of the cells. For Pseud. 
aerugi . nosa, especially, electron microscopy had demonstrated major structural 
damage in honey-treated cells and leakage of Pi, ATP and protein was expected. 
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Figure 60. Protein leakage from Pseud. aeruginosa cells incubated in MOPS buffer at 
370C with shaking (100 rprn) (error bars show the range of results). 
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Figure 61. Protein leakage from Pseud. aeruginosa cells incubated in MOPS buffer 
with 20% (w/v) manuka honey at 37T with shaking (100 rpm) (error bars show the 
range of results). 
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The concentration of protein recovered from supernatants of honey-treated Pseud. 
aeruginosa (Fig. 61) was almost 3 times higher than the concentration of protein 
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leaked in non-treated cells (Fig. 60), indicating an increase in protein leakage in the 
presence of honey. 
Figure 62. ATP leakage from Pselid. aeruginosa cells incubated in MOPS buffer at 
37C with shaking (100 rpm) (error bars show the range of results). 
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Figure 63. ATP leakage from Pseud. aeruginosa cells incubated in MOPS buffer 
with 20% (w/v) manuka honey at 37C with shaking (100 rprn) (error bars show the 
range of results). 
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The concentration of ATP detected in supernatants of honey treated Pseud. 
acruginosa (Fig. 63) was 10 times higher than the concentration of ATP leaked from 
non-treated cells (Fig. 62) indicating leaking caused by the presence of honey. 
7.3.4 Two dimensional protein electrophoresis of Staph aureus cells incubated 
with and without honey 
The results of the time-course for cellular protein extraction (not released protein) 
from Staph aureus, showed that the amount of protein extracted from honey-treated 
cells decreased with time (Fig. 64), this was a consistent result for 3 extraction 
experiments. Although initially the aim was to use protein collected from cells 
exposed to buffer with 10% (w/v) manuka, honey after 4 hours incubation in honey for 
2-D electrophoresis, the protein concentration extracted at that time point was too low 
to efficiently rehydrate the IEF strips. 
Figure 64. Collated data of the yield of protein from Staph aureus cells kept 
incubated in Tris buffer containing 10% (w/v) manuka honey (180 minutes) (arrow 
indicates final collection point). 
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It can be seen (Fig. 64 and 65) that the time point when the most protein was extracted 
from the treated samples was after 50 minutes incubation, so this time point was used 
to achieve the maximum concentration of protein to load the IEF strips. 
Figure 65. Time-course extraction of proteins from Staph. aureus incubated in buffer 
alone (control) and buffer with 10% (w/v) manuka honey (120 minutes) (arrow 
indicates the final collection point). 
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The proteome profiles obtained with the use of 2-D protein electrophoresis showed 
that all times points assayed (control at 0 minutes, control after 50 minutes incubation 
in buffer or 50 minutes honey-treated cellular protein) had different profiles of 
proteins. The cellular protein collected from cells at the start of this study (cells at 
time 0) yielded 79 different spots (Fig. 66), whilst the cellular protein profile of the 
cells that were incubated in buffer alone for 50 minutes yielded 85 different spots 
(Fig. 67). This suggests the switching on of protein synthesis during incubation in 
buffer. The 2-D profile of the cellular proteins of the cells incubated in buffer with 
10% (w/v) manuka honey presented 65 different spots (Fig. 68), thus demonstrating a 
possible down regulation of the protein synthesis. In total, 123 different spots were 
detected. 
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Figure 66. Two-dimensional protein electrophoresis profile of the cellular proteins of 
Slaph. aureus cells incubated in buffer for 0 minutes. 
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Figure 67. Two-dimensional protein electrophoresis profile of the cellular proteins of 
Slaph. aureus cells incubated in buffer for 50 minutes. 
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Figure 68. Two-dimensional protein electrophoresis profile of the cellular proteins of 
Slaph. aureus cells incubated in buffer with 10% (w/v) manuka honey for 50 minutes. 
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This experiment was repeated once to ensure reproducibility. The results were similar 
to those shown in Figure 69, although the picture quality was not as good. A different 
image-capturing device (BioRad, GelDoc) was used for the second experiment, 
because the UVP system used in the first experiment was not available. 
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Figure 69. Example of matching of some of the major spots between the two repeats 
of gels for cellular protein profile of Slaph. aureus a) is the analysed photograph and 
b) is the repeat of the same gel using the GelDoc system. 
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The analysis of the protein profile between the different gels was kindly performed by 
Nonlinear Dynamics using the software toot Progenesis PG200. The analysis of the 
photographs proved difficult as the quality of the images was poor due to tile 
limitations of the imaging capture system used. One of the problems was encryption 
of the photo. The capture device used only 12 bits (8 bits in the BioRad system) and 
this had to be transformed into 16 bits, which led to loss of quality. The limitations of 
the capture device also led to an increase in the background noise (Figure 70), which 
made spot detecting difficult. 
Figure 70. Example of background noise of the photos taken, to illustrate that it was 
rough when it should have been smooth. 
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As a baseline the spots identified in the control at time 0 minutes were used, as these 
were extracted from cells growing in media alone, with all the conditions necessary to 
thrive. Nine proteins were upregulated in the controls held in buffer without honey for 
50 minutes (yellow circles in Figure 71), 21 proteins were downregulated (green in 
Figure 71), 5 proteins remained unchanged (light blue in Figure 71) and 50 proteins 
were un-matched (dark blue in Figure 71). An inference was that these could be new 
proteins 
Figure 71. Proteome profile of the cellular proteins of Staph. aureus after 50 minutes 
of incubation in buffer compared with the protile at 0 minutes incubation. 
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The profile of the cellular protein of honey-treated Slaph. aureus was compared to 
both control at 0 minutes and to control at 50 minutes. When comparing the treated 
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sample profile to the control it was possible to deduce that 6 proteins were 
upregulated in the honey-treated cells (yellow circles in Figure 72), 11 proteins were 
downregulated (green in Figure 72), 2 proteins remained unchanged (light blue in 
Figure 72) and 13 proteins were un-matched (dark blue in Figure 72). 
Figure 72. Proteome profile of the cellular proteins of Staph. aureus after 50 minutes 
of incubation in buffer with 10% (w/v) manuka honey compared with the profile at 0 
minutes incLibation. 
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Although the comparison between the treated cells protein profile and the non-treated 
cells at 0 minutes indicated the presence of 13 "new" proteins and hence suggested 
the switching on of protein synthesis due (unmatched. dark blue in Figure 73), 
comparison with non-treated cells incubated for the same period of time (50 minutes) 
but in the absence of honey, suggested a different interpretation. It was possible to 
detect 10 upregulated proteins in the honey-treated cells (yellow circles in Figure 73) 
in comparison to the control incubated for the same period of time but in the absence 
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of honey, 13 proteins were downregulated (green in Figure 73), 15 proteins remained 
unchanged (light blue in Figure 73) and 27 proteins were un-matched (dark blue in 
Figure 73). 
Figure 73. Proteome profile of the cellular proteins of Slaph. aureus after 50 minutes 
of incubation in buffer with 10% (w/v) manuka honey compared with the profile of 
non-treated cells at 50 minutes incubatimi. 
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The most common method for the identification of the specific proteins present in 
each spot would be to perform matrix-assisted laser desorption ionisation-time of 
flight mass spectroscopy (MALDI-TOF MS), nevertheless due to time constraints and 
the unavailability of this methodology at UWIC another approach has been used as an 
indication of a possible identity of' some of the spots. Because of time constraints 3 
groups of spots were randomly selected for an indication of a possible identity 
through literature review shown in Figure 74 with the numbers 1.2 and 33. 
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Figure 74. Spots for identification (I to 3); a) non-treated cells incubated for 50 
minutes compared with non-treated and non-incubated cells, b) cells treated with 
honey for 50 minutes compared with non-treated and non-incubated cells, and c) cells 
treated with honey for 50 minutes compared with non-treated cells incubated for 50 
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Dark blue: unmatched 
Spot I is a protein with an approximate molecular size of 120 Kda (Fig. 74), the 
literature search of proteins characterised in Staph aureus with this size yielded a 
paper referring to a range of surface proteins (with variable size, from 120 to 33 KDa) 
that are associated with siderophore production (Courcol et al. 1997), or a collagen 
adhesion exoprotein (with a molecular size of 129 KDa) (Nakano et al. 2002). This 
spot was increased 1.5 fold more than the non-treated cells incubated for 50 minutes 
in comparison with the non-treated cells that were not incubated in buffer (Fig. 74a). 
If cells that were treated with honey lor 50 minutes, when comparing with cells that 
were not incubated, there was no diffcrence (Fig. 74b), but if the spot was compared 
with the same spot in the gel for non-treated cells incubated in buffer for the same 
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amount of time (Fig. 74c) there was a downregulation of the expression of this protein 
as there is more than a 1.5-fold decrease in the intensity of the spot when compared 
with the control cells exposed to the same conditions, but without the honey. 
Spot 2 is a protein with an approximate molecular size of 60 KDa (Fig. 74). The 
literature search for the identification of proteins with this size yielded a variety of 
papers that referred to two groups of proteins: heat-shock protein 60 or HSP60 
(Dziewanowska et al. 2000; Kwok et al. 1999) and surface binding proteins (Boden 
and Flock 1992; Heilmann et al. 1997; Hussain et al. 2002; McGavin et al. 1993; 
Tompkins et al. 1992). This spot was upregulated in the cells incubated both with and 
without honey, when compared with non-treated, non-incubated cells (Fig. 74a and 
b), but when the intensity of the spot incubated in honey, is compared with the spot of 
the cells incubated in buffer alone (Fig. 74c) the intensity was reduced by at least a 
factor of 1.5-fold. , 
Spot 3 has an approximate molecular size between 30 and 40KDa (Fig. 74). 
According to the literature this size range can include proteins from the autolysin- 
adhesin family (Heilmarm et al. 2005; Nakano et al. 2002), alpha and beta-hemolysin 
(Nakano et al. 2002) and extracellular binding proteins (Hussain et al. 2001). This 
spot had an increased expression when the cells were incubated in buffer alone, when 
compared with the protein profile of non-incubated cells (Fig. 74a) but had no 
difference between the non-incubated cells and the cells that were honey-treated (Fig 
74 b and c). 
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7.4 Discussion 
The determination of the susceptibility of the Staph. aureus mutants to manuka honey 
along with their parental strains showed that only the atl mutant had a significantly 
higher susceptibility (Table 17). 
The sigB gene is responsible for the regulation of Irg and cid genes that are in turn 
responsible for the regulation of murein hydrolase (one of the enzymes necessary for 
cytokinesis) and involved in sensitivity to penicillin (Rice et al. 2004). Sigma factor 
(Y13 has also been associated with the regulation of transcription of virulence- 
associated loci in Staph. aureus, as well as controlling general stress response in 
response to several environmental stresses. Also it might indirectly control the 
production of biofilms in Staph. epidermidis (Horsburgh et aL 2002). A mutant with a 
defect in this regulator factor will be expected to be deficient in a number of stress 
responses. A lack of difference in susceptibility between the parental strain and the 
strain deficient in sigB therefore indicated that this is not a target site of the 
antibacterial activity of manuka honey. 
The all gene codes for the AtI molecule (137 KDa) that is the precursor of the 
enzymes murein hydrolase and peptidoglycan hydrolase, which are 2 enzymes that are 
involved in the processes of cell wall turnover and cytokinesis. Mutants for this gene 
will have an incomplete complement of autolysins, and will generate giant clumps of 
undivided daughter cells (Foster 1995). Their inhibition does not lead to cell death, 
suggesting that cell division is not essential for cell survival (Foster 1995). The 
increased sensitivity of the all mutant strain to manuka honey might mean that this is 
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actually a defence mechanism of the cell, possibly through its role in cell wall 
turnover. These results seem to lead to the idea that the antimicrobial activity of 
honey may be due to interference in peptidoglycan biosynthesis, as in this case the Atl 
products would be responsible for overcoming the deficiency in peptidoglycan. In this 
case normal cells exposed to honey might recruit most of their Ad for the production 
of peptidoglycan leaving the actual cytokinesis process on hold. In cells that do not 
have this gene, this mechanism of counteracting the action of the honey would not be 
present and thus they would be more sensitive to inhibition by honey. 
The generation of energy is essential for the growth and division of bacterial cells. 
Energy production takes place in the cell membrane and is one of the prime targets for 
antimicrobial agents, especially those with the ability to disrupt the cell membrane. 
The effects of honey on bacterial respiration is therefore an important piece of 
information when trying to understand the mode of action of honey as an antibacterial 
agent. The observation that the endogenous rate of oxygen consumption for Staph. 
aureus, increased in the presence of honey (manuka, Gale's and artificial), might be 
an indication of increased metabolism (Fig. 47 and 49). This in turn could lead to 
depletion of the internal nutrient reserves and lead to either cell death, or entry to a 
dormant state, like Viable But Non-Culturablc (VBNQ. 
Initially the rapid rate of endogenous oxygen consumption in Staph aureus was 
thought to be due to uncoupling of the electron transport chain. The activity of 
autolysins seems to be regulated by the proton motive force (Calamita et al. 2001; 
Kemper et al. 1993) and if the cells were uncoupled, then the proton motive force 
would be absent and the autolysins non-functional. However, when the uncoupling 
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agent CCCP was added, the cells showed an increased rate of oxygen consumption, 
and this meant that they were still coupled. If they were not coupled the addition of 
uncoupling agent would have made no difference. The possibility of Staph. aureus 
being in a VBNC state following exposure to manuka honey is supported by the data 
collected in chapter 5, where the total counts of bacteria remained high whilst the 
culturable counts decreased (Fig. 18). 
It is possible that because the experiments with the oxygen electrode were done using 
cells suspended in buffer, that a VBNC state could have been brought about because 
limited nutrient availability, and lead to starvation (one of the signals for induction of 
the VBNC state). Yet total and culturable counts were perfonned in the presence of 
nutrients, and demonstrated that the total counts remained constant whilst the 
culturable counts decreased. At the moment it is not possible to conclude that these 
observations prove that the honey treated Staph aureus enter the VBNC state. More 
studies are needed to assess the viability of cells exposed to honey, before a definitive 
conclusion can be made. 
In the case of the Pseud. aeruginosa the endogenous oxygen consumption rate 
decreased in the presence of all of the honeys tested (Fig. 48 and 50). The addition of 
uncoupling agent to honey-treated Pseud. aeruginosa cells also elicited a response, 
which meant that the cells were coupled. From the electron microscopy (Chapter 7) it 
was possible to observe that the damage to this Gram negative bacterium was more 
extensive than that observed in the Gram positive Staph. aureus. The disruptions 
observed in the membranes of Pseud. aeruginosa cells might explain the decreases in 
respiration, by affecting the normal functioning of the electron transport chain and 
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consequently of the cellular respiration. Honey-treated Pseud. aeruginosa still 
remained coupled as they continued to respond to the addition of the uncoupler to the 
oxygen electrode chamber. 
Since the effects of manuka, honey on the respiration rates of both Staph. aureus and 
Pseud. aeruginosa seemed to occur in the presence of other two honeys (Gale's and 
artificial), it is possible to suggest a non-specific common factor (like sugar) rather 
than an influence specific to manuka honey. 
The leakage studies of Staph. aureus showed that there was leakage of inorganic 
phosphate (Fig. 53) and ATP (Fig. 57) from honey treated cells compared with non- 
treated cells (Fig. 52 and 56 respectively). There did not seem to be any leakage of 
proteins (Fig. 54 and 55). This does not tic up with the timc-coursc extraction of 
proteins from Staph. aureus cells for the 2D protein gcl elcctrophorcsis, where a 
decrease in extracted protein with time was seen (Fig. 62 and 63). There is not enough 
information to draw a conclusion about the significance of protein release. 
This type of leakage (ATP and inorganic phosphate) is indicative of membrane 
damage (Johnston et al. 2003), and concurs with the electron microscopy observations 
previously described in chapter 6 (Fig. 26), where there was a significant increase in 
the number of observable damaged cells using scanning electron microscopy, with 
exposure to honey. 
For Pseud. aeryginosa, leakage studies revealed a marked release of protein (Fig. 59) 
and ATP (Fig. 61), with a 10-fold increase in the recorded concentrations of these 
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substances in comparison to control cells (Fig. 58 and 60). In the case of inorganic 
phosphate there was a steady trend towards the increase of leaked inorganic phosphate 
in honey-treated cells (Fig. 57), but the range of detected phosphate was similar to the 
control cells (Fig. 56). ATP and proteins are larger molecules than phosphate, and 
could only be present in the buffer by passing through major holes in the cell wall of 
Pseud. aeruginosa (Johnston et A 2003). In fact these results are once more 
supported by the data collected with electron microscopy (Chapter 6) where physical 
damage to the cell wall of Pseud. aeruginosa was observed with both SEM and TEM. 
Initially, potassium leakage was to have been assayed in this study, but it was found 
that the methodology available (selective potassium electrode) was not sensitive 
enough to detect the amounts of potassium expected to be leaked from the bacterial 
cells. For inorganic phosphate the same applied. In the case of Pseud. aeruginosa, 
where electron microscopy (shown in chapter 6) demonstrated altered cell 
morphology and cell wall damage, and leakage of protein and ATP were detected, it is 
likely that phosphate leakage also occurred because phosphate is a smaller molecule. 
This was not observed. It is possible to speculate that the method for determination of 
inorganic phosphate was not sensitive enough to detect the small quantities of ion that 
might have leaked into the buffer. 
The proteome analysis of Staph. aureus (using 2D gel electrophoresis) was performed 
in order to better understand the effects of honey on the expression of proteins in this 
bacterium. It was performed only in Staph. aureus because the previous results 
suggested that the mechanism of action of honey on these bacteria was not limited to 
physical damage. Increased incidence of cell walls in cells incubated in honey 
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suggested physiological changes which might have been reflected by differences in 
the proteome profile between honey-treated cells and non-treated cells. 
Initially the aim was to use cells maintained in buffer and honey for 4 hours, but a 
time-course extraction of protein from honey-treated Staph. aureus, showed a marked 
decrease in the concentration of extracted proteins, which were not enough to 
rchydrate the IEF strips and perform 2D gel electrophoresis. This was another 
indication of the down-regulation of protein synthesis. 
The time point chosen for this experiment was 50 minutes incubation in either buffer 
alone and buffer and honey, as this was the time point when the most proteins could 
be recovered from honey-treated cells. At this point the concentration of protein 
extracted from cells was too low for rehydration of strips with the minimum allowable 
volume of protein 10 gl. therefore concentration of buffer was increased to allow the 
use of a greater volume of protein solution, to ensure correct protein loading of strips. 
The pH gradient chosen was the 3-10 NL (non-linear) because it was the widest range 
available. As the aim was to determine the type of changes that could occur in the 
proteome profile of Staph. aureus, this would include all extractable proteins, 
although the compromise was on separation of the proteins, because they would have 
a smaller area to separate in. 
The quality of the gels was not ideal, as there was a lot of streaking (non-specific 
bands in the gels, fig 66-68), this can have been due to high salt concentration in the 
protein sample used to rehydrate the IEF strips. In this study, care was taken to use 
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ultrapure water at all stages, so as to limit the concentration of salts in the final 
extracts, but in the future additional cleaning up (removal of salts) might yield a better 
image. Furthermore, the limitation of the imaging apparatus, in terms of quality of the 
photographs, led to problems in the detection of small spots, this could be overcome 
with the use of more powerful imaging tools that include for example a 16-bit camera. 
Another step that could improve the results obtained would be the use of larger IEF 
strips, or strips with a narrower pH range which would give better separation of 
proteins. 
The 3 spots that were selected for an indication of possible identity using literature 
search, seem to be possibly responsible for the adhesion Of cells to the extracellular 
matrix. Spot 1 (-120 KDa) might possibly code for a collagen adhesion protein 
(Nakano et al. 2002) or for an extracellular protein that is involved in siderophore 
production. Iron is an essential nutrient for the survival of bacterial; in order to 
overcome the low levels of iron uptake in vivo, bacteria produce siderophores (low 
molecular weight iron chelators) and iron-regulated membrane proteins. These 
mechanisms are thought to be important virulence factors in Staph aureus. Recent 
work by Courcol et al. (1997) has demonstrated that proteins with the size 120 KDa, 
could be repressible in the absence of iron. Because this protein is downregulated 
after incubation in honey, when compared with control cells that were incubated but 
not exposed to honey (Fig. 74) it is possible that honey might be acting on the 
available iron chelating it, and making the iron unavailable to these proteins, thus 
downregulating their expression, and ultimately leading to cells death due to the lack 
of this nutrient. 
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ý'Spot 2 is a protein with the approximate molecular size of 60KDa; this spot is 
upregulated in cells incubated in the presence or absence of honey when compared 
with cells that were not incubated (Fig. 74a and b), but downregulated in cells 
incubated in honey when compared with cells incubated in buffer alone (Fig. 74c). 
Proteins with an approximate size of 60 KI)a in Staph. aureus can belong to the heat- 
shock protein family and regulate attachment to surfaces. It is possible to observe 
when comparing the image of the gel containing the cellular proteins from the treated 
cells (Fig. 68) that the density of spots around the 60-80 KI)a size was higher than in 
the cells that were not incubated (Fig. 66). 
Heat shock proteins are a family of molecular chaperone proteins responsible for the 
cellular response to not only heat but to many other environmental stresses. They act 
by helping in the folding and translocation of other proteins across membranes 
(Qoronfleh et al. 1998). Their role in pathogenesis is still poorly understood, but there 
are virulence factors, which are influenced by temperature, so Hsp can possibly have 
a role here. These proteins are known to be present in the cytoplasm, periplasm, 
associated with membrane proteins and in the membrane surface (when the bacteria 
are intracellular) (Qoronfleh et al. 1998). The fact that there are not many proteins 
expressed with the size of HSP60 in the cells that were not honey-treated or incubated 
(Fig. 67 and 68), when compared with incubated cells (Fig. 66) is not surprising, as 
the cells were collected from an environment that provided the nutrients to grow 
(isosensitest broth) and incubated in buffer which does not contain any nutrients for 
the bacteria to growth, thus increasing the cellular stress. Nevertheless, this response 
seems to be decreased in the honey treated cells (Fig. 74c) when compared with cells 
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'incubated in buffer alone, this could be the result of down-regulation of protein 
expression or of inhibition of protein synthesis. 
Spot 3 contained a protein with an approximate molecular size of 30-40 KDa, whose 
expression increased in cells incubated in buffer alone (Fig. 74a), but not in the honey 
treated cells (Fig. 74b and c). This spot could possibly be an autolysin protein 
(Heilmann et al. 2005; Nakano et al. 2002). Autolysins, as previously described in 
chapter 6, are proteins that are responsible for the cell wall turnover, cytokinesis and 
cell growth. If spot 3 is indeed an autolysin, the fact that it did not increase in 
expression upon incubation when resuspended in buffer with 10% (w/v) honey, like 
the control cells resuspended in buffer alone could explain the increase in septated 
cells observed using TEM in chapter 6 (Fig. 28). If the control cells require an 
increase in expression of autolysins in response to incubation in buffer and when 
observed through the TEM, there was no significant increase in the number of 
septated cells (Table 15), the increase in septation might mean that the honey-treated 
cells were stimulated to divide (possibly by the incubation in buffer), but as the 
autolysins did not increase in expression the cells remained septated and could not 
divide. 
Furthermore, all of the protein sizes used for the literature search yielded as possible 
fidentifications a range of proteins responsible for adhesion, which were down 
regulated in the honey treated cells. One of the mechanisms for bacteria to cause 
persistent infections in wounds is the formation of biofilms, and for that they require 
the possibility of attachment to the surface. Honey has been used many times as a 
effective treatment of persistent infections (Cooper et al. 2001; Dunford and Hanano 
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2004; Cooper et al. 2001; Dunford and Hanano 2004; Natarajan et al. 2001). It is 
possible. that one of its mechanisms of action on these wounds could be the inhibition 
of bacterial adhesion formation that makes debridement more effective. 
The main conclusion from this work is that the antimicrobial action of honey is 
different in Gram negative and Gram positive bacteria. In Grain negative it seems to 
have a more physical action of disrupting cells walls, whilst in Grain positive bacteria 
although it also acts by disrupting cell walls, perhaps by inhibiting peptidoglycan 
biosynthesis, as P-lactams do, it also seems to affect the cell physiology. More work 
needs to be done on the differences between the activity of honey on Gram negative 
and Gram positive bacterial physiology so that a better understanding of the 
mechanism of action of honey is achieved. 
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III Conclusions 
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8.1 General discussion and conclusion 
Traditionally medicinal honey would have been of local origin, but from carefully 
selected floral sources (Molan 2000). Nowadays, one of the most popular honeys for 
wound management is manuka honey, derived from the manuka shrub 
(Leptospermum scoparium), as it has been shown to possess a high antibacterial 
activity. Today, honeys can be divided into two main types: those with hydrogen 
peroxide derived antimicrobial activity, and those with non-hydrogen peroxide 
derived antimicrobial activity. All honeys possess high sugar content, low water 
content and low pH which helps to limit the growth of microorganisms. 
Since the recent publicity of the non-hydrogen peroxide activity of manuka honey, it 
has been exported from New Zealand to many countries and formulated into several 
medical products for use in wound management. These include non-adherent 
impregnated dressings, alginate and honey wound dressings, ointments and sterilised 
honey in tubes for use with individual patients. Honeys for medical purposes have 
been recommended to possess at least a non hydrogen peroxide activity equivalent to 
10% (w/v) phenol equivalent (Unique manuka Factor, or UMF 10). This standard has 
been proposed because some wound environments possess large volumes of exudate, 
that among other components possesses hydrogen peroxide-degrading enzymes, so in 
order to assure a high antibacterial activity on wounds of this type, honeys with a high 
non-hydrogen peroxide activity are preferred as the antibacterial activity is guaranteed 
(Molan, 2000). 
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! The work presented in this thesis has demonstrated that honeys with non-hydrogen 
peroxide derived antimicrobial activity above UMF 10 have been found in Europe. 
Although a survey of 139 Welsh honeys did not find any honeys with non-hydrogen 
peroxide derived antimicrobial activity (Wheat 2004), here a pilot study of 30 
Portuguese honeys found some honeys (Lavandula stoechas) with activity in high 
enough potency to be used in the treatment of infected wounds. This result suggest 
that the potential exists to find honeys with a similar antimicrobial activity in Europe. 
Some researchers have suggested that the non-hydrogen peroxide derived 
antimicrobial activity of manuka honey is unreal and that if more catalase was used to 
"knock out" the production of hydrogen peroxide during the bioassay, that all honeys 
would show a hydrogen peroxide derived antimicrobial activity (Weston 2000). EPR 
spectroscopy used during this work has shown that there is no detectable generation 
of hydrogen peroxide in manuka honey, thus disproving this theory, and confirming 
the findings of (Snow and Manley-Harris 2004), who found non-peroxide activity in 
the presence of high catalase concentrations. 
The nature of the non-hydrogen peroxide derived antimicrobial activity of manuka 
honey is still unknown. Attempts have been made at fractionation, and active fractions 
were found, the compositions of which were never fully determined (Bogdanov 1997; 
Snow and Manley-Harris 2004). The complexity of the honey composition has been 
recognised as one of the factors preventing a full characterisation of its chemical 
composition. There are many components present at low concentrations that can 
interfere with assays for chemical definitions and an increasing number of new more 
sensitive techniques that are able to identify new components. The way in which these 
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components interact in honey to create the antibacterial activity that can be observed 
in vitro and in vivo is also not well understood. 
The production of honey is not a sterile process. In the hive envirom-nent there are 
bacteria, yeasts and mould that readily contaminate honey but which do not generally 
grow on honey, due to its sugar concentration and pH (Snowdon and Cliver 1996). 
Organisms commonly known to be present in soil and other environmental samples 
have been known to produce antimicrobial agents (Takahashi et al. 1986a; Zheng and 
Slavik 1999; Huddleston et al. 1997). Their presence in the hive allows their possible 
presence in honey. This work has determined that some of the organisms that are 
present in non-sterile honeys have the potential to produce antimicrobial agents. 106 
isolates were recovered from the 14 honeys tested, all Gram positive organisms and 
the majority were from the Bacillus genus. Not every strain of a bacterial species that 
is known to produce an antimicrobial substance will do so, nevertheless some of the 
strains isolated from the manuka honeys tested in this work showed the potential to 
inhibit different strains of wound infecting bacteria in a solid medium assay. Assays 
in liquid medium were also performed with reduced success, leading to the conclusion 
that the production of the antimicrobial agent(s) by the strains isolated from honey is 
stimulated by growth in a solid medium, which has previously been reported to 
stimulate production of antimicrobial agents in other microorganisms (Codon et al. 
1995). 
It has been reported that a bee-pathogen Paenibacillus larvae subsp larvae could 
produce an antimicrobial substance (Holst 1945). This is a bacterium which is specific 
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'to hives and can be transferred to honey (Alippi 1995). In the manuka honey samples 
tested this bacterium was not detected; however, it must be acknowledge that it is a 
fastidious organism and difficult to identify. 
Problems were encountered in identifying to species level some of the isolated bacilli. 
This was probaby because Bacillus species were closely related (Bottone et al. 2003; 
Chen and Tsen 2002; Manzano et al. 2003) and the identification kits available have 
been developed for use with clinical or type culture isolates, rather than 
environmental isolates. 
Honey-based products available for wound management are generally made of 
gamma irradiated honey after manufacture and before use, so as to be safe for use in 
all patients, including immuno-compromised patients, nevertheless there are reports 
of the use of non-sterile honey being as effective (Molan and Allen 1996). It is 
possible that the bacteria that are present in the raw honey (non-sterilised) can secrete 
some of the antimicrobial compounds that they produced in order to elicit the 
inhibition of the growth of the wound pathogens tested in this work, thus contributing 
to the overall antimicrobial activity of the honey. 
The benefit of honey for wound management does not seems to be limited to its 
antimicrobial properties, as it has been described as a stimulator of the immune 
response in wounds, leading to an improved wound healing (Snowdon and Cliver 
1996; Tonks et al. 2001; Tonks et al. 2003). This activity seems to be distinct from 
the honey's antimicrobial activity, as honey with a weak antibacterial activity has 
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been shown to stimulate the release of cytokines important in the wound healing 
process in vitro (Snowdon and Cliver 1996; Wheat 2004). 
Another recognised benefit of honey is its antioxidant potential, and its ability to 
quench radical production. The observations presented in Chapter 4 are in agreement 
with previously published work which found that darker honey possess a higher 
antioxidant potential than lighter honeys (Taormina et al. 2001). Also it has revealed 
that even honeys that produce hydrogen peroxide with the potential to give rise to free 
radicals like hydroxyl radicals (as is the case with pasture honey) have a self-limiting 
production of these radicals, as the free radical signal detected using EPR 
spectroscopy was quenched with time. Thus pasture honey has a self-modulatory 
capacity for the production of free radicals (meaning that it is able to produce free 
radicals, but at the same time it possesses antioxidant activity that modulates its 
effects). The presence of radicals might be desirable for the recruitment of some 
immune cells, but this needs to be self limiting so as not to damage healthy cells 
through oxidation/ reduction reactions. 
In order to better understand the mechanism of action of honey, in particular manuka 
honey, as an antimicrobial agent in wound management, its mechanism of action in 
two important wound pathogens, Staphylococcus aureus and Pseudomonas 
aeruginosa, was investigated, with the use of kinetics studies, resistance training, 
electron microscopy, leakage, oxygen consumption and mutant and proteome 
analysis. 
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All the assays have revealed that the mechanism of action of honey on Gram positive 
bacteria is different to that on Gram negative. In the kinetic studies honey was shown 
to be bactericidal for both Staph. aureus and Pseud aeruginosa in the presence or 
absence of catalasc and also in the presence of serum, whose proteins arc known to 
interfere with the activity of some antimicrobial agents (Craig and Ebert 1989). The 
susceptibility of Staph. aureus and Pseud. aeruginosa to honey was decreased in the 
presence of serum, but bactericidal activity was still recorded at concentrations that 
could be achievable in a clinical setting (Table 18). 
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Table 18. Summary of investigation of the antibacterial action of manuka honey on 
bacterial cells 
Staph. aureus 
Gram positive 
Pseud. aeruginosa 
Gram negative 
Sensitivity Lower MIC than Gram negative but Higher MIC than Gram 
slower time-kill curves positive but faster time-kill 
curves 
Commitment to 8 hours 4 hours 
death 
Resistance training No resistance observed Resistant strain recovered in 
single concentration exposure 
(phenotypic adaptation) 
Electron microscopy 
Damage Increase in surface damage in honey Increase in surface damage in 
treated cells honey treated cells 
Septa Increase of fully septated cells in No septa observed 
honey treated cultures 
Stationary Vs Exponential cells significantly more Exponential cells significantly 
Exponential susceptible to honey more susceptible to honey 
Leakage 
A TP Some leakage Major leakage 
Inorganic Perhaps some leakage Some leakage 
phosphate 
Protein Some leakage Major leakage 
Respiration rates 
Endogenous Increased rate Decrease rate 
Respiration Respond to media Respond to media 
Coupling state Coupled Coupled 
Mutant sensitivity 
atl Mutant more sensitive than parental Not done 
strain 
sigB No difference Not done 
2D protein Down regulation of protein synthesis, Not done 
electrophoresis maybe of stress proteins and autolysins 
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Time-to-kill studies, have demonstrated that susceptibility to honey, not only varies 
among bacterial species, but also among strains of the same species. Clinical strains 
have shown a variety of sensitivity to manuka honey. These results suggest that 
susceptibility should not be assumed and that the kinetics/ sensitivity of a strain 
causing wound infection, for which treatment with honey is going to be used, should 
be verified, so that the appropriate treatment regime is achieved. For example if the 
bacteria has a lower susceptibility and the wound to be treated has a lot of exudate, 
which will dilute the honey, in order to maintain honey concentrations, the dressing 
should be changed more often, whilst if the bacteria has a high susceptibility less 
changes may be used, plus a honey with a higher non-peroxide activity should be used 
to overcome any breakdown of hydrogen peroxide by the wound fluid. 
Resistance to antimicrobial agents is a concern, even with new antimicrobial agents 
like linezolid, one of the newest agents used to combat MRSA infection. Linezolid 
has recently been introduced in general use (introduced in 2001), resistance has been 
reported both in MRSA and Staph aureus (Peeters and Sarria 2005). This work has 
shown that, in the short-term, phenotyping resistance is possible to arise especially in 
Pseud. aeruginosa. This result stresses the point that with honey, as with any other 
antimicrobial agent, care must be taken in its use and surveillance of resistance 
patterns should be done. 
There are bacteria capable of entering a dormant state where they remain viable but 
become sterile and as such cannot be cultured. Some researchers believe that these 
sterile cultures have entered a recently recognised stress response state, named Viable 
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but non culturable (VBNC), in which they are still metabolically active but are not 
able to divide in order to form colonies in an agar plate (Barer and Harwood 1999). 
Therefore these bacteria will have a different count for viability and culturability 
whilst maintaining a relatively constant total cell count (Barer and Harwood 1999). In 
the observations made in this thesis although the culturable counts of the bacteria 
decreased with time in the presence of honey the total numbers remained constant for 
both Staph. aureus and Pseud aeruginosa, which could be an indication that the 
honey might be leading these bacteria into this VBNC state. In order to verify this an 
accurate viable count (usually done with fluorescent dyes and flow cytometry) needs 
to be performed, which was not possible in this study. 
Recently the VBNC state existance has been questioned (Nystrom, 2003). The main 
question that is raised is: Is this state of sterility a stress coping response or just one 
step in programmed cell death? The VBNC cell formation is said to be a response to 
environmental stresses which is genetically controlled and reversible, but none of 
these claims have been proved. Another theory for cell sterility is the theory of 
programmed, cell death. If the balance between toxin and anti-toxin production by the 
bacterial cells is tipped towards a decrease in production of anti-toxin, this may lead 
to cell death, which is claimed to be a system of altruistic cell death during 
environmental stresses such as starvation. Once this balance is changed, the cells lose 
their ability to form colonies but retain viability. The last theory to explain the loss of 
culturability in some cultures is the theory of stochastic deterioration. This claims that 
the loss of culturability of these cells is due to the increase in the demand for 
oxidation management of starved cells, leading to the depletion of the SigB factor, 
that reaches a point where it cannot cope with the damages inflicted by the oxidation 
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reactions occuring during starvation and so cells lose the ability to be cultured before 
eventually dying (Nystrom, 2003). 
Regardless of what this sterility state is leading to (survival or death) it seems that 
honey is inducing this response in Staph aureus and Pseud aeruginosa. 
Electron microscopy results have shown that there is an increase in visible damage in 
both bacterial species used, with exponentially growing cells demonstrating a greater 
sensitivity than stationary phase cells, and in Staph. aureus there was also a 
significant increase in the number of cells with a complete septum. The increase in 
septation could be due to an arrest in the cell cycle just before cytokinesis. In Pseud 
aeniginosa an increase in external damage could be observed but no septa were 
observed. This confirms that the activity of honey upon Gram negative bacteria is 
different from the activity upon Gram positive cells. 
Honey is a broad spectrum antimicrobial agent. Usually broad spectrum antimicrobial 
agents, like tetracycline, target the same targets in Grain positive and Gram negative 
cells (Madigan et al. 2000). Honey seems to possess two different modes of action, 
perhaps with different substances in its composition acting as the antibacterial agents 
in different bacteria. 
The assay of the susceptibility to honey of mutant Staph. aureus strains and their 
parental strains, led to the conclusion that the stress response gene o-8 (Horsburgh et 
aL 2002) and its products were not targets for the manuka honey as the susceptibility 
of the knock-out mutant was the same as the parent strain. So any effects of honey on 
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'the stress response of Staph aureus are the result of other damages and not the direct 
targeting of the SigB gene or gene product. The results for the screening of the atl 
mutant on the other hand showed an increased susceptibility of the mutant to the 
antimicrobial action of honey, this means that the gene and its products are implicated 
in the activity of honey. As the atl gene codes for the major autolysins in Staph. 
aureus, which are involved in the separation of the daughter cells and cell wall 
turnover (Foster 1995), if the honey was interfering with peptidoglycan biosynthesis, 
the atl gene products would be needed to try and counteract this activity. Possibly all 
or most of the autolysins produced would be recruited for this resistance mechanism, 
leaving less available to continue the cells cycle and cleave the two daughter cells at 
the point of cytokinesis. 
In Staph aureus exposure to honey (not only manuka, but also Gale's and artificial 
honey) led to an increase in the endogenous respiration rate, not due to the uncoupling 
of the electron transport chain. This increase in respiration might be a response from 
the cells to the interference of honey with the cell cycle, as some responses may need 
to be activated that consume more oxygen. Nevertheless protein synthesis did not 
seem to be one of the upregulated responses as the proteome analysis and time-course 
extraction of protein from treated Staph. aureus cells seemed to indicate an inhibition 
of protein synthesis. It is possible to speculate that incubation of Staph aureus in 
honey either stimulates respiration that leads to starvation or that this stimulation is a 
response to overcome damages in the cell. Also an increase in the 02 levels 
introduced in the cells would favour a metabolic increase and an increase of the 
cellular concentration of reactive oxygen species that could damage the cells and 
bring about the sterility state observed in chapter 5, through the of stochastic 
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theory. On the other hand Pseud. aeruginosa oxygen consumption 
studies showed a decrease in the endogenous rate of oxygen consumption after honey 
treatment. This can be due to the fact that these cells present more clear membrane 
damage and thus the site where respiration needs to occur is damaged and it cannot 
take place normally. 
Leakage studies demonstrated that in both bacteria honey causes membrane damage 
as the level of release ATP, protein and inorganic phosphate were elevated, with a 
bigger increased in the amount of leaked material noted in the Pseud. aeruginosa in 
comparison to Staph. aureus. This was expected, as with electron microscopy the 
damaged observed in Pseud. aeruginosa was more extensive than in Staph. aureus, 
leading to an increase in the leakage of intracellular materials into the surrounding 
media. Further studies are required to investigate different aspects of the changes in 
physiology, perhaps with studies of differences in membrane potential, lipid profile in 
membranes and gene expression. Also more assays on the leakage of different 
metabolites from honey treated cells, not only Staph. aureus and Pseud aeruginosa 
but other clinically relevant bacteria such as Enterococci sp. and yeasts such as 
Candida sp., are required. 
The 2D electrophoresis of the extractable cellular proteins of Staph. aureus 
demonstrated that there was a general downregulation of protein synthesis in honey 
treated cells in comparison with control, possibly their stress response as well. 
Indicating a possible mechanism of action: by reducing the stress response the honey 
makes the bacteria more vulnerable to antimicrobial agents, which would otherwise 
have been counteracted by the bacterial stress response. The definite identification of 
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some of the downregulated spots on the proteome profile of honey-treated Staph. 
aureus cells would allow a more accurate analysis of the effects of honey upon 
bacterial cells. It would be expected that the differences in proteome profile in Pseud. 
aeruginosa as all the other observations made suring this thesis would indicate a 
different mode of action in the two species. 
It is possible to conclude that there are many areas relating to the use of honey in 
wound management that require further investigation, nevertheless this work has 
attempted to shed some light into some of these. The main conclusion to be drawn 
from this work, is that honey's antimicrobial activity is likely as complex as its own 
composition, and that its activity is due to a combination and synergistic action of 
more than one antimicrobial component, rather than a single substance. Most of all, 
although this is a broad spectrum antimicrobial agent, the mechanisms of antibacterial 
action among Gram positive and negative bacteria are different. Care must be taken in 
its use for medical purposes just as for any other agent, so that it remain a useful 
wound remedy for another 4000 years. 
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8.2 Future work 
The pilot study of the Portuguese honeys demonstrated the potential for medical grade 
honey to exist in Europe. This work needs to be further developed with the collection, 
analysis and characterisation of a bigger number of Portuguese honeys. Also a 
European Network for honey research, where ideas could be shared and a bigger 
volume of samples tested and characterised, would be valuable. 
The development of the results obtained in chapter 4, the production of antimicrobial 
agents by the bacteria present in honey, should include an accurate identification of 
the bacterial strains isolated from the honeys tested, possibly using sequencing or 
other molecular techniques such as RAPD analysis (Chen and Tsen 2002) and also the 
identification of the products that these strains were producing that led to the 
inhibition of the clinical isolates tested, perhaps with the use of chromatography 
techniques (Leifert et al. 1995). 
The EPR and antioxidant potential of honeys should be further investigated not only 
for its potential in wound healing, but also because antioxidants have been shown to 
possess some antimicrobial activity (Alcaraz et al. 2000; Basile et al. 1999; Mori et 
al. 1987; Ng et al. 1996; Sato et al. 2000). Hence the assay of a bigger number of 
honeys for their antioxidant potential and the characterization of the components 
responsible for this activity, with the use of HPLC, GC-MS or LC-mass spectroscopy 
(Inoue et al. 2005) for their identification is possible. 
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Further studies on the kinetics of death of species other than Staph. aureus and Pseud. 
aeruginosa are necessary for the characterisation of honey's antimicrobial activity as 
well as long term studies on the possibility of resistance arising. Furthermore, the 
characterisation antimicrobial activity of manuka honey through the use of electron 
microscopy should include more time points of exposure to honey, different 
concentration of honey and the use of different types of honey to determine if the 
activity observed is characteristic of the action of manuka honey or general to all 
honeys. 
Bigger leakage studies including more molecules such as DNA and potassium ions 
(Johnston et al. 2003) would provide more information about mode of action. A better 
understanding of the intracellular signalling in honey treated cells is also necessary 
and bigger proteome and RNA transcription studies could provide such information. 
A study of the kinetics of RNA and protein synthesis, with the use of radioactive 
isotopes incorporation (Clements and Foster 1998), would also provide valuable 
information for the better understanding of the mechanism of action of honey in 
bacterial cells. More studies on the effect of honey on bacterial proteomes is also 
required, using higher definition image capturing devices, larger IEF strips and a 
wider range of bacteria and times of exposure, in order to better understand the effects 
of honey on protein expression. Further work should also include the utilisation of 
methods such as MALDI-TOF for the identification of specific upregulated or 
downregulated proteins in the proteome profiles obtained with two-dimensional 
electrophoresis. 
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Further investigation into the effects of honey on the stress response of cells should be 
studied with techniques like western blotting which would allow for the collection of 
specific data into the effects of honey upon the expression of specific stress proteins. 
One of the main problem in this case is that commercially available antibodies for use 
in western blots are usually not tested or developed for use with bacterial samples, 
and further work to verufy the usefulness of these products should be considered. 
Finally more in vivo data is required on the action and effectiveness of the action of 
honey on wound management for it to be accepted by the medical community as a 
real alternative to the use of topical antibiotics. 
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